RNA-dependent chromatin association of transcription elongation factors and Pol II CTD kinases by Battaglia, Sofia Luciana
 
Dissertation zur Erlangung des Doktorgrades  
der Fakultät für Chemie und Pharmazie  
der Ludwig-Maximilians-Universität München  
 
 
 
 
 
RNA-dependent chromatin 
association of transcription elongation 
factors and Pol II CTD kinases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sofia Luciana Battaglia 
aus  
San Pedro, Argentinien 
 
 
2017 
 
 2 
  
 3 
 
Erklärung 
Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. 
November 2011 von Herrn Prof. Dr. Patrick Cramer betreut.  
 
 
 
Eidesstattliche Versicherung  
Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet.  
 
München, den 07.04.2017  
 
---------------------------- 
Sofia Battaglia  
 
 
 
 
 
Dissertation eingereicht am 12.04.2017 
 
1. Gutachter: Prof. Dr. Patrick Cramer  
2. Gutachter: PD Dr. Dietmar Martin  
 
Mündliche Prüfung am 29.05.2017 
 
 4 
  
 5 
Acknowledgments 
First of all, I would like to thank my supervisor Professor Patrick Cramer for 
giving me the opportunity to work in his group. He gave me freedom to explore the field, 
but was also present for discussion and troubleshooting any time when needed. I thank 
him for all the support, advice and positivity during the last four years. His trust was 
essential for my development as a scientist. 
I am very thankful to have worked with Michael Lidschreiber, who was an 
amazing collaborator. He is a smart co-worker and a good friend now. He was very calm 
even when the science was not doing what we expected. Finally, we managed to have a 
super nice story! 
I thank Margaux Michel for troubleshooting together during the optimization of 
the ChIP protocol and many other general discussions. I also thank her for her wonderful 
atmosphere. Seychelle Vos helped me with one very important and interesting experiment 
for this thesis. She gave me a lot of smart advices and was always very motivated with 
our work. I also thank Amelie Schreieck for sharing her expertise in several techniques at 
the beginning of my PhD. I also want to give Kerstin Maier a big thank you for constant 
discussions and advise as a desk colleague and an expert in the yeast field. Petra Rus was 
always very nice and gave our little yeast lab the perfect atmosphere to work in a good 
mood. She was also very flexible to help me with experiments when needed. Mark 
Böhning was a perfect join in the lab, we often stayed late discussing about our projects 
and trying to help one another. I thank Carlo Baejen for teaching me the PAR-CLIP 
protocol. Christian Roth was very patient showing me how to deal with sequencing data 
and perform basic analysis myself. In this regard, I also want to thank Johannes Söding 
for discussions about PAR-CLIP data.  
I also would like to specially thank Luis Fonseca, Marc Böhning, Anna Sawicka, 
Kerstin Maier, Michael Lidschreiber and Quinn Klinge for critical reading of parts of this 
thesis. Special thanks to my committee members PD Dr. Dietmar Martin, Professor Peter 
Becker, Professor Andreas Ladurner, Dr. Fabiana Perocchi and Professor Klaus 
Förstemann for their time. And of course a big thanks to all the members of the Cramer 
group. It was an enormous pleasure to work with such a good team. 
I deeply thank Luis Fonseca, my best friend. Without his company and support 
this thesis would have been a lot harder for me. His good mood and positivity were a big 
help for me in difficult times. It was also very productive and fun having science 
discussions with him. 
Many thanks to my dear girl friends for all the great moments together. Spending 
time with them was a way to recharge my energies. I have been very blessed in my life to 
have their love and friendship. I thank my siblings, Alba y Francisco, for being part of my 
family and sharing so many wonderful things in this life. I love laughing with them. 
And my very special thanks go to my parents, Irene and Horacio, that even being 
far away they were always close and supportive any day and any time I needed. I thank 
them for the person who I am today. Gracias. I also thank my lovely Oma. I am sure she 
would be celebrating this moment with me. 
 6 
  
 7 
Summary 
For transcription through chromatin, RNA polymerase (Pol) II associates with 
transcription factors. Recent work revealed that transcription factors also interact with 
the nascent RNA to regulate gene expression. The focus of this thesis relies on the 
characterization of this form of interactions during the process of transcription 
elongation. I used our recently optimized PAR-CLIP protocol to show that many 
elongation factors (EFs) crosslink to RNA emerging from transcribing Pol II in the 
yeast Saccharomyces cerevisiae. These in vivo direct interactions were most notable 
for the kinases Ctk1 and Bur1 that phosphorylate the C-terminal repeat domain (CTD) 
of the largest Pol II subunit and for the histone H3 methyltransferases Set1 and Set2. 
Bioinformatic analysis indicated that most EFs crosslink preferentially to mRNAs, 
rather than to unstable non-coding RNAs, consistent with their recruitment to 
transcribed protein-coding genes. Furthermore, I developed an RNA degradation 
assay to test whether the observed RNA-protein interactions affect protein-chromatin 
binding under native conditions. Comparing protein-chromatin binding in the 
presence and absence of RNA revealed that RNA contributes to chromatin association 
in particular of the CTD serine 2 kinases Ctk1 and Bur1 and the histone H3 
methyltransferases Set1, Set2 and Dot1. Additionally, I confirmed the in vivo 
observed EF-RNA interactions for an active CTDK-I kinase complex in vitro using 
fluorescence anisotropy. Finally, I optimized our ChIP protocol for high-throughput 
sequencing and performed ChIP-Seq experiments of most Pol II EFs and histone 
marks involved in this study. Comparison of factor occupancies on DNA (ChIP-Seq) 
and on RNA (PAR-CLIP) revealed that interactions of EFs with nascent RNA are 
established before EFs are recruited to chromatin. Taken together, these studies argue 
for a role of nascent RNA in EF recruitment. In this model, EF-RNA interactions 
facilitate assembly of the elongation complex on transcribed genes when RNA 
emerges from Pol II, and loss of EF-RNA interactions upon RNA cleavage at the 
polyadenylation site trigger disassembly of the elongation complex. 
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1 Introduction 
Transcription is a fundamental process in living cells and part of the central dogma of 
molecular biology, which states that genetic information encoded in DNA is 
transcribed to RNA, and RNA is translated to protein (Crick 1970, Crick 1958). 
Transcription is the first step in gene expression, and malfunctions within this process 
have devastating pleiotropic effects in all living systems. In humans, for example, 
most tumorigenic processes that lead to different types of cancer are associated with 
defects in transcription machinery (Villard 2004). Therefore, understanding this 
system is of paramount concern for the scientific community. 
1.1 RNA synthesis by RNA polymerases 
Multisubunit DNA-dependent RNA Polymerase enzymes catalyze the transcription of 
DNA into RNA in all kingdoms of life (reviewed in (Thomas and Chiang 2006)). 
RNA polymerases developed early in evolution, and their 5 subunits core structure is 
conserved from bacteria to humans (Ebright 2000), deeply emphasizing the 
importance of this process during evolution and development. Since the year 2000, 
many high-resolution structures of bacterial and eukaryotic RNA polymerases and 
complexes of RNA polymerases with nucleic acid scaffolds or basal transcription 
factors have been obtained, providing insights into the molecular mechanisms that 
govern transcription (Armache, Kettenberger, and Cramer 2003, Armache et al. 2005, 
Bushnell and Kornberg 2003, Bushnell et al. 2004, Cramer, Bushnell, and Kornberg 
2001, Wang et al. 2006, Westover, Bushnell, and Kornberg 2004). More recently, also 
structures of the archaeal RNA polymerase were solved (Hirata, Klein, and Murakami 
2008, Kusser et al. 2008). 
A single RNA polymerase performs prokaryotic transcription. In contrast, 
RNA synthesis in eukaryotic organisms is mainly performed by three distinct RNA 
polymerases (Pol), namely Pol I, Pol II and Pol III in the nucleus of cells (Kusser et 
al. 2008). Pol I transcribes the ribosomal RNA (rRNA) precursor (35S rRNA in yeast; 
45S rRNA in human) (Moss et al. 2007, Venema and Tollervey 1999), and Pol III 
produces short untranslated RNAs such as transfer RNAs (tRNAs) and 5S ribosomal 
RNA (rRNA) (White 2011). Pol II carries out transcription of all protein-coding genes 
Introduction 
 14 
to produce messenger RNAs (mRNAs), as well as several non-coding RNAs, 
including small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and 
cryptic unstable transcripts (CUTs) (Barrandon, Spiluttini, and Bensaude 2008, 
Kusser et al. 2008, Xu et al. 2009). Pol I, Pol II and Pol III consist of a structurally 
conserved 10-subunit core and specific additional subunits located on the periphery 
(Kusser et al. 2008). 
Eukaryotes have an additional, single-subunit RNA polymerase that transcribes 
the mitochondrial genome (mitochondrial RNA polymerase or mitoPol). The mitoPol, 
which is distantly related to the RNA polymerase of the bacteriophage T7, produces 
polycistronic transcripts that are subsequently cleaved to generate individual mRNAs, 
tRNAs and rRNAs (Asin-Cayuela and Gustafsson 2007, Mercer et al. 2011, 
Schwinghammer et al. 2013). Furthermore, two non-essential RNA polymerases have 
been recently identified in plants: Pol IV and Pol V. These polymerases generate non-
coding RNAs with specific functions in RNA-directed DNA methylation and 
transcriptional silencing (Pikaard et al. 2008). 
1.2 The RNA polymerase II transcription cycle 
The transcription cycle consists of three well-defined stages: initiation, elongation and 
termination (Figure 1). During these stages, the 12-sbunit RNA polymerase (Pol) II 
enzyme is highly regulated (Thomas and Chiang 2006). Although all eukaryotic RNA 
Polymerases and the prokaryotic RNA polymerase are homolog to each other, Pol II 
possesses a peculiar C-terminal extension on its largest subunit (Rpb1), referred to as 
the C-terminal domain (CTD) (Hsin and Manley 2012). The CTD is composed of 
tandem heptad repeats that constitutes a unique feature of Pol II and distinguishes it 
from all other polymerases. It is an unstructured domain consisting of 26 (yeast), 42 
(Drosophila) and 52 (mammals) heptapeptide repeats of the consensus sequence: 
tyrosine-serine-proline-threonine-serine-proline-serine (YSPTSPS) (Chapman et al. 
2008). The amino acids in the CTD heptapeptide can be phosphorylated at serines 
(positions 2, 5 and 7: Ser2-P, Ser5-P and Ser7-P), at threonine (position 4: Thr4-P) 
and at tyrosine (position 1: Tyr1-P) (Jeronimo, Bataille, and Robert 2013). 
Furthermore, both prolines (Pro3 and Pro6) can be found in either cis or trans 
conformation (Eick and Geyer 2013). In higher eukaryotes, many of the heptad 
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repeats diverge from the consensus sequence and are acetylated at position 7 on lysine 
(Lys7) (Schroder et al. 2013). These posttranslational modifications in the CTD and 
the CTD in its entirety play a key role in transcription regulation throughout the 
transcription process as described below. 
 
Figure 1 Simplified overview of the Pol II transcription cycle in the yeast Saccharomyces 
cerevisiae. Pre-initiation: Pol II binds to the promoter region (TATA) via general 
transcription factors (GTFs), TATA box binding protein (TBP), and Mediator to form the 
preinitiation complex (PIC). Initiation: Kin28 (a subunit of the general transcription factor 
TFIIH) phosphorylates the C-terminal domain (CTD) of Pol II on Ser5 and Ser7 leading to 
promoter clearance. Early elongation: capping enzymes (CE) and the complex containing the 
transcription elongation factors Spt4 and Spt5 are recruited to Pol II. Elongation: the cap 
binding complex (CBP) binds the capped nascent RNA (red); the kinase complexes CTDK-I 
and BUR further phosphorylate the CTD of Pol II on Ser2 and the C-terminal repeat (CTR) of 
Spt5; the CTD gets partially dephosphorylated at Ser5. Termination: the cleavage and 
polyadenylation factor (CPF) is recruited to the CTD, the RNA is cleaved and polyadenylated 
at its 3' end, followed by degradation of the downstream RNA by Rat1 and release of Pol II 
from the template. Recycling and re-initiation: the CTD is completely dephosphorylated and 
the free polymerase can initiate another round of transcription. For simplicity, all CTD 
phosphorylation sites are depicted in yellow. TSS: transcription start site; pA: 
polyadenylation site. 
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The transcribing DNA is packed in form of chromatin, which enables 
activators and repressors of transcription to access specific regions in a correct 
temporal and spatial manner (reviewed in (Smolle and Workman 2013)). The histone 
units of chromatin are important targets for modifications that act as a recruitment 
platform for proteins involved in the synthesis of mRNAs. Some of the writers of 
active histone modifications are part of this work and will be discussed below. 
1.2.1 Transcription initiation and promoter clearance 
For initiation of eukaryotic gene transcription, general transcription factors (TFII) and 
Pol II assemble in a stepwise manner at promoter DNA to form the preinitiation 
complex (PIC). General transcription factors in eukaryotes include TFIIA, TFIIB, 
TFIID, TFIIE, TFIIF and TFIIH (Hahn 2004). Promoters are sequence specific 
regions on the DNA that are located upstream of a transcribed region. Many Pol II 
promoters contain a TATA element (or TATA box) that is recognized by the TATA 
box-binding protein (TBP), a subunit of TFIID (Davison et al. 1983, Nakajima, 
Horikoshi, and Roeder 1988, Parker and Topol 1984, Pelham 1982). In multicellular 
organisms, cis-regulatory DNA regions called enhancers act in gene activation. 
Enhancers increase transcription independently of their orientation, position and 
distance to a promoter (Banerji, Rusconi, and Schaffner 1981). Enhancers are 
prevalently found in higher eukaryotes and are beyond the scope of this thesis (for a 
detailed review see: (Andersson et al. 2014, Li, Notani, and Rosenfeld 2016)). 
The PIC comprises closed, double-stranded promoter DNA that is first 
unwound by the ATPase/helicase subunit of TFIIH (Ssl2 in yeast; XBP in human) to 
form an open complex enabling transcription to take place (Fishburn, Galburt, and 
Hahn 2016). In the catalytically active open complex, a single-stranded DNA 
“transcription bubble” is formed from −9 to −2 position relative to the transcription 
start site (TSS) (Holstege, Fiedler, and Timmers 1997, Wang, Carey, and Gralla 
1992). Transcription begins at the +1 position on the TSS with the formation of the 
first phosphodiester bond. At this stage, transcription often last only up to the +8/+10 
position resulting in the production and release of numerous abortive short RNAs 
(Holstege, Fiedler, and Timmers 1997). Stability in the synthesis of the transcript is 
obtained when Pol II reaches the +9 position (Margaritis and Holstege 2008). General 
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transcription factors dissociate from Pol II, and elongation factors (EFs) are recruited 
(Orphanides and Reinberg 2000, 2002, Pokholok, Hannett, and Young 2002). Pol II 
escapes the abortive cycle of RNA synthesis and is capable of productive RNA 
synthesis. This transition of Pol II from an initiation complex to an elongation 
complex is known as “promoter clearance” or “promoter escape” (Luse 2013, Pal, 
Ponticelli, and Luse 2005). 
1.2.2 Transcription elongation 
For promoter clearance and productive mRNA elongation, the kinase subunit of the 
multisubunit factor TFIIH (Kin28 in yeast; CDK7 in human) phosphorylates the CTD 
at Ser5 and Ser7 positions leading to the recruitment of RNA 5′ capping enzymes 
(Hsin and Manley 2012, McCracken et al. 1997). It is worth mentioning that the 
Mediator complex, a transcriptional coactivator, stimulates the kinase activity of 
TFIIH (Plaschka et al. 2015, Sogaard and Svejstrup 2007). Capping enzymes (Cet1, 
Ceg1, and Abd1 in yeast) catalyze the formation of a 7-methyl-guanosine (m7G) cap 
on the 5′ end of the growing mRNA (Wei and Moss 1977, Wei and Moss 1975). The 5′ 
cap prevents degradation of the RNA by 5′ exonucleases and promotes translation 
during protein synthesis (Schwer, Mao, and Shuman 1998, Sonenberg and 
Hinnebusch 2009). It also associates with the cap-binding complex (CBC), which 
functions in pre-mRNA splicing and mRNA export (Lewis and Izaurralde 1997, 
Schwer and Shuman 1996). 
During the past decade, genome-wide sequencing studies have detected high 
occupancy levels of Pol II during early steps of elongation (Adelman and Lis 2012, 
Kwak et al. 2013, Rahl et al. 2010). This phenomenon, primarily observed in 
Drosophila and humans, is currently subject of intensive research and refers to the 
promoter-proximal pausing of Pol II. Pol II pauses 30–60 nucleotides downstream of 
the TSS and is released via phosphorylation of negative elongation factor (NELF) and 
DRB-sensitivity-inducing factor (DISF) by the CDK9 kinase subunit of positive 
transcription elongation factor-b (P-TEFb) (Nechaev and Adelman 2011, Peterlin and 
Price 2006, Zhou, Li, and Price 2012). Several studies showed that pausing and 
release of Pol II at promoter-proximal regions is a key step in transcription regulation 
(reviewed in (Jonkers and Lis 2015)). CDK9 (yeast Bur1) also phosphorylates the 
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CTD of Pol II at Ser2 position (Marshall et al. 1996, Ramanathan et al. 2001) and 
triggers productive elongation (Cheng and Price 2007, Marshall and Price 1995, Ni et 
al. 2008). Phosphorylation of Pol II CTD on the Ser2 position by Bur1 (human 
CDK9) and Ctk1 (human CDK12) helps to recruit factors important for transcription 
elongation, termination and pre-mRNA splicing as well as histone modifiers and 
remodelers (Bartkowiak et al. 2010, Henikoff 2008, Smolle and Workman 2013). 
During transcription elongation, the spliceosome is recruited to the splice sites 
of transcripts containing introns. Intron sequences of pre-mRNAs are removed before 
transcripts are exported to the cytoplasm and translated into proteins. The splicing 
machinery can either catalyze the splicing reactions during transcription (co-
transcriptional splicing) or immediately after transcription termination (Carrillo 
Oesterreich et al. 2016). Despite the fact that the S. cerevisiae genome only contains 
about 4% of genes with introns, they represent an important aspect of gene expression 
(Qin et al. 2016). 
1.2.3 Transcription termination and re-initiation 
At the end of genes, Pol II discontinues elongation of the RNA product and releases 
the DNA template, entering the transcription termination process. Termination 
involves endonucleolytic cleavage of the nascent RNA followed by synthesis of a 
poly-A tail on the new 3' end of the cleaved product by the poly-A polymerase Pap1 
(Baejen et al. 2017, Richard and Manley 2009). 
The release of DNA and mRNA at the end of transcripts requires an exchange 
of Pol II associating factors. When Pol II transcribes over the polyadenylation (pA) 
site –which marks the end of protein-coding genes– the nascent RNA displays the pA 
sequence. This signal then leads to the recruitment of the protein machinery for pre-
mRNA cleavage and polyadenylation (CPF and CF complexes), formally promoting 
the termination of transcription (Keller and Minvielle-Sebastia 1997, Manley and 
Takagaki 1996, Mischo and Proudfoot 2013, Porrua and Libri 2015, Proudfoot 2011). 
Proteins involved in these processes are recruited through binding to the 
phosphorylated CTD of Pol II at Ser2 position (Komarnitsky, Cho, and Buratowski 
2000, Mayer, Heidemann, et al. 2012, Meinhart and Cramer 2004), or to the C-
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terminal region (CTR) of the Pol II-associated general elongation factor Spt5 (Mayer, 
Schreieck, et al. 2012). 
After assembly of the 3'-processing machinery, the RNA is cleaved and the 
resulting RNA 3'-end is poly-adenylated to complete the mRNA transcript. The new 
5'-end of the nascent RNA is unprotected and prone to degradation by the 
exonuclease Rat1/XRN2 (yeast/human). The exonuclease degrades nascent RNA to 
chase the transcribing polymerase and promote its release from DNA and RNA 
(Connelly and Manley 1988, Proudfoot 1989). This termination mechanism is now 
commonly referred to as ‘torpedo’ termination because the exonuclease acts like a 
torpedo to dismantle the Pol II elongation complex (Baejen et al. 2017, Luo and 
Bentley 2004). 
Despite extensive research, it is not clear where in the yeast genome 
termination occurs and whether Pol II termination at protein-coding genes is generally 
achieved by the torpedo mechanism. In one of our recent studies, we used various 
functional genomics techniques that allowed to distinguish Pol II termination from 
RNA degradation downstream of the pA site, and to provide evidence that Rat1 is 
generally required for Pol II termination at the end of protein-coding genes (Baejen et 
al. 2017). 
Finally, remaining of a subset of general transcription factors and the Mediator 
complex at promoters facilitates transcription re-initiation of genes and following 
rounds of Pol II transcription (Yudkovsky, Ranish, and Hahn 2000). Additionally, the 
formation of gene loops brings the promoter and the 3' end of genes in physical 
proximity and helps re-initiation (Hampsey et al. 2011). 
1.3 Regulation of transcription during elongation 
For productive transcription through chromatin, RNA polymerase (Pol) II associates 
with general elongation factors (EFs) (Perales and Bentley 2009, Shilatifard 2004, 
Shilatifard, Conaway, and Conaway 2003, Sims, Belotserkovskaya, and Reinberg 
2004) that are recruited to the body of transcribed genes in yeast (Mayer et al. 2010). 
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1.3.1 Elongation factors in Saccharomyces cerevisiae 
EFs in the yeast Saccharomyces cerevisiae include Spt5 (a subunit of human DSIF), 
the histone chaperone Spt6, and the Paf1 complex (Paf1C). The Pol II CTD kinases 
Bur1 (human CDK9) and Ctk1 (human CDK12), and their cyclin partners Bur2 and 
Ctk2, respectively, can also be classified as EFs. In addition, the histone 
methyltransferases Set1 (a subunit of the COMPASS complex), Set2, and Dot1, are 
recruited to elongating Pol II to set the ‘active’ histone marks H3K4me3, H3K36me3, 
and H3K79me3, respectively. A simplified schematic representation of the active 
transcription elongation phase is illustrated in Figure 2. 
 
Figure 2 Schematic representation of transcribing Pol II and its interaction with 
transcription elongation factors (EFs). Spt5 (brown) binds the body of Pol II and its 
phosphorylated C terminal repeat (CTR) recruits the five subunit Paf1 complex (Paf1C; 
purple). Paf1C facilitates ubiquitination of histone H2B on Lys123 by the monoubiquitinase 
complex Rad6/Bre1 (not shown). The three and two subunit kinase complexes CTDK-I (light 
green) and BUR (dark green), respectively, phosphorylate the Ser5 pre-phosphorylated CTD 
of Pol II on Ser2. The three histone methyltransferases Set1, Set2 and Dot1 that set the 
‘active’ histone marks H3K4me3, H3K36me3, and H3K79me3, respectively, are depicted in 
beige. Nascent pre-mRNA: red; nucleosome units: light gray; chromatin: dark gray. TSS: 
transcription start site; pA: polyadenylation site. 
 
The transcription elongation factor Spt5 is a subunit of the heterodimeric 
complex Spt4-Spt5 and functions as part of the stable Pol II elongation machinery 
mediating interactions between Pol II and other proteins (Hartzog and Fu 2013). Spt5 
is conserved in all domains of life; however, eukaryotic Spt5 contains an unstructured 
region at its C terminus (the C-terminal repeated region [CTR]), which comprises a 
set of short repeats whose consensus motifs vary across species. The CTR is subject 
to phosphorylation and participates in Spt5’s mediation of nuclear activities, such as 
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recruitment of additional elongation factors, as shown for the Paf1 complex ((Qiu et 
al. 2006); Figure 2). 
The Paf1 (Pol II-associated factor 1) complex (Paf1C) is composed of five 
subunits in yeast, namely Cdc73, Ctr9, Leo1, Paf1 and Rtf1. Paf1C has a direct role in 
transcription elongation consistent with accumulation of Paf1 over the transcribed 
region of genes revealed by chromatin immunoprecipitation (ChIP; (Mayer et al. 
2010)). Recently, Paf1C has been shown to have a regulatory function determining 
differential transcript fate at selected genes (Fischl et al. 2017). It is also required for 
deposition of ubiquitin on Lys123 of histone H2B (H2Bub) by the Rad/Bre1 E2/E3 
ubiquitin ligase complex (Robzyk, Recht, and Osley 2000, Wood et al. 2003) that in 
turn facilitates recruitment of nuclear-cytoplasmic export factors (Tuck and Tollervey 
2013). Furthermore, H2Bub enables recruitment of the Set1/COMPASS complex that 
methylates histone 3 at Lys4 (H3K4), a hallmark of active promoters and the 5' end of 
ORFs that correlates well with increased levels of gene expression (Pokholok et al. 
2005). Methylation of H3K4 is a highly conserved pathway in eukaryotes, though, in 
yeast, the Set1 complex is the only H3K4 methyltransferase, whereas methylation of 
H3K4 in Drosophila is carried out by three methyltransferase complexes and in 
mammals by at least six such complexes (Smolle and Workman 2013). Dot1 mediates 
the methylation of H3K79, which also requires prior ubiquitination of histone H2B 
and it has been linked to transcription elongation (Nguyen and Zhang 2011).  
The essential kinase Bur1 and its associated cyclin Bur2 form the BUR kinase 
complex that phosphorytes the CTR of Spt5 and the CTD of Pol II at Ser2 position 
(Liu et al. 2009, Murray et al. 2001). The Pol II CTD is further phosphorylated on 
Ser2 by the CTDK-I kinase complex (Bartkowiak et al. 2010). CTDK-I contains the 
cyclin-dependent kinase Ctk1, the cyclin Ctk2, and the yeast-specific subunit Ctk3, 
which is required for CTDK-I stability and activity (Muhlbacher et al. 2015). Pol II 
CTD phosphorylation on Ser2 by Ctk1 and Bur1 promotes recruitment of the Set2 
methyltransferase catalyzing mono-, di- and trimethylation of H3K36 (Krogan, Kim, 
et al. 2003, Li et al. 2003, Li, Moazed, and Gygi 2002, Youdell et al. 2008). This 
methylation mark leads to recruitment of the Rpd3s histone deacetylase complex, a 
key step in preventing cryptic transcription initiation within open reading frames 
(Carrozza, Li, et al. 2005). Phosphorylated Ser2 CTD also leads to the recruitment of 
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Spt6, an essential histone chaperone and remodeler of chromatin in eukaryotes 
(Bortvin and Winston 1996, Youdell et al. 2008). Besides recruiting RNA processing 
factors to Pol II, Spt6 is required to establish a repressive chromatin environment that 
prevents initiation of long non-coding RNAs (lncRNAs) within coding regions (Ard 
and Allshire 2016). 
1.3.2 Elongation factor recruitment 
Despite extensive research, it remains unclear for several EFs how they are recruited 
to active genes. EFs may be recruited by interactions with the body of transcribing 
Pol II, or by contacts with the tail-like CTD of Pol II, or they may bind via other 
Pol II-associated EFs. Spt5 binds the body of the Pol II elongation complex 
(Grohmann et al. 2011, Klein et al. 2011, Martinez-Rucobo et al. 2011), whereas 
Bur1, Spt6 and Set2 bind the CTD (Dengl et al. 2009, Kizer et al. 2005, Li et al. 2003, 
Phatnani, Jones, and Greenleaf 2004, Sun et al. 2010, Yoh et al. 2007, Qiu, Hu, and 
Hinnebusch 2009, Li, Moazed, and Gygi 2002). Interaction of Paf1C with Pol II 
involves Spt5 (Liu et al. 2009, Mayekar, Gardner, and Arndt 2013, Wier et al. 2013, 
Zhou et al. 2009, Qiu et al. 2012, Qiu, Hu, and Hinnebusch 2009) and the CTD (Qiu 
et al. 2012), whereas interaction of Set1 with Pol II involves Paf1C (Krogan, Dover, 
et al. 2003, Ng et al. 2003). 
However, it is likely that other recruitment mechanisms exist because 
mutations in EFs that prevent their interactions with Pol II do not abolish gene 
occupancy of such factors, including Bur1, Paf1C subunits, Spt6, and Set2 (Ng et al. 
2003, Qiu et al. 2012, Qiu, Hu, and Hinnebusch 2009, Mayer et al. 2010, Zhou et al. 
2009, Krogan, Kim, et al. 2003). Further, it remains unknown how the yeast CTD 
serine 2 (Ser2) kinase Ctk1 is recruited, which is apparently a prerequisite for 
recruitment of Spt6 and Set2, since these factors bind the Ser2-phosphorylated CTD 
(Dengl et al. 2009, Kizer et al. 2005, Li et al. 2003, Phatnani, Jones, and Greenleaf 
2004, Sun et al. 2010, Yoh et al. 2007). More generally, it is unknown whether and 
how EFs can distinguish transcribing Pol II from free or initiating polymerase based 
on polymerase interactions alone, in particular at an early stage of elongation when 
Ser2 phosphorylation is absent. 
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An alternative mechanism of EF recruitment would involve interactions with 
the nascent pre-mRNA. Such RNA interactions are well established for RNA 
processing factors that are recruited during Pol II elongation (Perales and Bentley 
2009, Bentley 2005, Baejen et al. 2014, Tuck and Tollervey 2013) for co-
transcriptional capping (Martinez-Rucobo et al. 2015), splicing (Bentley 2005, Saldi 
et al. 2016), and 3′-processing (Proudfoot 2011, Shi and Manley 2015) of the pre-
mRNA. Some observations indeed suggest that nascent RNA contributes to the 
recruitment of EFs to Pol II. Spt5 and Set1 bind RNA in vitro (Meyer et al. 2015, 
Missra and Gilmour 2010, Tresaugues et al. 2006, Halbach et al. 2009), Ctk1 and 
Bur1 in vivo occupancy at active genes depends on the cap-binding complex, which 
binds 5′-capped RNA (Hossain et al. 2013, Lidschreiber, Leike, and Cramer 2013), 
and Paf1C binds RNA, which is required for full gene occupancy (Dermody and 
Buratowski 2010). 
1.4 Nascent RNA as a transcription regulator 
The movement of Pol II along genes is a key mechanism for the control of gene 
expression regulated by proteins that bind to DNA, nucleosomes and Pol II itself. 
That nascent non-coding RNA can also regulate transcription and chromatin function 
was first demonstrated for the transactivation response element (TAR; reviewed in 
(Peterlin and Price 2006)). TAR is an RNA stem-loop formed at the 5′ end of nascent 
HIV transcripts that recruits the viral protein transactivator of transcription (Tat) and 
the positive transcription elongation factor b (P-TEFb; (Wei et al. 1998, Zhu et al. 
1997)).  
A rapidly accumulating wealth of studies are identifying and functionally 
characterizing diverse types of non-coding RNAs that directly bind to regulatory 
proteins and modulate their recruitment to genes. These ncRNAs, including lncRNAs 
and enhancer RNAs (eRNAs), contribute to gene regulation in either their nascent or 
mature forms (reviewed in (Skalska et al. 2017)). However, recent studies revealed 
that also nascent pre-mRNAs directly interact with activators and repressors of 
transcription during initiation, elongation, termination and RNA processing (Beltran 
et al. 2016, Di Ruscio et al. 2013). For instance, for co-transcriptional splicing, splice-
site sequences in the nascent pre-mRNA recruit the splicesome, and Pol II pauses at 
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these sequences, thereby enhancing splicing fidelity (Alexander et al. 2010). In higher 
eukaryotes, the polycomb repressive complex 2 (PRC2) methylates H3K27 to 
maintain gene repression during development. In vivo sequencing methods 
demonstrated that PRC2 directly interact with several nascent pre-mRNAs, and RNA 
degradation experiments revealed that loss of RNA leads to increased interactions of 
PRC2 with chromatin at active genes (Beltran et al. 2016, Davidovich et al. 2013, 
Kaneko et al. 2014, Kaneko et al. 2013, Zhao et al. 2010). Thus, indicating a role for 
nascent RNA in preventing PRC2 association with chromatin at transcriptionally 
active genes (reviewed in (Skalska et al. 2017)). 
Nascent pre-mRNAs can also interact with activators of transcription. The 
WD repeat-containing 5 (WDR5) protein, a subunit of the mammal Set1/COMPASS 
complex, was originally shown to bind lncRNAs and recently revealed to also 
associate with pre-mRNAs and mRNAs (Hendrickson et al. 2016, Wang et al. 2011, 
Yang et al. 2014). The interaction of WDR5 with these RNAs positively correlates 
with di- and trimethylation levels of H3K4 (H3K4me2 and H3K4me3) in cis 
(Hendrickson et al. 2016). Thus, suggesting that nascent pre-mRNA can form a 
positive feedback loop that promotes gene expression. 
Similarly, the human transcription factor yin and yang 1 (YY1) was first found 
to bind to the mature lncRNA XIST (Jeon and Lee 2011) and recent crosslinking and 
immunoprecipitation (CLIP) data detected that YY1 also interacts with nascent pre-
mRNA and nascent eRNA (Sigova et al. 2015). Interestingly, YY1 binding to 
chromatin was largely decreased when cells were treated with RNase, and binding to 
chromatin increased when RNA was tethered to DNA (Sigova et al. 2015). This data 
supports a model where nascent RNA functions to recruit and maintain transcription 
factors near the DNA. 
1.5 In vivo methods for detection of RNA-protein interactions 
It is likely that nascent RNAs conduct their regulatory functions in the form of RNA-
protein complexes. Therefore, techniques to study RNA-protein interactions are 
essential to further uncover the mechanisms governing biological processes, such as 
transcription, chromatin remodeling and splicing. Proteins interact with RNA in a 
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similar manner as with DNA. In both cases, electrostatic and hydrophobic 
interactions, hydrogen bonding, and base stacking are the driving forces that govern 
this complex association. During the last decade, the role of RNA in biological 
processes has been recognized as an area of deep interest, and a variety of methods to 
study protein-RNA interactions have been –and continue to be– developed. The most 
relevant and latest reported methods for identifying RNA-protein interactions in vivo 
consist of a combination of genetic, biochemical and computational approaches.  
1.5.1 RIP methods 
RNA immunoprecipitation (RIP) is used to detect the interaction between individual 
proteins and specific RNA molecules in vivo (Gilbert and Svejstrup 2006, Keene, 
Komisarow, and Friedersdorf 2006). Following immunoprecipitation of the protein of 
interest, co-precipitated RNAs are isolated and quantitated by qRT-PCR. The basic 
mechanisms of RIP are very similar to ChIP. RIP-Chip and RIP-Seq combine RIP 
with microarray profiling of RNAs and high-throughput sequencing, respectively 
(Jain et al. 2011, Zhao et al. 2010). These techniques have been used to find 
interactions between one specific protein and RNAs at transcriptome level. RIP 
methods, however, are limited to the characterization of kinetically stable interactions 
and are prone to detecting nonspecific interactions (Hendrickson et al. 2016, Mili and 
Steitz 2004). Recently, an improved formaldehyde crosslinking RNA 
immunoprecipitation technique followed by deep sequencing (fRIP-Seq) was used to 
detect RNA interactions of several proteins containing RNA binding domains, but 
also proteins that lack classically defined RNA binding domains (Hendrickson et al. 
2016). fRIP-Seq uses lower formaldehyde concentrations than ChIP and RIP methods 
and requires smaller amounts of input RNA than CLIP methods. However, similar to 
ChIP and RIP, it can lead to detection of indirect interactions between proteins and 
nucleic acids. 
1.5.2 CLIP methods 
Crosslinking and immunoprecipitation (CLIP) combines ultraviolet light (UV)-
crosslinking with immunoprecipitation of a specific protein followed by the isolation 
of crosslinked RNA segments and cDNA sequencing (Ule et al. 2003). Here, UV 
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irradiation of cells or tissues at the wavelength of 254 nm generates covalent bonds 
between RNA and protein when they are in close contact. In the original CLIP 
protocol, amplified cDNAs are subjected to Sanger sequencing and the resulting 
sequences mapped to the reference genome to reveal protein-binding sites within the 
corresponding transcripts. The combination of CLIP with high-throughput sequencing 
(HITS-CLIP or CLIP–Seq) is used now for transcriptome-wide studies (Licatalosi et 
al. 2008).  
The binding site resolution of traditional CLIP corresponds to the length of the 
fragmented RNAs. Recent methods allow now single-nucleotide resolution of RNA-
binding proteins. Individual nucleotide resolution CLIP (iCLIP) makes use of the 
covalently bound polypeptide fragment at the cross-link site on the RNA (Konig et al. 
2010). During reverse transcription, the reverse transcriptase enzyme produces 
truncated cDNAs that are used for the identification of binding sites genome-wide at 
nucleotide resolution. 
Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immuno-
precipitation (PAR-CLIP) is an improved method that also allows direct identification 
of RNA-binding proteins transcriptome-wide at single-nucleotide resolution (Hafner 
et al. 2010). However, PAR-CLIP uses photoreactive ribonucleoside analogs, such as 
4-thiouridine (4sU), that are readily taken up by cells and become incorporated into 
U-containing regions of newly synthesized transcripts (Schwalb et al. 2016). 
Additionally, PAR-CLIP involves crosslinking with 365 nm UV light (instead of 254 
nm) to establish covalent crosslinks between aromatic amino acids of the protein of 
interest and the thio group of 4sU. During reverse transcription, reverse transcriptase 
reads through the crosslink site and mistakenly incorporates a guanosine (G) instead 
of an adenosine (A), which allows to precisely identify binding sites by scoring for 
thymidine (T) to cytidine (C) transitions in the sequenced cDNA (Hafner et al. 2010). 
Due to the use of photoreactive nucleoside analogs and a longer wavelength, PAR-
CLIP induces specific crosslinks between labeled RNAs and interacting proteins, thus 
allowing detection of direct RNA–protein interactions and reducing the amount of 
false positive results. 
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1.6 Aims and scope of this thesis 
Several recent studies revealed that proteins known to interact with transcribing 
chromatin and regulate gene expression also interact with the nascent RNA (see 
section 1.4). Furthermore, in most of the reports this interaction was shown to have 
either a positive or a negative effect on gene transcription (reviewed in (Skalska et al. 
2017)), suggesting a model in which RNA, together with the chromatin structure and 
proteins, is a main player in regulating the highly conserved process of transcription. 
The aims of this study focus on the characterization of RNA-protein 
interactions during transcription elongation and their possible roles in gene 
expression. We took advantage of the powerful technique PAR-CLIP, to investigate 
interactions between EFs in the yeast S. cerevisisae and the nascent transcribed RNA 
in vivo (Figure 3). Based on our results, we further aimed to analyze if binding 
preferences can differ for coding RNAs and for non-coding (nc) RNAs, such as 
CUTs. Moreover, we aimed to investigate whether these RNA-protein interactions 
have an implication on the protein-DNA interactions. To answer this question, we 
established RNA degradation assays to compare protein-chromatin binding in the 
presence and absence of RNA. 
 
Figure 3 Representation of EFs interaction with transcribed chromatin and nascent RNA 
during Pol II transcription. The nascent RNA could have a role in establishing and also 
maintaining EF-chromatin interaction. 
 
Another aim during this work was to investigate whether the in vivo observed 
interactions are also detectable in vitro. In order to do so, we tested one prominent EF, 
the CTDK-I kinase complex, for RNA binding in vitro. We established a protocol to 
purify recombinant CTDK-I containing all three subunits and performed activity 
assays to test the kinase activity of the purified complex. Finally, we used 
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fluorescence anisotropy to test whether the CTD Ser2 kinase complex binds RNA in 
vitro.  
To further study recruitment mechanisms of EFs, we compared factor 
occupancies on DNA and on RNA. Our laboratory and others have previously 
obtained genome-wide occupancy profiles for EFs by chromatin immunoprecipitation 
followed by tiling microarray analysis (ChIP-chip; (Liu et al. 2005, Mayer et al. 2010, 
Ng et al. 2003, Pokholok et al. 2005, Weiner et al. 2015)). However, this data is not 
sufficiently suitable for comparison with our high-resolution genome-wide PAR-
CLIP data. In this regard, we established and performed ChIP-Seq experiments of 
most S. cerevisiae Pol II EFs and histone marks involved in this study. With both 
PAR-CLIP and ChIP-Seq data sets, we can now directly compare when specific 
transcription factors are recruited to RNA and when to DNA.  
 Based on our results, we were able to suggest a model where nascent RNA 
actively participates in the assembly and stability of the Pol II elongation complex. 
RNA-EF interactions provide a missing link for understanding the coordination and 
fine-tuning of the transcription cycle. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Bacterial and yeast strains 
Table 1 Bacterial strains. 
Strain Genotype Source 
XL1-Blue recA1; endA1; gyrA96; thi-1; hsdR17; supE44; relA1; lac[F´ proAB lacIqZ∆M15 Tn10(Tetr)] 
Stratagene 
BL21(DE3)pLysS B; F
–; ompT; hsdSB(rB–, mB–); dcm; gal; λ(DE3); pLysS; 
CmR 
Stratagene 
 
Table 2 Yeast strains. 
Strain Genotype Source 
BY4741 (wild-type) MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 Euroscarf 
Bur1-TAP BY4741; BUR1-TAP::HIS3MX6 Euroscarf 
Bur2-TAP BY4741; BUR2-TAP::HIS3MX6 Euroscarf 
Cdc73-TAP BY4741; CDC73-TAP::HIS3MX6 Euroscarf 
Ctk1-TAP BY4741; CTK1-TAP::HIS3MX6 Euroscarf 
Ctk2-TAP BY4741; CTK2-TAP::HIS3MX6 Euroscarf 
Ctr9-TAP BY4741; CTR9-TAP::HIS3MX6 Euroscarf 
Paf1-TAP BY4741; PAF1-TAP::HIS3MX6 Euroscarf 
Rpb1-TAP BY4741; RPB1-TAP::HIS3MX6 Euroscarf 
Rpb3-TAP BY4741; RPB3-TAP::HIS3MX6 Euroscarf 
Rtf1-TAP BY4741; RTF1-TAP::HIS3MX6 Euroscarf 
Spt5-TAP BY4741; SPT5-TAP::HIS3MX6 Euroscarf 
Spt6-TAP BY4741; SPT6-TAP::HIS3MX6 Euroscarf 
TFIIB-TAP BY4741; TFFIIB-TAP::HIS3MX6 Euroscarf 
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2.1.2 Cell lines 
Table 3 Cell lines used for expression of recombinant CTDK-I (2.2.7.2). 
Cell line Description 
DH10EMBacY 
Modified Autographa californica multicapsid nucleopolyhedrovirus 
(AcMNPV) genome as Bacmid; helper plasmid for Tn7 transposon 
enzyme; YFP reporter gene in virus backbone; LacZ for blue-white 
screening. 
High five (Hi5) Insect cell line used for expression of recombinant proteins; Trichoplusia ni embryonic tissue. 
Sf9 Insect cell line used for isolation and propagation of recombinant baculoviral stocks; Spodoptera frugiperda ovarian tissue. 
Sf21 Insect cell line used for isolation and propagation of recombinant baculoviral stocks; Spodoptera frugiperda ovarian tissue. 
2.1.3 Growth media and media additives 
Table 4 Growth media. 
Name Description/source Species/cell line 
LB 1% (w/v) tryptone; 0.5% (w/v) yeast extract; 0.5% (w/v) NaCl; (+1.5% (w/v) agar for solid media plates)  E. coli 
YPD 2% (w/v) peptone; 2% (w/v) glucose; 1.5% (w/v) yeast extract (+1.8% (w/v) agar for solid media plates)  S. cerevisiae 
Minimal 
medium 
6.9 g/L yeast nitrogen base; 2% (w/v) glucose; 0.4 g/L CSM 
drop-out: complete; 0.4 g/L CSM drop-out: -URA S. cerevisiae 
Sf-900 III 
SFM Growth and maintenance medium/ThermoFisher Sf9 cells 
ESF921 
medium Expression medium/Expression Technologies 
Hi5 and Sf21 
cells 
 
Table 5 Growth media additives. 
Name Description Working concentration 
Ampicillin (Amp) Antibiotic 100 µg/mL 
4-thiouracil (4tU) Metabolic labeling of nascent RNAs  1 mM 
X-tremeGENE9 Transfection reagent - 
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2.1.4 Oligonucleotide sequences 
Table 6 Primers used for CTDK-I cloning (2.2.7.1). Lowercase sequences: overhangs for 
homologous recombination with the desired vector.  
Name Sequence (5'-3') 
Ctk1_438-A fwd tacttccaatccaatcgATGTCCTACAATAATGGCAATACTTATTCAAAGAGTTATAGC 
Ctk1_438-A rev ttatccacttccaatgttattaTTTATCATCATCGTCATTATTATTATTATTATTATTATTACTATTACCATTACCCTTATTG 
Ctk2_438-C fwd tacttccaatccaatgcaCCTAGCACGTTTGAATCCCAGC 
Ctk2_438-C rev ttatccacttccaatgttattaTGCATGTCTTGTAGAACTATTTATGCTGGAC 
Ctk3_438-A fwd tacttccaatccaatcgATGGACTCTCTTGAAGCTAGATTACAATTCATTC 
Ctk3_438-A rev ttatccacttccaatgttattaATATATGTAAGATGCCTTCGCAATGTCATTTAAAGC 
 
Table 7 Adapters, primers and barcodes used for PAR-CLIP (2.2.4.1).  
Name Sequence (5'-3') 
3'-adapter /5rApp/TGGAATTCTCGGGTGCCAAGG/3ddC/ 
5'-adapter /5InvddT/rGrUrUrCrArGrArGrUrUrCrUrArCrArGrUrCrCrGrArCrGrArUrCrNrNrNrNrN 
RT primer  CCTTGGCACCCGAGAATTCCA 
NEXTflex 
barcode primer 
(fwd): 
CAAGCAGAAGACGGCATACGAGA-Barcode-GTGACTGGAGTTC
CTTGGCACCCGAGAATTCCA 
Barcode 1 TCGTGAT 
Barcode 2 TACATCG 
Barcode 3 TGCCTAA 
Barcode 4 TTGGTCA 
Universal primer 
(rev) 
AATGATACGGCGACCACCGAGATCTACACGTTCAGAGTTCTAC
AGTCCGA 
Nextera primer 1 AATGATACGGCGACCACCGA 
Nextera primer 2 CAAGCAGAAGACGGCATACGA 
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Table 8 Primers used for ChIP-qPCR (2.2.5.2). 
Gene Sequence (5'-3') fwd primer Sequence (5'-3') rev primer Binding site 
ADH1 CTACGAATCCCACGGTAAGT ACAATTCGTTGGCCTTTG 5'-end 
ADH1 AGCCGCTCACATTCCTCAAG ACGGTGATACCAGCACACAAGA ORF 
ADH1 ACCTTGCCAGAAATTTACGA CAACAACGTATCTACCAACGA 3'-end 
ALD5 AAAAGCCAAAGAAGAAGAAATGC GAATATTCTGGAATTCGGAGCTG 5'-end 
ALD5 CTTTTCGCTTCCCAGTTGTG GGAACCCGGAAGGATATTGA ORF 
ALD5 CCCGAGTTGACTGCTCATTG TGTCACGAGGCATTTTTCATT pA site 
ILV5 ACCCAGTATTTTCCCTTTCC TTGTCTATATGTTTTTGTCTTGC Prom. 
ILV5 CTATCAAGCCATTGTTGACC CTTGAAGACTGGGGAGAAAC ORF 
ILV5 ACACCATCAGAAACATGGAA TGGTTTTCTGGTCTCAACTTT 3'-end 
MUP1 AGCAATGTCGGAAGGAAGAA TGATAGTTCTCCTTGTTGAAGACA 5'-end 
MUP1 AGGACGTGAAGGTGTGTTGC TTGGGGAGTTGAATGGCTTA ORF 
MUP1 TTTAAGATGCTATTCCGTTTCG TTGATTTCGCGCAATAGTAGG pA site 
PDC1 TGTTCGAAAGATTAAAGCAAGTCA TTGAAGTCACCTGGCAAACC 5'-end 
PDC1 CACTTTCCCAGGTGTCCAAA CTTAGCGGCGTCAGCAATAG ORF 
PDC1 GTTGCCAGTCTTCGATGCTC AGCGTTGGTAGCAGCAGTCA 3'-end 
PMA1 TGACTGATACATCATCCTCTT TTGGCTGATGAGCTGAAACAGAA 5'-end 
PMA1 GGGTTCCGTGCTTTAGGTGT CACCCAAGATTTCCCAGTGA ORF 
PMA1 TTGATGAACGGTAAGCCAATG GCAGCCATGAAGTCTTCGAC 3'-end 
YER TGCGTACAAAAAGTGTCAAGAGATT ATGCGCAAGAAGGTGCCTAT Chr5 
YER: Heterochromatic region on chromosome V.   
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Table 9 5'-FAM labeled ssRNA, ssDNA and dsDNA sequences used for fluorescence 
anisotropy experiments (2.2.9). 
Name Sequence (5'-3') 
ssRNA, 24% GC, A-rich /56-FAM/rArArUrArUrUrCrArArGrArCrGrArUrUrUrArGrArCrGrArUrArArUrArUrCrArUrA 
ssRNA, 24% GC, U-rich /56-FAM/rArUrGrUrUrGrUrArUrGrArUrArUrCrUrUrGrCrUrArArCrUrUrArArUrUrUrGrArU 
ssRNA, 45% GC, A-rich /56-FAM/rArArGrCrArGrCrCrArArArCrArArGrCrArGrUrCrArArCrArUrCrArArGrUrCrGrU 
ssRNA, 45% GC, U-rich /56-FAM/rUrUrCrGrUrCrGrGrUrUrUrGrUrGrCrGrUrCrArGrUrUrGrUrArGrUrUrCrArUrCrA 
dsDNA, 45% GC, A-rich /56-FAM/AAGCAGCCAAACAAGCAGTCAACATCAAGTCGT 
2.1.5 Antibodies 
Table 10 Antibodies. 
Name Dilution Application(s) Source 
Anti-Histone H3 (HRP), ab21054 1:5000 Western blot Abcam 
Peroxidase Anti-Peroxidase (PAP), 
P1291 1:2000 Western blot Sigma 
Anti-rat IgG (HRP), A9037 1:3000 Western blot Sigma 
Anti-Ser2-P, 3E10 1:14; 25 µL/IP 
Western blot; 
ChIP 
Dirk Eick 
lab 
Anti-Ser5-P, 3E8 1:14; 20 µL/IP 
Western blot; 
ChIP 
Dirk Eick 
lab 
Anti-Tyr1-P, 3D12 1:7; 100 µL/IP 
Western blot; 
ChIP 
Dirk Eick 
lab 
Anti-Histone H3 (tri methyl K4), 
ab8580 30 µg/IP ChIP Abcam 
Anti-Histone H3 (tri methyl K36), 
ab9050 15 µg/IP ChIP Abcam 
Anti-Histone H3 (tri methyl K79), 
ab2621 10 µg/IP ChIP Abcam 
IgG from rabbit serum 100 µg/IP ChIP, PAR-CLIP Sigma 
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2.1.6 Plasmids 
Table 11 Series-438 MacroBac Expression Vectors used for CTDK-I cloning (2.2.7.1).  
Vector name Description Addgene 
438-A Modified pFastBac cloning vector with BioBrick PolyPromoter LIC Subcloning; yORF 55218 
438-C 
Modified pFastBac His6-MBP-Asn10-TEV cloning vector with 
BioBrick PolyPromoter LIC Subcloning; His6-MBP-N10-TEV-
yORF 
55220 
2.1.7 Buffers and solutions 
Table 12 Buffers and solutions. 
Name Description Application(s) 
Amylose elution 
buffer 
400 mM NaCl, 20 mM Na•HEPES pH 7.4, 10% 
glycerol (v/v), 1 mM DTT, 30 mM imidazole pH 8.0, 
10 g maltose 
2.2.7.3 
ChIP lysis buffer 
150 mM NaCl, 50 mM HEPES-KOH pH 7.5, 1 mM 
EDTA, 1% Triton X-100, 0.1% Na deoxycholate, 
0.1% SDS 
2.2.5, 2.2.6 
ChIP wash buffer 100 mM Tris-HCl at pH 7.5, 500 mM LiCl, 1% NP-40, 1% Na deoxycholate 2.2.5 
CLIP lysis buffer 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 0.5% NP-40 2.2.4 
CLIP wash buffer 50 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 0.5% NP-40  2.2.4 
CTDK-I dilution 
buffer 
 200 mM NaCl, 20 mM Na•HEPES pH 7.4, 1 mM 
DTT and 10% glycerol 2.2.9 
CTDK-I lysis 
buffer 
400 mM NaCl, 20 mM Na•HEPES pH 7.4, 10% 
glycerol (v/v), 1 mM DTT, 30 mM imidazole pH 8.0 2.2.7.2, 2.2.7.3 
High salt wash 
buffer 
800 mM NaCl, 20 mM Na•HEPES pH 7.4, 10% 
glycerol (v/v), 1 mM DTT, 30 mM imidazole pH 8.0 2.2.7.3 
HU buffer 
5% (w/v) SDS, 0.2 M Tris-HCl pH 6.8, 10 mM 
EDTA, 215 mM β-mercaptoethanol, 8 M urea, 
0.01% (w/v) bromophenolblue 
2.2.3.1 
Nickel elution 
buffer 
400 mM NaCl, 20 mM Na•HEPES pH 7.4, 10% 
glycerol (v/v), 1 mM DTT, 500 mM imidazole pH 
8.0 
2.2.7.3 
1× PBS 140 mM NaCl, 3 mM KCl, 4 mM Na2HPO4, 2 mM KH2PO4; pH 7.4 
2.2.4 
PBS-T 1% (for Western blot) or 0.02% (for IPs) Tween 20 in 1× PBS 
2.2.3.3, 2.2.5, 
2.2.6 
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Phosphatase 
reaction buffer 
50 mM Tris-HCl pH 7.0, 1 mM MgCl2, 0.1 mM 
ZnCl2 
2.2.4 
Phosphatase 
wash buffer 
50 mM Tris-HCl pH 7.5, 20 mM EGTA, 0.5% 
NP-40 2.2.4 
PNK buffer 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM MgCl2 
2.2.4 
1× protease-
inhibitor mix  
1 mM leupeptin, 2 mM pepstatin A, 100 mM PMSF, 
280 mM benzamidine in 100% ethanol  
2.2.4, 2.2.5, 
2.2.6, 2.2.7 
Proteinase K 
buffer 
50 mM Tris-HCl pH 7.5, 6.25 mM EDTA, 75 mM 
NaCl 2.2.4.1 
RNase storage 
buffer 
10 mM HEPES pH 7.5, 20 mM NaCl, 0.1% Triton 
X-100, 1 mM EDTA, 50% glycerol 2.2.6 
SE buffer 400 mM NaCl, 20 mM Na•HEPES pH 7.4, 10% (v/v) glycerol, 1 mM DTT 2.2.7.3 
T1 buffer 50 mM Tris-HCl pH 7.5, 2 mM EDTA 2.2.4 
1× TAE 40 mM Tris, 20 mM acetic acid, 1 mM EDTA pH 8.0  2.2.2.2 
1× TBS 150 mM NaCl, 50 mM Tris-HCl; pH 7.5 2.2.5, 2.2.6 
TE buffer 10 mM Tris-HCl at pH 7.5, 1 mM EDTA 2.2.5 
 
2.2 Methods 
2.2.1 S. cerevisiae strain validation  
Saccharomyces (S.) cerevisiae strains containing C-terminally TAP-tagged ORFs 
were obtained from Euroscarf and were isogenic to BY4741 wild-type strain. All TAP 
strains used in this work are listed in Table 2. These strains were validated before 
using them for experiments. Firstly, colony PCR (2.2.2) using a gene-specific 
upstream primer and a reverse primer within the TAP tag was performed to confirm 
that the DNA coding for the TAP-tag was at the correct genomic position. Secondly, 
the expression level of TAP-tagged proteins was controlled by Western blotting 
(2.2.3), using an anti-TAP antibody (PAP; Table 10).  
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2.2.2 General DNA methods 
2.2.2.1 Amplification of genomic S. cerevisiae DNA (colony PCR) 
A pinhead-sized amount of cells from an YPD plate (Table 4) was dissolved in 100 
µL of 20 mM NaOH. Approximately 50 µL of 0.5 mm glass beads (Roth) were added 
to the solution and samples were boiled for 5 min at 95°C and 1,400 rpm. Samples 
were then centrifuged at 13,000 rpm for 1 min and 3 µL of the supernatant was used 
as template for PCR amplification. Colony PCRs were performed using Taq 
polymerase (NEB), 0.25 µM primers, 2 mM MgCl2, 0.1 mM dNTPs, and 35 cycles of 
a 3-step PCR reaction: 94°C for 1 min, 50-60°C for 30 sec, 72°C for 30 sec. 
Annealing temperatures and elongation times were optimized for specific primer 
pairs. For validation of TAP-tagged yeast strains, suggested primer pairs from 
Euroscarf were used. DNA sequences for other primers are given in Table 6. 
2.2.2.2 Electrophoretic separation of DNA 
PCR samples were analyzed by agarose gel electrophoreses. Samples were mixed 
with Orange DNA Loading Dye (ThermoFisher) and loaded onto 1× TAE (Table 12) 
agarose gels containing 1% agarose and 1× SYBR Safe (Invitrogen). Along PCR 
samples, 5 µL of 100 bp or 1 kb O’GeneRuler Plus DNA Ladder, ready-to-use 
(ThermoFisher) were loaded onto the gel. DNA was separated at 120 V for 
approximately 45 min and visualized under UV light. DNA bands were excised with a 
scalpel and the DNA was purified using the QIAquick gel extraction kit (Qiagen) 
following the manufacturer’s instructions.  
2.2.3 General protein methods 
2.2.3.1 Protein extraction from S. cerevisiae cells 
A pinhead-sized amount of cells from an YPD plate was resuspended in 1 mL of cold 
water. 150 µL of 7.5% β-mercaptoethanol in 1.85 M NaOH were added and cells 
were incubated for 15 min on ice. Afterwards, 150 µL of 55% TCA were added and 
the sample incubated for 10 min on ice. Next, cells were centrifuged for 10 min at 
14,000 rpm and 4°C, the supernatant discarded and the pellet resuspended in 50 µL 
HU buffer (Table 12). The sample was neutralized using 5-15 µL of 1 M Tris base 
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and incubated for 10 min at 1,400 rpm and 65°C. Cells were centrifuged for 5 min at 
14,000 rpm at room temperature and the supernatant, containing denaturated proteins, 
was collected.  
2.2.3.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein were separated by SDS-PAGE according to their size using 4-15% Mini-
PROTEAN® TGX™ precast protein gels and the Mini-PROTEAN® Tetra Cell 
Systems chambers in 1× Tris/glycine/SDS running buffer (Bio-Rad). Along protein 
samples, 3 µL PageRuler Prestained Protein Ladder (ThermoFisher) was loaded onto 
the gel. Proteins were separated at 200 V for approximately 45 min. Protein gels were 
either stained using InstantBlueTM (expedeon) for 20 min and destained with H2Odd 
overnight or used for Western blot analysis (2.2.3.3). 
2.2.3.3 Western blot analysis 
Proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane using 
the Trans-Blot Turbo Transfer System (Bio-Rad). The membrane was blocked with 
2% milk powder (Roth) in PBS-T (Table 12) for 1 h at RT. Primary antibodies or 
HRP-coupled antibodies were diluted accordingly (Table 10) in a 2% milk/PBS-T 
solution and incubated with the membrane for 1 hr at RT or at 4°C overnight. 
Afterwards, the membrane was washed three times for 10 min with PBS-T and, if 
necessary, incubated for 1 hr with a secondary antibody diluted accordingly in a 2% 
milk/PBS-T solution (Table 10). If incubated with a secondary antibody, membranes 
were washed again three times for 10 min with PBS-T. Antibody detection was 
performed using the SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Fisher). The membrane was imaged with an Advanced Fluorescent Imager (Intas).  
2.2.4 PAR-CLIP 
PAR-CLIP experiments were performed as previously described (Baejen et al. 2014, 
Schulz et al. 2013), with some modifications. S. cerevisiae cells expressing the TAP-
tagged protein were grown overnight in YPD medium (Table 4) at 30°C and 160 rpm. 
Overnight cultures were diluted to an OD600 of ~ 0.1 in 1 L minimal medium (Table 
4) supplemented with 100 mM 4-thiouracil (4tU). Here, we used 4tU instead of 4-
thiouridine (4sU) for RNA labeling, because S. cerevisia do not express a nucleoside 
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transporter and cannot take up 4sU. 4tU is taken up by S. cerevisiae without 
expression of a nucleoside transporter (Sun et al. 2012). Yeast cultures were then 
grown to OD600 ~ 0.5 before 4tU was added to a final concentration of 1 mM and cells 
grown further for 4 hr (OD600 ~ 1.2). Following RNA labeling, cells were harvested, 
washed with 1× PBS, resuspended in 20 mL 1× PBS and UV-irradiated on ice with an 
energy dose of 12 J/cm2 at 365 nm under continuous shaking (Bio-Link BLX-365, 
Vilber Lourmat). Cells were harvested, flash frozen in liquid nitrogen and stored 
at -80°C. All subsequent steps were performed at 4°C with precooled buffers and in 
the presence of 1× protease-inhibitor mix (Table 12). Cells pellets were resuspended 
in 3 mL CLIP lysis buffer (Table 12) and divided into three 2 mL FastPrep tubes. Cell 
disruption was performed by bead beating (FastPrep®-24 Instrument, MP 
Biomedicals, LLC.) in the presence of 1 mL of 0.5 mm zirconia/silica beads (Roth) 
for 40 sec at 4 m/s, followed by an incubation of the sample for 1 min on ice. This 
was repeated 8 times. The success of the cell lysis was monitored by photometric 
measurements and the cell lysis efficiency was usually >80%. Samples were 
solubilized for 1 min via sonication with a Covaris S220 instrument (COVARIS, 
INC.) using following parameters: Peak Incident Power (W): 140; Duty Factor: 5%; 
Cycles per Burst: 200. Samples were pooled and the lysate was cleared by 
centrifugation. Immunoprecipitation (IP) was performed on a rotating wheel 
overnight at 4°C with rabbit IgG-conjugated Protein G magnetic beads (Invitrogen). 
After IP, beads were washed twice in CLIP wash buffer (Table 12) and once in T1 
buffer (Table 12). Immunoprecipitated and crosslinked RNA was partially digested 
with 50 U of RNase T1 per mL for 20 min at 25°C and 400 rpm. Beads were washed 
twice in T1 buffer and once in phosphatase reaction buffer (Table 12). For 
dephosphorylation, 1× antarctic phosphatase reaction buffer (NEB) with 1 U/µL of 
antarctic phosphatase and 1 U/µL of RNase OUT (Invitrogen) were added and the 
suspension was incubated at 37°C for 30 min and 800 rpm. Beads were washed once 
in phosphatase wash buffer (Table 12) and twice in polynucleotide kinase (PNK) 
buffer (Table 12). Beads were resuspended in 1× T4 PNK reaction buffer A 
(Fermentas) with a final concentration of 1 U/µL T4 PNK and 1 U/µL RNase OUT. 
Phosphorylation of PAR-CLIP samples was performed using either 1 mM ATP per 
mL (cold-labeling) or 0.5 µCi of gamma-32-P-ATP per mL (radioactive labeling). 
The bead suspension was incubated for 1 hr at 37°C and 800 rpm and washed 
subsequently five times with PNK buffer. For visualization of protein-RNA 
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interactions, the radioactively labeled samples were subjected to SDS-PAGE analysis. 
Radioactive RNA-protein bands were detected with the Typhoon FLA 9500 
instrument. 
2.2.4.1 PAR-CLIP library preparation and high-throughput sequencing 
For 3' adapter ligation, beads were resuspended in 1× T4 RNA ligase buffer (NEB) 
containing 10 U/µL T4 RNA ligase 2 (KQ) (NEB, M0373), 10 µM 3' adapter (Table 
7), 1 U/µL RNase OUT, and 15% (w/v) PEG 8000. The bead suspension was 
incubated for 18 hr at 16°C and 600 rpm. Beads were washed in PNK buffer to 
remove unligated adapters. For 5' adapter ligation, beads were resuspended in 1× T4 
RNA ligase buffer (NEB) containing 6 U/µL T4 RNA ligase 1 (NEB), 10 µM 
5' adapter (Table 7), 1 mM ATP, 1 U/µL RNase OUT, 5% (v/v) DMSO, and 10% 
(w/v) PEG 8000. The suspension was incubated for 4 hr at 24°C and 600 rpm. Beads 
were washed twice in PNK buffer, and twice in proteinase K buffer (Table 12). Beads 
were boiled twice at 95°C for 5 min in proteinase K buffer containing 1% SDS and 
eluted RNA-protein complexes were treated with 1.5 mg/mL proteinase K (NEB) for 
2 hr at 55°C. RNA was recovered by acidic phenol/chloroform extraction followed by 
ethanol precipitation supported by addition of 0.5 µL GlycoBlue (Invitrogen) and 
100 µM RT primer (Table 7). Reverse transcription was performed for 1 hr at 44°C 
using SuperScript III RT (Invitrogen). For PCR amplification, NEXTflex barcode 
primer and universal primer (Table 7) and Phusion HF master mix (NEB) were added. 
After PCR amplification, cDNA was size-selected on a precast 4% E-Gel® EX 
Agarose Gel (Invitrogen) and DNA fragments between ~170 bp and 350 bp were 
extracted from the gel using the MinElute gel extraction kit (Qiagen) following the 
manufacturer’s instructions. Concatemers and other PCR artifacts in the generated 
cDNA were eliminated through an additional PCR cycle (One-Step-PCR) using the 
KAPAHiFi™ PCR Kit (Peqlab Biotechnologie GmbH). PCR was performed using 
Nextera primers 1 and 2 (Table 7) with a 3 min denaturing step at 94°C, followed by 
30 sec at 55°C and 4 min at 72°C. PCR products were subsequently purified using 
AMPure XP beads with a 1.8x ratio (Beckman Coulter, Inc.), quantified on an Agilent 
2200 TapeStation instrument, and sequenced on an Illumina HiSeq 1500 sequencer. 
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Three independent biological replicates for Bur1, Cdc73, Leo1 and Rtf1 and two 
TFIIB, Spt6, Set2, Dot1, Set1, Paf1, Ctr9, Ctk2, Ctk1 and Bur2 were performed for 
this study. 
2.2.4.2 PAR-CLIP data processing and analysis 
PAR-CLIP data was analyzed as described (Baejen et al. 2014, Schulz et al. 2013), 
with some modifications by Dr. Michael Lidschreiber. mRNA and CUT transcript 
annotations were taken from (Pelechano, Wei, and Steinmetz 2013) and (Xu et al. 
2009), respectively. Unless stated otherwise, for PAR-CLIP analyses mRNA 
transcripts were selected to be at least 150 nt away from neighboring transcripts on 
the same strand. Unless stated otherwise, mRNAs and CUTs were selected to be 800-
5000 nt and 350-1500 nt long, respectively. Bidirectional promoters were selected as 
follows: distance between TSS of mRNAs and divergent CUTs was smaller than 350 
bp. Moreover, only mRNAs and CUTs that did not overlap with any other transcripts 
in the region from their TSS to 400 nt downstream on the same strand were 
considered. PAR-CLIP processing indices and colocalization measures were 
calculated essentially as described (Baejen et al. 2014, Schulz et al. 2013).  
Data quality control and mapping was essentially performed as described 
(Baejen et al. 2014). Briefly, quality-trimmed reads are aligned to the S. cerevisiae 
genome (sacCer3, version 64.2.1) using the short read aligner STAR (version 2.5.2b; 
options: --outFilterMultimapNmax 1, --outFilterMismatchNmax 1, --scoreDelOpen -
10000, --scoreInsOpen -10000, --alignSJoverhangMin 10000, --
alignSJstitchMismatchNmax 0 0 0 0 (Dobin et al. 2013)). The resulting SAM files are 
then converted into BAM and PileUp files using SAMTools (Li et al. 2009). 
We calculated the P-values for true crosslinking sites as described (Baejen et 
al. 2014).  Briefly, we had to quantitatively model the null hypothesis, i.e., the 
probability that the T-to-C mismatches observed in reads covering a certain T 
nucleotide in the genome were not caused by crosslinks between the 
immunoprecipitated factor and RNA but are due to the other sources of mismatches. 
Owing to the exquisite sensitivity of our experimental PAR-CLIP procedure, we 
could set a very stringent P-value cut-off of 0.005 and a minimum coverage threshold 
of 2. For true crosslinking sites passing our stringent thresholds, the PAR-CLIP-
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induced T-to-C transitions strongly dominate over the contributions by sequencing 
errors and SNPs. For any given T site in the transcriptome, the number of reads 
showing the T-to-C transition is proportional to the occupancy of the factor on the 
RNA times the concentration of RNAs covering the T site. Therefore, the occupancy 
of the factor on the RNA is proportional to the number of reads showing the T-to-C 
transition divided by the concentration of RNAs covering the T site. This 
concentration was estimated either from the RNA-Seq read coverage measured under 
comparable conditions as described (Baejen et al. 2014) or by the read coverage 
obtained from a Rpb1 PAR-CLIP experiment (this study) and was used to obtain 
normalized occupancies. We compared RNA and Pol II (Rpb1) normalized 
occupancy profiles and found that the latter were less prone to biases introduced due 
to difficulties in measuring unstable RNA species, including CUTs, introns and 
nascent transcripts downstream of the pA site. 
For transcript annotation, we used the recent TIF-Seq data from (Pelechano, 
Wei, and Steinmetz 2013) to derive TSS and pA site annotations for 5,578 coding 
genes. TSS and TTS positions of non-coding RNAs were taken from (Xu et al. 2009) 
for CUTs and from the Saccharomyces Genome Database (SGD, version=R64-2-1) 
for snoRNAs. Annotated transcripts were distance-filtered for downstream analysis to 
reduce ambiguous signals from overlapping transcripts.   
To generate transcript class-averaged heat maps and profiles, transcripts were 
aligned at their 5'-end (‘TSS’) and pA sites and either scaled to the same length 
(median) or cut around the TSS and pA sites before taking the average RNA-binding 
occupancy at each genomic position. Average occupancies were smoothed (sliding 
window averaging, window half size of 30 nt) and for each factor individually re-
scaled between 0 (0% occupancy) and 1 (100% occupancy) for all figures but Figure 
6A, for which all factors were globally scaled to show the relative strength of factor 
binding. To compare averaged RNA-binding occupancies between transcript classes, 
they were scaled together by setting min (transcript class 1, transcript class 2) to 0 and 
max (transcript class 1, transcript class 2) to 1 (Figure 10 and Figure 11).  
For generation of non-averaged heat maps of filtered mRNAs (Figure 7 and 
Figure 9A) transcripts were sorted by length and aligned at their 5'-end (‘TSS’). 
Smoothed occupancies were binned in cells of 20 nucleotide positions times 10 
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transcripts to avoid aliasing effects due to limited resolution of the plots. The color 
code displays the occupancy of the PAR-CLIPped factor (with the 97% quantile of 
these bins scaled to 1). In Figure 9B, all introns (SGD annotation) with lengths 
between 150 and 650 nt were aligned at the 5'-splice site (5'SS) and the occupancy of 
each intron is displayed without binning in either x or y direction. 
To calculate processing indices (PIs) (Figure 8B) we assume that read counts 
(not crosslinking sites) 𝑁!"#$ downstream of a pA site can only occur from pre-
mRNAs, 𝑁!"#$ = 𝑁!"#$ , whereas read counts 𝑁!" upstream of a pA site are a 
mixture of mature mRNA counts 𝑁!"#  and pre-mRNA counts 𝑁!"#$. Therefore, 
𝑁!" = 𝑁!"# + 𝑁!"!". For increased robustness with regard to different transcript 
isoforms and uncertainties in the exact location of pA sites, we computed 𝑁!
!" and 
𝑁!!"#$ as average of the read counts for each transcript 𝑖 of a given annotation 𝐴:  
𝑁!
!" = 1/50 𝑟𝑒𝑎𝑑𝑐𝑜𝑢𝑛𝑡𝑠!
!"!!"
!!!"!!"
 
𝑁!!"#$ = 1/50 𝑟𝑒𝑎𝑑𝑐𝑜𝑢𝑛𝑡𝑠!
!"!!"
!!!"!!"
 
Transcriptome wide averages of 𝑁!" and 𝑁!"#$ are defined as  
𝑁!
!" = 1/ 𝐴 𝑁!
!"
!
!
 
𝑁!!"#$ = 1/ 𝐴 𝑁!!"#$
!
!
 
Finally the processing index is given by 
𝑃𝐼 = 𝑙𝑜𝑔2(
𝑁!!"#$
𝑚𝑎𝑥(1, 𝑁!
!" − 𝑁!!"#$ )
) 
Colocalization analysis was done as described (Baejen et al. 2014), with 
modifications. Briefly, to calculate the tendency of pairs of factors A and B to bind 
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locations in the transcriptome near each other, we computed the average occupancy of 
factor B within ±20 nt of occupancy peaks of factor A (unsmoothed occupancy data). 
First, crosslink sites of factor A are sorted according to their occupancy and the 
strongest n=3000 sites are selected. For each crosslink site 𝑎! of this selection the 
maximum occupancy value of factor B 𝑚!!  is identified based on the occupancies of 
factor B 20 nt ± around 𝑎!. The average colocalization 𝑐 is then given by 1/𝑛 𝑚!!!! . 
Next, the background binding of factor B is defined as the median of all occupancies 
of factor B. The colocalization is defined as 𝑙𝑜𝑔2(𝑐/𝑏). Finally, we constructed a 
data matrix containing the calculated colocalization values between all EF pairs. After 
data normalization the derived colocalization dissimilarity matrix (Euclidean 
distance) was subjected to average-linkage hierarchical clustering (Figure 8C). 
2.2.5 ChIP-Seq 
Yeast strains were grown in 600 mL YPD medium (Table 4) to mid‐log phase 
(OD600, ~ 0.8) and treated with formaldehyde (1%, Sigma F1635) for 20 min at 20°C. 
Crosslinking was quenched with 75 mL of 3 M glycine for 5 min at 20°C. All 
subsequent steps were performed at 4°C with precooled buffers and in the presence of 
1× protease-inhibitor mix (Table 12). Cells were collected by centrifugation, washed 
with 1× TBS (Table 12) and twice with ChIP lysis buffer (Table 12). Cell pellets were 
flash frozen in liquid nitrogen and stored at −80°C. Cells were thawed, resuspended in 
2 mL ChIP lysis buffer and lysed as described in 2.2.4. Chromatin was washed with 
ChIP lysis buffer (15 min at 14,000 rpm) and solubilized via sonication with a 
Covaris S220 instrument (COVARIS, INC.). Parameters were optimized to yield the 
average DNA fragment size of 200 bp. This was achieved by sonicating the sample 
for 18 min using the following parameters: Peak Incident Power (W): 140; Duty 
Factor: 5%; Cycles per Burst: 200. After chromatin sharing, samples were centrifuged 
for 40 min at 14,000 rpm. 30 µL of the supernatant were saved as input material and 
also used as a control for the average chromatin fragment size (2.2.5.1). Magnetic 
Dynabeads® Protein G (life technologies) were prewashed two times with PBS-T 
with 1× protease-inhibitor mix (Table 12), coated with the respective antibody for 
30 min at 4°C and washed again three times. The remaining chromatin sample was 
immunoprecipitated with antibody-coated beads at 4°C for 3 hr (ChIP of TAP-tagged 
proteins) or overnight (ChIP with protein-specific antibodies) on a turning wheel. 
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Immunoprecipitated chromatin was washed 5 times with ChIP wash buffer and one 
time with TE buffer (Table 12). Chromatin was eluted from the beads for 10 min at 
70°C with 120 µL ChIP elution buffer (Table 12). 80 µL TE buffer were added to the 
IP samples; input samples were mixed with 110 µL ChIP elution buffer and 60 µL TE 
buffer. IP and input material were incubated with 10 µL RNase A (10 mg/mL) at 
37°C for 30 min and subsequently subjected to Proteinase K (20 µL of 20 mg/mL 
Proteinase K) digestion (37°C for 2 hr) and reversal of crosslinks (65°C overnight). IP 
DNA and input samples were purified with the QIAquick MinElute PCR Purification 
Kit (Qiagen) according to the manufacturer’s instructions. Elution was performed 
adding three times 15 µL H2Odd to the columns with a 5 min incubation time in 
between. The DNA concentration of the IP and input samples was determined with 
Qubit 2.0, dsDNA HS (Invitrogen). 
2.2.5.1 Fragment size control 
Chromatin fragment size was determined for each experiment. 1 µL of the purified 
input samples was analyzed on an Agilent 2200 TapeStation instrument using a 
D1000 ScreenTape (Agilent Technologies, Figure 16A).  
2.2.5.2 ChIP-qPCR (quantitative real-time PCR) 
Input and immunoprecipitated (IP) samples from ChIP experiments were analyzed via 
qPCR on 4 housekeeping genes to assess the extent of protein occupancy at different 
genomic regions. Primer pairs directed against promoter, coding and terminator 
regions of the housekeeping genes ADH1, ALD5, ILV5, MUP1, PDC1 and PMA1 as 
well as against a heterochromatic control region of chromosome V (YER) (Table 8) 
were designed and the corresponding PCR efficiencies determined. All primer pairs 
used in this study had PCR efficiencies in the range of 95-100%. PCR reactions 
contained 1 µL DNA template, 0.8 µM of each primer and 10 µL 2× SensiFAST 
SYBR No-ROX Mix (BIOLINE). Quantitative real-time PCR was performed on a 
qTOWER 2.2 Real-Time System (Analytik Jena AG) using a 2 min denaturing step at 
95°C, followed by 40 cycles of 5 sec at 95°C, 10 sec at 61°C and 15 sec at 72°C. 
Threshold cycle (Ct) values were determined using the corresponding qPCRsoft 3.1 
software. The enrichment of specific DNA sequences in the IP sample over the input 
sample (percent input) was determined as following: 
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% 𝐼𝑛𝑝𝑢𝑡 =  100×2( !" !"#$% !!"#! !"" !!" !" ) 
2.2.5.3 Library preparation and high-throughput sequencing of ChIP samples  
For Illumina sequencing of ChIP samples, 1–10 ng of IP or input DNA were used for 
library preparation according to the manufacturer's recommendations using the 
ThruPLEX® DNA-Seq Kit. Libraries were size selected to exclude adapters and 
adapter dimers using AMPure XP beads with a 1.0x ratio. Samples were qualified on 
an Agilent 2200 TapeStation instrument (Figure 16B). ChIP libraries were quantified 
with Qubit 2.0, pooled and sequenced on an Illumina HiSeq 1500 sequencer. 
2.2.5.4 ChIP-Seq data processing and analysis 
ChIP-Seq data was processed and analyzed by Dr. Michael Lidschreiber. Paired-end 
50 bp reads were aligned to the S. cerevisiae genome (sacCer3, version 64.2.1) using 
the short read aligner Bowtie (version 2.2.3) (Langmead and Salzberg 2012). 
SAMTools was used to quality filter SAM files (Li et al. 2009). Alignments with 
MAPQ smaller than 7 (-q 7) were skipped and only proper pairs (-f99, -f147, -f83, -
f163) were selected. The BEDTools toolset (Quinlan and Hall 2010) was used to 
obtain coverage tracks that were subsequently imported into R/Bioconductor where 
further processing of the data was carried out. Normalization between IP and input 
was done using the signal extraction scaling (SES) factor obtained with the 
estimateScaleFactor function from deepTools (Ramirez et al. 2014) with options: –l 
100 –n 100000 and the median fragment size (-f) estimated from the data (around 
200 bp). ChIP enrichments were obtained by dividing SES-normalized IP intensities 
by the corresponding input intensities: log2(IP/Input). 
The same transcript annotations as for PAR-CLIP data analysis (see above) 
were used for ChIP-Seq data analysis, except that filtering criteria had to be more 
stringent due to the lack of strand-specificity and lower resolution of ChIP-Seq data. 
Thus, for Figure 15, the distance filtering between transcripts was increased to 200 bp 
and transcripts on both strands were considered. 
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2.2.6 Chromatin association assay 
Yeast cultures were grown in 200 mL of YPD medium (Table 4) at 30°C to mid-log 
phase (OD600, ~ 0.8). Subsequent steps were performed at 4°C with precooled buffers 
and in the presence of 1× protease-inhibitor mix (Table 12). Cells were collected by 
centrifugation, washed with 1× TBS buffer and with ChIP lysis buffer (Table 12). 
Cell pellets were flash frozen in liquid nitrogen and stored at −80°C. Pellets were 
thawed, resuspended in 1 mL lysis buffer, and disrupted via beat beating (2.2.4). The 
lysate was divided into two samples. One half was treated with 7.5 U of RNase A and 
300 U of RNase T1 (Ambion); the other half was treated with the same volume of 
RNase storage buffer (Table 12). After 30 min incubation at room temperature, 
chromatin was isolated by centrifugation at 15,000 rpm for 15 min. Chromatin was 
solubilized in 1 mL ChIP lysis buffer via sonication with a Covaris S220   instrument 
(COVARIS, INC.). Chromatin solutions were then analyzed by SDS-PAGE and 
Western blotting (2.2.3.2, 2.2.3.3) against the C-terminal TAP tag of the analyzed 
factor and against H3, which served as loading control. Three independent biological 
replicates for TFIIB, Rpb1, Rtf1, Paf1, Ctk2, Bur1, Set2 and Spt6 and 
two independent biological replicates for Leo1, Ctk1, Bur1, Set1, Dot1 and Spt5 were 
performed. Band  intensities were quantified using ImageJ software (1.49v). For 
statistical analysis, multiple group comparisons were done by one-way ANOVA with 
Dunnett post-hoc  test. Data are presented as mean ± SD. Differences were considered 
significant when  p < 0.5 (*p < 0.05; **p < 0.01; ***p < 0.001; n.s. = not significant).  
2.2.7 Purification of recombinant CTDK-I protein complex 
2.2.7.1 Cloning of CTDK-I  
The full-length subunits of the CTDK-I complex, Ctk1, Ctk2 and Ctk3, were 
amplified from genomic S. cerevisiae DNA (BY4741 strain) as described in 2.2.2.1 
using primers listed in Table 6. Gel purified DNA inserts (2.2.2.2) were cloned into 
modified pFastBac vectors (Series-438 MacroBac Expression Vectors; Table 11; a 
gift of Scott Gradia, UC Berkeley) via ligation independent cloning (LIC). Prior 
ligation, vectors were linearized with SspI and gel purified. Purified vectors and DNA 
inserts were treated with T4 DNA polymerase in the presence of dGTP or dCTP, 
respectively, and ligated for 30 min at RT. Ctk1 and Ctk3 were cloned into the 438-A 
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vector; Ctk2 was cloned into the 438-C vector bearing an N-terminal 6xHis-MBP-tag 
followed by a tobacco etch virus protease cleavage site (TEV site). After ligation, 
plasmids were transformed into E. coli XL1Blue cells (Table 1). Ligation reaction 
was added to 50 µL competent cells and incubated on ice for 10 min. Suspension was 
heat-shocked at 42°C for 45 sec and then cooled down on ice for 2 min. 450 µL LB 
medium was added and cells were incubated for 4 hr at 37°C and 400 rpm. Cells were 
harvested by centrifugation for 5 min at 4,000 rpm, resuspended in 150 µL LB 
medium and plated on ampicillin selective LB plates. Plates were incubated overnight 
at 37°C and single colonies were picked and grown overnight at 37°C in LB medium 
containing ampicillin. Plasmid DNA was isolated using QIAprep spin miniprep Kit 
(Qiagen) and sequence-verified (Seqlab, Göttingen). Ctk1 and Ctk3 subunits, encoded 
in the 438-A plasmids, were combined into the Ctk2_438-C plasmid by successive 
rounds of LIC reactions (Figure 4) using SwaI and PmeI for restriction digests. The 
plasmid containing all three subunits of the CTDK-I complex was amplified and 
verified as described above. Each subunit is preceded by a PolH promoter and 
followed by an SV40 termination site.  
 
Figure 4 Schematic procedure of LIC reactions to generate a plasmid encoding all three 
subunits of the CTDK-I kinase complex. 
 
2.2.7.2 Expression of CTDK-I 
Insect cell culture work was performed by Dr. Seychelle M. Vos. Purified plasmid 
DNA (0.5 µg) was electroporated into DH10EMBacY cells to generate bacmids 
(Berger, Fitzgerald, and Richmond 2004). Bacmids were prepared from positive 
clones by isopropanol precipitation and transfected into Sf9 cells grown in Sf-900 III 
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SFM (ThermoFisher) with X-tremeGENE9 transfection reagent (Sigma) to generate 
V0 virus. V0 virus was harvested 72 hr after transfection. V1 virus was produced by 
infecting 25 mL of Sf21 cells grown at 27°C, 300 rpm with V0 virus (1E6 cell/mL, 
1:50 (v/v) cells:virus). V1 viruses were harvested 48 hr after proliferation arrest and 
stored at 4ºC. For protein expression, 600 mL of Hi5 cells (1E6/mL) grown in 
ESF921 medium (Expression Technologies) were infected with 200 µL of V1 virus 
and grown for 72 hr at 27°C. Cells were harvested by centrifugation (238xg, 4°C, 30 
min), resuspended in CTDK-I lysis buffer at 4ºC containing 1× protease-inhibitor mix 
(Table 12), snap frozen, and stored at -80ºC.  
2.2.7.3 Purification of complete CTDK-I 
Protein purification steps were performed at 4°C. Frozen cell pellets were thawed and 
lysed by sonication with CTDK-I lysis buffer (Table 12) containing 1× protease-
inhibitor mix. Lysates were clarified by centrifugation in an A27 rotor 
(ThermoFisher) (26,195 g, 4°C, 30 min), followed by ultracentrifugation in a Type 45 
Ti rotor (Beckman Coulter) (235,000 g, 4°C, 60 min). Clarified lysates were filtered 
through 0.8 mm syringe filters (Millipore) and applied to a 5 mL HisTrap column (GE 
Healthcare) equilibrated in CTDK-I lysis buffer. HisTrap columns were washed with 
10CV of CTDK-I lysis buffer followed by 5CV of high salt wash buffer (Table 12) 
containing 1× protease-inhibitor mix and 5CV of CTDK-I lysis buffer. An amylose 
column (New England Biolabs) equilibrated in CTDK-I lysis buffer was directly 
coupled to the HisTrap column. Protein was eluted from the HisTrap column by a 
gradient from 0–100% nickel elution buffer (Table 12) containing 1× protease-
inhibitor mix, after which the HisTrap and amylose column were decoupled. The 
amylose column was washed with 5CV of CTDK-I lysis buffer and protein was eluted 
with amylose elution buffer (Table 12) containing 1× protease-inhibitor mix. Peak 
fractions were analyzed by SDS-PAGE (2.2.3.2). Amylose column fractions 
containing CTDK-I were combined with 1.5 mg of His6-TEV protease and dialyzed 
overnight at 4°C in a Slide-A-Lyzer (3–12 mL 10 kDa MWCO) (ThermoFisher) 
against 1 L of lysis buffer. Protein was removed from the Slide-A-Lyzer cassette and 
applied to a 5 mL HisTrap column to remove uncleaved protein and TEV protease. 
Protein was concentrated in an Amicon 15 mL centrifugal 30 kDa MWCO 
concentrator (Millipore) to 500 µL. The protein was applied to a Superdex 200 
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Increase 10/300 column (GE Healthcare) equilibrated in SE buffer (Table 12). Peak 
fractions were analyzed by SDS-PAGE. Pure fractions were concentrated as described 
above to 500 µL, aliquoted, flash frozen, and stored at −80°C. Protein preparation 
yielded ~4 mg of full-length CTDK-I from 3.8 L of insect cell culture. 
2.2.8 CTDK-I kinase activity assays 
Purified human GST-CTD (see 2.2.8.1) and S. cerevisiae Pol II (Plaschka et al. 2016) 
were used as kinase substrates. In vitro kinase assays were performed in 20 µL 
reactions. Recombinant purified CTDK-I (0.4 µM) was mixed together with either 
GST-CTD (10 µM) or Pol II (2 µM) and the following final conditions: 1 mM DTT, 
100 mM NaCl, 30 mM NaHEPES pH 7.5, 4% (v/v) glycerol and 3 mM MgCl2. 
Reactions were incubated at 30°C for 5 min; 1 µL “0 min” time point was taken 
before adding 3 mM ATP. Reactions were then incubated at 30°C with constant 
shaking at 300 rpm. 2 µL were taken for each time point (reaction with CTD 
substrate: 5, 10, 20, 30, 60 and 120 min; reaction with Pol II substrate: 2, 4, 6, 10, 20, 
30, 60 and 90 min). The reactions were stopped with LDS-loading buffer and heated 
at 95°C for 5 min before SDS-PAGE (2.2.3.2). Western blotting was performed as 
described above (2.2.3.3) using anti-Ser2-P as primary antibody and anti-rat IgG 
(HRP) as secondary antibody (Table 10). 
2.2.8.1 His6-TEV-GST 52x human CTD expression and purification 
Dr. Seychelle M. Vos purified His6-TEV-GST 52x human CTD. For expression, 
Bl21(DE3)pLysS E. coli cells were used. Cells were grown in 2xYT to OD600 of 0.5 
(37ºC, 160 rpm), changed to 18ºC, and induced overnight with 0.5 mM IPTG. Protein 
purification steps were performed at 4°C. 4L Bl21(DE3)pLysS) frozen cells were 
thawed and lysed by sonication. Lysates were clarified by centrifugation in an A27 
rotor (ThermoFisher) (26,195 g, 4°C, 30 min). Clarified lysate was applied to a 5 mL 
HisTrap nickel column (GE Healthcare) equilibrated in lysis buffer (150 mM NaCl, 
20 mM Na•HEPEs pH 7.4, 1 mM DTT, 10% glycerol, 30 mM imidazole) with 1× 
protease-inhibitor mix (Table 12). Column was then washed in high salt wash buffer 
(800 mM NaCl, 20 mM Na•HEPEs pH 7.4, 1 mM DTT, 10% glycerol, 30 mM 
imidazole) containing 1× protease-inhibitor mix followed by lysis buffer. A 5 mL 
HiTrap Q column was equilibrated in lysis buffer and added in line after the nickel 
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column. Protein was eluted with a gradient of 0-100% nickel elution buffer (150 mM 
NaCl, 20 mM Na•HEPEs pH 7.4, 1 mM DTT, 10% glycerol, 500 mM imidazole) 
containing 1× protease-inhibitor mix. Following imidazole elution, the nickel column 
was removed and the Q column washed in 150 mM NaCl, 20 mM Na•HEPEs pH 7.4, 
1 mM DTT, 10% glycerol and 1× protease-inhibitor mix. Gradient elution was 
performed with 1 M NaCl, 20 mM Na•HEPEs pH 7.4, 1 mM DTT and 1× protease-
inhibitor mix. Peak fractions from Q column elution were concentrated in a 5 mL 
30 kDa MWCO concentrator to 500 µL. Protein was centrifuged for 10 min at 15k 
prior loading to a Superdex 200 Increase 10/300 column (GE Healthcare), 
equilibrated in in SE buffer (300 mM NaCl, 20 mM Na•HEPEs pH 7.4, 1 mM DTT, 
10% glycerol). Peak fractions were analyzed by SDS-PAGE (2.2.3.2), pure fractions 
concentrated in 5 mL 30 kDa MWCO Amicon Millipore concentrator to 40 µM, 
aliquoted, flash frozen, and stored at −80°C. 
2.2.9 Fluorescence anisotropy assays with CTDK-I 
5'-FAM labeled ssRNA and dsDNA were obtained from Integrated DNA 
Technologies and dissolved in water to 100 µM. ssRNA sequences had different 
GC-contents and were either A- or U-rich (Table 9). The dsDNA sequence 
corresponds to the 45% GC, A-rich ssRNA sequence. 24% GC, A-rich, 24% GC, U-
rich and 45% GC, A-rich sequences correspond to natural coding sequences in S. 
cerevisiae. RNA oligos were unfolded by incubating the RNA at 95°C for 1 min and 
transferring to ice for 10 min. Oligonucleotides were diluted in water for all 
experiments.  
Purified CTDK-I was serially diluted in two fold steps in dilution buffer 
(Table 12). Nucleic acids (8 nM final concentration) were added on ice and the 
reaction was incubated for 10 min. The assay was brought to a final volume of 30 µL 
and incubated for 20 min at RT in the dark (final conditions: 100 mM NaCl, 2 mM 
MgCl2, 20 mM NaHEPES pH 7.4, 1 mM TCEP, 4% glycerol, 0.01 mg/mL BSA and 
5 µg/mL yeast tRNA (Sigma) as a competitor for non-specific binding). 18 µL of 
each reaction were transferred to a Greiner 384 Flat Bottom Black Small volume 
plate.  
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Fluorescence anisotropy (FA) was measured at 30°C with an Infinite 
M1000Pro reader (Tecan) with an excitation wavelength of 470 nm (±5 nm), an 
emission wavelength of 518 nm (±20 nm) and a gain of 63. All experiments were 
done in triplicate and analyzed with GraphPad Prism Version 7. Binding curves were 
fitted with a single site quadratic binding equation:  
𝐹𝐴 =  (
𝐵𝑚𝑎𝑥 ∗  ([𝑃] + [𝐿] + 𝐾𝑑, 𝑎𝑝𝑝 −  ([𝑃] + [𝐿] + 𝐾𝑑, 𝑎𝑝𝑝)! − 4 ([𝑃] ∗ [𝐿]))
2 ∗ [𝐿]
) 
where Bmax is the maximum specific binding, L is the concentration of nucleic acid, P 
is the concentration of CTDK-I, Kd,app is the apparent disassociation constant for 
CTDK-I and nucleic acid. Error bars represent the standard deviation from the mean 
of three experimental replicates. 
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3 Results 
Some of the results presented here were obtained in collaboration with colleagues. For 
detailed author contributions see publications (page 7) and section 2.2. 
3.1 Elongation factors directly crosslink to RNA in vivo 
To investigate whether elongation factors (EFs) interact with RNA in vivo, we used 
photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation 
(PAR-CLIP) (Hafner et al. 2010), a method that detects and maps direct protein-RNA 
interactions without chemical crosslinkers. We applied our recently optimized PAR-
CLIP protocol (Baejen et al. 2014) to 14 EFs of the yeast Saccharomyces (S.) 
cerevisiae (Figure 5, Table 13, 2.2.4). These EFs included Spt5, Spt6, the five Paf1C 
subunits Cdc73, Ctr9, Leo1, Rtf1, and Paf1, the kinases Bur1 and Ctk1, the cyclins 
Bur2 and Ctk2, and the histone methyltransferases Set1, Set2, and Dot1. 
 
Figure 5 Many elongation factors (EFs) bind RNA in vivo. PAR-CLIP signal strength for 
EFs varies. The bar plots show log2 fold-enrichments of transcript-averaged PAR-CLIP 
signals over the averaged PAR-CLIP signal for initiation factor TFIIB, which shows 
background RNA binding. Averaged PAR-CLIP signals were calculated by taking mean 
transcript PAR-CLIP signals averaged over all mRNAs, which were filtered to be 
800-5,000 nt long and at least 150 nt away from neighboring transcripts (2,532 mRNAs). 
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For 12 of the above mentioned 14 EFs we obtained PAR-CLIP signals that were more 
than two-fold above background, showing that these EFs interact with RNA in vivo 
(Figure 5, Figure 6A). We obtained between 42,000 and 520,000 high-confidence 
protein-RNA crosslinking sites per factor with p-values below 0.005 (Table 13). The 
collected data sets were highly reproducible (Figure 6B). To estimate background 
RNA binding, we collected PAR-CLIP data for the transcription initiation factor 
TFIIB that is recruited to promoter DNA before nascent RNA is made (Sainsbury, 
Bernecky, and Cramer 2015). Only very low levels of background binding were 
observed, further emphasizing the significance of EF-RNA interactions detected by 
UV crosslinking. 
Table 13 PAR-CLIP analysis of elongation factors (EFs). 
EF Complexa Number of crosslink sitesb 
Bur1 
BUR kinase complex 
77,931 
Bur2 46,293 
Ctk1 
CTDK-I 
129,352 
Ctk2 98,993 
Cdc73 
Paf1C 
57,603 
Ctr9 55,807 
Leo1 27,665 
Paf1 20,742 
Rtf1 60,068 
Set1 COMPASS 189,723 
Set2  68,875 
Dot1  42,848 
Spt5c DSIF 517,568 
Spt6  93,902 
TFIIBd  16,686 
aDSIF, DRB sensitivity inducing factor; CTDK, C-terminal domain kinase; Paf1C, Paf1 
complex; COMPASS, Complex Proteins Associated with Set1 
bAverage number of crosslink sites with p-values < 0.005 
c(Baejen et al. 2017) 
dInitiation factor, used to determine the level of RNA background crosslinking 
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Figure 6 (A) Smoothed, raw PAR-CLIP signals (as measured by the number of PAR-CLIP 
U-to-C transitions per U site) over a set of 2,532 selected mRNAs were aligned at their 5'-end 
(TSS), scaled to a common length, then averaged (2.2.4.2). The color code shows the PAR-
CLIP signal relative to the maximum PAR-CLIP signal of all profiles (dark blue). Since 
PAR-CLIP signals of Set1 and Spt5 were much higher than those of other EFs, Set1 and Spt5 
occupancies were divided by a factor of 1.5 and 3, respectively, for visualization purposes. 
(B) Replicate (Rep) measurements show very high correlations. Smoothed, averaged PAR-
CLIP profiles of replicate measurements for Ctk2, Cdc73, Ctr9 and Set1. (C) Paf1C interacts 
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with RNA through its subunits Rtf1, Ctr9 and Cdc73. (Top) SDS-PAGE analysis of Paf1C 
subunits after IP (InstantBlue stain). Paf1C subunits can be individually pulled down with IgG 
coated beads against the C-terminal TAP tag of each of the five Paf1C subunits. (Bottom) 
Phosphorimage of SDS-gel with Paf1C subunits after IP and radioactive labeling of co-
precipitated RNA. RNA co-precipitated only with Rtf1, Ctr9 and Cdc73. 
 
 We then classified EFs into factors with moderate and high PAR-CLIP 
signals, based on their fold enrichments (>2 and >4-fold, respectively) over 
background TFIIB signals (Figure 5). Spt5, Set1, Ctk1, Spt6, Ctk2 and Bur1 showed 
high PAR-CLIP signals (Figure 5, Figure 6A, Table 13). EFs with moderate signals 
included Rtf1, Ctr9, Cdc73, Bur2, Set2 and Dot1. PAR-CLIP signals were clearly 
specific for individual subunits of known complexes. For instance, only the Paf1C 
subunits Rtf1, Cdc73 and Ctr9 bound RNA according to the PAR-CLIP results, and 
the same subunits were detected after IP and radioactive labeling of co-precipitated 
RNA (Figure 6C). A low background signal was observed for other subunits, whereas 
the enriched bands were due to the protein of interest. These data revealed that many 
EFs directly bind RNA in vivo, including the Pol II Ser2 kinases Ctk1 and Bur2 and 
the histone H3 methyltransferases Set1, Set2 and Dot1. 
3.2 Comparisons of PAR-CLIP data require normalization 
We have previously noted the importance of normalizing the raw PAR-CLIP signal, 
as measured by the number of U-to-C transitions per U site, to account for differences 
in RNA abundance (Baejen et al. 2014). Briefly, the raw PAR-CLIP signal is 
proportional to the occupancy of the factor on RNA and to the concentration of RNAs 
covering the U site. Therefore, normalization is crucial to enable comparison of PAR-
CLIP signals between individual transcripts and transcript classes. Relative 
occupancies can be estimated by dividing the observed PAR-CLIP signal by RNA-
Seq reads that have been obtained under the same experimental conditions (Baejen et 
al. 2014). An alternative approach is to divide the observed PAR-CLIP signal by a 
PAR-CLIP signal obtained for Pol II (Baejen et al. 2017), although this is only 
suitable for proteins that associate with nascent RNA during transcription, which is 
the case for the EFs studied here.  
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Figure 7 Normalization of PAR-CLIP data shown for two representative EFs, Ctk2 
(top) and Spt5 (bottom). (A) Smoothed, raw RNA-binding strength as measured by the 
number of PAR-CLIP U-to-C transitions per U site for all mRNAs sorted by length and 
aligned at their RNA 5'-end (transcription start site, TSS). (B) Relative occupancy estimated 
by dividing the number of U-to-C transitions for each U site by the RNA-Seq signal at the 
corresponding genomic position for all mRNAs. A heat map showing the transcript-averaged 
RNA-Seq reads for all mRNAs scaled to the same length is shown below. (C) Relative 
occupancy estimated by dividing the number of U-to-C transitions for each U site by the 
Rpb1 PAR-CLIP signal at the corresponding genomic position for all mRNAs. A heat map 
showing the transcript-averaged Rpb1 PAR-CLIP reads for all mRNAs scaled to the same 
length is shown below. (D) Smoothed, raw and normalized PAR-CLIP signals as shown in A-
C, but averaged over all mRNAs. Before averaging RNA occupancy profiles were aligned at 
the RNA 5'-end and length-scaled such that the 5'-ends and pA sites coincided. 
 
Figure 7 shows how the two different normalization methods affect EF 
occupancy profiles on mRNA transcripts. For two representative EFs, Ctk2 and Spt5, 
the raw data (Figure 7A) was either normalized with RNA-Seq reads (Figure 7B) or 
with reads from Pol II (Rpb1 subunit) PAR-CLIP data (Figure 7C). Meta-transcript 
profiles are shown in Figure 7D. In the case of Ctk2, the raw data profile and the 
Pol II normalized profile look very similar, whereas the RNA-normalized profile 
shows slightly less occupancy of Ctk2 in the 3' part of the transcripts, due to the 
slightly higher RNA-Seq signal in this region (Figure 7B, bottom). The PAR-CLIP 
signal for Spt5 is enriched around the 5'-end of mRNAs, decreases towards the 3'-end, 
and this was independent of the normalization approach (Figure 7D, bottom). 
However, Spt5 signals peak just downstream of the pA site, and the size of this peak 
varies in function of the normalization approach. This is due to the intrinsic instability 
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of transcripts downstream of the pA site, which reduces the number of RNA-Seq 
reads and artificially increases the PAR-CLIP peak after RNA-Seq-based 
normalization.  
Taken together, the PAR-CLIP metagene profiles over stable transcripts were 
largely independent of the type of normalization used. However, proper normalization 
becomes critical when crosslinking to unstable RNAs is investigated. Since we were 
interested in comparing EF occupancies between transcript classes, including unstable 
RNAs, we used Pol II PAR-CLIP normalization to calculate normalized EF PAR-
CLIP occupancies and used these for further analysis. 
3.3 Differences in EF occupancy along RNAs 
3.3.1 EF localization along mRNA transcripts 
To localize EFs on transcripts, we mapped the Pol II normalized PAR-CLIP 
occupancies onto transcripts in different classes (2.2.4.2). We then calculated factor 
occupancies for 2,532 mRNA transcripts that were filtered to reduce ambiguous 
signals from overlapping transcripts. We calculated heat maps with occupancies 
averaged around the transcript 5′-end, which corresponds to the transcription start site 
(TSS), and around the polyadenylation (pA) site (Figure 8A). The obtained profiles 
were also visible on individual transcripts (Figure 9A). 
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Figure 8 (A) mRNA-binding profiles of EFs. Smoothed, transcript-averaged Pol II 
normalized PAR-CLIP occupancy profiles of EFs centered around the transcript 5'-end 
(transcription start site, TSS) [-150 nt to +400 nt] and pA site [-400 nt to +150 nt] of a set of 
2,532 filtered mRNAs (compare Figure 5). Only factors with average RNA-binding 
occupancies >2-fold above background are shown. The Spt5 PAR-CLIP profile reveals a 
peak downstream of the pA site that is discussed in detail elsewhere (Baejen et al. 2017). The 
color code shows the occupancy relative to the maximum occupancy per profile (dark blue). 
(B) EFs bind to pre-mRNA. Processing indices (PIs) measure preferential binding of factors 
to uncleaved pre-mRNA with respect to cleaved RNA, computed as log2 odds ratios 
uncleaved versus cleaved RNA bound by the factor (2.2.4.2). The PIs for Pab1 and Pub1, as 
typical factors binding mature mRNA (Baejen et al. 2014), are shown for comparison. (C) 
Colocalization of factor crosslinking sites on transcripts. Euclidean distances between 
pairwise colocalization measures were subjected to average-linkage hierarchical clustering 
(2.2.4.2). The cluster dendrogram shows similarities in crosslinking locations on transcripts 
between EFs and published RNA processing factors (Baejen et al. 2014, Schulz et al. 2013). 
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Generally, PAR-CLIP occupancies were high at the 5'-end of mRNAs and 
decreased shortly before the pA site, with few exceptions (Figure 3A). First, the 
histone methyltransferases Set2 and Dot1, for which the corresponding methylation 
marks accumulate in gene bodies (Bannister et al. 2005, Pokholok et al. 2005), 
showed more RNA-binding sites over transcript bodies. Second, Set1 crosslinked to 
mRNAs mainly near the beginning of transcripts, which was expected since Set1 and 
its methylation mark, H3K4me3, are observed in promoter-proximal regions of genes 
(Ng et al. 2003). Third, the kinases Ctk1 and Bur1 and their cyclin partners Ctk2 and 
Bur2 were enriched near the 5'-end but also in the transcript body. The 5'-peak for 
Bur1-Bur2 slightly preceded that of Ctk1-Ctk2. The three Paf1C subunits Cdc73, Ctr9 
and Rtf1 showed similar occupancy profiles as the kinases but with a focused peak at 
the 5'-end. Fourth, Spt5 and Spt6 showed high PAR-CLIP occupancy at the 5'-end of 
mRNAs and decreased occupancy towards the pA site. This analysis revealed specific 
differences in EF localization on mRNAs, and additionally suggested that EFs bind 
nascent RNA during transcription. 
3.3.2 EFs bind nascent pre-mRNA 
To test whether EFs interact with nascent pre-mRNA or with spliced, mature mRNA, 
we measured factor occupancies at introns, which are co-transcriptionally spliced out 
and subsequently degraded (Carrillo Oesterreich et al. 2016). All EFs crosslinked to 
introns (Figure 9B), indicating that they bind pre-mRNA. Most EFs bound to introns 
with a frequency that was comparable to that at exons, although Spt5 and Set1 
showed slightly higher occupancy within introns, whereas Bur2, Set2 and Dot1 
showed lower occupancy (Figure 9B). Taking into account that splicing generally 
occurs co-transcriptionally (Kornblihtt et al. 2004, Tennyson, Klamut, and Worton 
1995, Listerman, Sapra, and Neugebauer 2006), our data show that EFs interact with 
nascent pre-mRNA. However, only ~4% of yeast genes contain introns (Qin et al. 
2016), preventing general statements related to all pre-mRNAs. We therefore 
calculated a processing index (PI) that measures preferential binding of factors to 
uncleaved pre-mRNA with respect to cleaved RNA (2.2.4.2) (Baejen et al. 2014). All 
EFs showed positive PIs, indicating binding to pre-mRNA, in contrast to the negative 
PIs that we previously obtained for typical RNA binders of processed, mature mRNA, 
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such as Pab1 and Pub1 (Figure 8B) (Baejen et al. 2014). We conclude that EFs 
preferentially interact with nascent pre-mRNA. 
 
Figure 9 Non-averaged elongation factor RNA occupancies over mRNAs and introns. 
(A) PAR-CLIP occupancies of Pol II normalized EFs transcript-wise. Smoothed occupancy 
profiles derived from PAR-CLIP data for a set of 2,532 selected mRNAs. Transcripts were 
sorted by length and aligned at their 5'-end (transcription start site, TSS). Plots for Ctk2 and 
Spt5 are shown in Figure 2C. (B) Smoothed Pol II normalized PAR-CLIP occupancy profiles 
over all introns. Each line represents an intron, and introns were sorted by length and aligned 
at their 5' splice site (5'SS). Only introns of lengths between 150 and 650 nt are shown. 
 
We next investigated where EFs localize on RNAs in relation to previously 
mapped mRNA biogenesis factors (Baejen et al. 2014). We determined the extent of 
factor colocalization by computing the average occupancy of factor A within ±20 
nucleotides (nt) around RNA-binding sites of factor B and subjected the pairwise 
colocalization measures to hierarchical clustering (Figure 8C, 2.2.4.2). We found that 
Spt5 colocalizes with the Cbc2 subunit of the cap-binding complex, consistent with its 
recruitment during early elongation. Both Ctk1 and Bur1 colocalized with binding 
sites of Set1 and splicing factors. Paf1C subunits colocalized with Set2, whereas RNA 
3'-processing and surveillance factors formed separate groups (Figure 8C). Together 
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these data show a distinct distribution of EFs over RNAs, and suggested that EFs 
cooperate with other mRNA biogenesis factors during pre-mRNA binding. 
3.3.3 Most EFs preferentially interact with coding transcripts  
We next analyzed our PAR-CLIP data for EF binding to non-coding Pol II transcripts 
including short-lived cryptic unstable transcripts (CUTs), which often arise from 
upstream antisense transcription of bidirectional promoters (Wyers et al. 2005, Xu et 
al. 2009). We selected CUTs with a minimum length of 350 nt and compared 
transcript-averaged RNA-binding occupancies between CUTs and mRNAs (Figure 
10A). This revealed that EFs bind to these transcript classes with distinct preferences. 
Spt5 was equally distributed between CUTs and mRNAs whereas Set1 preferentially 
bound mRNAs. All other EFs were depleted at CUTs relative to their mRNA 
occupancies (Figure 10A). This was essentially independent of RNA length (Figure 
11A). Thus, most EFs preferentially crosslink to coding RNAs. 
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Figure 10 Asymmetric distribution of EFs at coding and non-coding transcripts. (A) 
PAR-CLIP occupancies over mRNAs (left) and non-coding CUTs (right). Smoothed, 
averaged Pol II normalized RNA occupancy profiles were aligned at the RNA 5'-end 
(transcription start site, TSS) and scaled to a common length. The color code shows the 
occupancy relative to the maximum occupancy per factor over both transcript classes (dark 
blue). (B) and (C) PAR-CLIP occupancies at selected bidirectional promoters. Smoothed, 
averaged Pol II normalized RNA occupancy profiles for sense mRNA (right) and divergent 
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CUT (left) were centered around their 5'-end (TSS) [-75 nt to +400 nt]. We considered only 
bidirectional promoters producing mRNAs and CUTs that did not overlap with any other 
transcripts in the depicted region. After normalization, average mRNA and CUT profiles were 
rescaled, setting the maximum occupancy to 1 and the minimum occupancy to 0. 
 
We then analyzed PAR-CLIP signals at bidirectional promoters, which 
produce mRNA in one direction and a CUT in the divergent direction (Figure 10B). 
We observed clear differences in PAR-CLIP signals for divergent directions. As in 
Figure 10A, Set1 and Spt5 showed high signals on CUTs and mRNAs (Figure 10B, 
top) whereas all other EFs bound exclusively to mRNAs (Figure 10B, bottom). These 
differences were also observed when the analysis was restricted to bidirectional 
promoters producing CUTs and mRNAs of similar lengths (Figure 11B).  
How can some EFs distinguish between CUTs and mRNAs? We carried out 
motif analysis around the strongest PAR-CLIP sites for each EF using XXmotif 
(Luehr, Hartmann, and Söding 2012) and could not find any significantly enriched 
motifs, indicating that EFs bind RNA in a non-specific manner. We hypothesize that 
another RNA-binding factor blocks binding of EFs to CUTs. CUTs are rapidly 
degraded by a surveillance system, which includes Nrd1 (Schulz et al. 2013, Vasiljeva 
et al. 2008, Steinmetz and Brow 1996). Nrd1 selectively binds to CUTs (Figure 10C) 
via motifs that are enriched in CUTs compared to mRNAs (Schulz et al. 2013). 
Binding of Nrd1 to CUTs might hinder RNA binding of some EFs, especially those 
which possess lower RNA binding affinity. This may explain how stable elongation 
complexes preferentially assemble on mRNAs. 
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Figure 11 Asymmetric distribution of EFs at coding and non-coding transcripts of 
similar length. (A) PAR-CLIP occupancy heat map similar to that shown in Figure 10A, but 
with mRNAs and CUTs selected to be of similar lengths, 350-700 nt. (B) and (C) PAR-CLIP 
occupancy profiles for elongation factors as in Figure 10B, with sense mRNAs and divergent 
antisense CUTs of similar lengths, 350-700 nt, selected from bidirectional promoters. 
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3.4 Chromatin association of EFs depends on RNA 
We next investigated whether RNA binding of EFs contributes to their association 
with chromatin. Yeast cells were lysed and incubated with buffer containing RNases 
or with buffer only. Chromatin was isolated and associated protein factors were 
detected by Western blotting (see 2.2.6). We found that RNase treatment strongly 
decreased the levels of chromatin-associated enzymes Set1, Set2, Dot1, Bur1, Ctk1, 
and the cyclins Bur2 and Ctk2 (Figure 12). Thus, RNA stabilizes chromatin 
association of these factors. Chromatin association of two non-enzymatic EFs also 
depended on RNA, although less strongly. With respect to Paf1C, Rtf1 was partially 
lost upon RNase treatment, whereas Leo1 and Paf1 were not significantly affected. 
Spt5 binding to chromatin also depended on RNA, whereas Spt6 was not significantly 
affected by RNase treatment (Figure 12). These few discrepancies between chromatin 
association and PAR-CLIP results are explained by additional EF interactions, and by 
the dependence of the PAR-CLIP signal on the concentration of the RNA-interacting 
protein in the cell (Chong et al. 2015, Kulak et al. 2014).  
 
Figure 12 Chromatin association of EFs depends on RNA. Western blot analysis (top) and 
quantitative densitometry (bottom) of exemplary EFs bound to chromatin before and after 
treatment with RNase A/T1 mix. H3 was used as loading control. Densitometry data are 
expressed as mean ± SD from two to three independent experiments. *p < 0.05; **p < 0.01; 
***p < 0.001; n.s. = not significant (one-way ANOVA Dunnett post-hoc test). 
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As a negative control, we subjected TFIIB to the RNase assay. We observed no 
differences in chromatin binding after RNase treatment (Figure 12), consistent with 
recruitment of TFIIB to DNA during transcription initiation (Sainsbury, Bernecky, 
and Cramer 2015). Also as expected, RNase treatment did not affect association of 
Pol II with chromatin, showing that the observed losses of EFs from chromatin upon 
RNase treatment were not due to a loss of Pol II (Figure 12). The above results show 
that the association of many EFs with chromatin depends on RNA. 
3.5 Ctk1 kinase complex binds RNA in vitro 
The observed RNA-EF crosslinking in vivo and the RNA-dependent chromatin 
association data strongly suggested that EFs can directly bind RNA. To investigate 
this in vitro, we prepared one EF complex in recombinant form. We chose the 
prominent Ser2 kinase complex CTDK-I that comprises the subunits Ctk1, Ctk2, and 
Ctk3 (Muhlbacher et al. 2015, Sterner et al. 1995). CTDK-I is the main yeast kinase 
responsible for phosphorylating the Pol II CTD at Ser2 (Patturajan et al. 1999, Cho et 
al. 2001), and this is a decisive event in establishing the mature Pol II elongation 
complex. Further, RNA-dependent chromatin association of Ctk1 and Ctk2 were most 
unexpected, as for several other EFs RNA interactions were already reported 
(compare introduction).  
We co-expressed recombinant Ctk1, Ctk2, and Ctk3 in insect cells and 
purified a complete, intact CTDK-I complex (2.2.7, Figure 13A). We then tested the 
purified CTDK-I complex for its kinase activity using a purified GST-CTD construct 
and dephosphorylated full-length S. cerevisiae Pol II (2.2.8). Both the GST-CTD and 
the Rpb1 subunit of Pol II were readily phosphorylated by CTDK-I at the Ser2 
position in vitro (Figure 13B,C), showing that our purified CTDK-I complex is active. 
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Figure 13 Recombinant CTDK-I complex is active and binds RNA in vitro. (A) The 
three-subunit CTDK-I complex from S. cerevisiae was recombinantly expressed in insect 
cells and purified to homogeneity. The purified complex was run on a 4–15% gradient SDS-
PAGE and stained with InstantBlueTM. (B) Purified human GST-CTD (10 µM) was incubated 
with 0.4 µM CTDK-I and 3 mM ATP. Time points were taken at 0 (no ATP), 5, 10, 20, 30, 
60 and 120 min and CTDK-I activity was determined by Western blot analysis using an 
antibody that recognizes the Ser2 phosphorylated form of the CTD of Pol II. Molecular mass 
of GST-CTD is ~70 kDa. (C) Purified and dephosporylated Pol II (2 µM) from S. cerevisiae 
was incubated with 0.4 µM CTDK-I and 3 mM ATP. Time points were taken at 0 (no ATP), 
2, 4, 6, 10, 20, 30, 60 and 90 min and CTDK-I activity was determined by Western blotting as 
in (B). Molecular mass of the CTD containing subunit of Pol II, Rpb1, is ~200 kDa. (D) 
Increasing concentrations (0–5.8 µM) of the complete CTDK-I kinase complex were 
incubated with 8 nM of a 24% GC (green line; Kd,app (nM) = 210 ± 18) and with a 45% GC 
(purple line; Kd,app (nM) = 277 ± 21) ssRNA sequences. Binding was determined by relative 
change in fluorescence anisotropy. Data was fit with a single site binding equation. Error bars 
reflect the standard deviation from three experimental replicates. (E) Increasing 
concentrations (0–5.8 µM) of the complete CTDK-I kinase complex were incubated with 
8 nM of a U-rich ssRNA (orange line; Kd,app (nM)  = 123 ± 10), an A-rich ssRNA (purple line; 
Kd,app (nM) = 277 ± 21) and a dsDNA (grey line; Kd,app (nM) = 1007 ± 67) sequences. Binding 
strength, data fitting and standard deviation was determined as in (D). 
 
We then tested the purified CTDK-I complex for RNA binding in vitro. We 
performed fluorescence anisotropy titration experiments using single-stranded (ss) 
RNA oligonucleotides with 45% or 24% GC-content and bearing a 5' FAM label 
(Figure 13D,E). CTDK-I bound both ssRNAs with similar affinities (Figure 13D). We 
also tested U- or A-rich sequences for association with CTDK-I and found some 
preference for U-rich RNA (Figure 13E, Figure 14). Fitting the data with binding 
curves by linear regression resulted in apparent Kd’s in the nanomolar range (Figure 
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13D,E, Figure 14). All experiments were done in the presence of tRNA as competitor, 
indicating that flexible, single-stranded nucleic acids are preferentially bound. 
Consistent with this, CTDK-I bound to duplex DNA much more weakly (dsDNA, 
Figure 13E). These experiments show that the EF complex CTDK-I binds to single-
stranded RNA in vitro, consistent with direct EF-RNA interactions in vivo. 
 
Figure 14 Recombinant and active CTDK-I complex binds preferentially U-rich ssRNA 
in vitro. Binding of CTDK-I to U- and A-rich ssRNA sequences with 24% GC.  Increasing 
concentrations (0–5.8 µM) of the full-length CTDK-I kinase complex were incubated with 
8 nM of a U-rich ssRNA (blue line; Kd,app (nM)  = 83 ± 6) and an A-rich ssRNA (green line; 
Kd,app (nM) = 210 ± 18) sequences. Binding strength, data fitting and standard deviation was 
determined as in Figure 13D. 
3.6 Evidence that RNA contributes to EF recruitment 
We also measured gene occupancies of EFs using ChIP-Seq and compared 
them with our PAR-CLIP occupancies (Figure 15). To do so, we first optimized our 
ChIP protocol for high-throughput sequencing (Figure 16). The obtained ChIP-Seq 
data sets were highly reproducible (Figure 17). For comparability with PAR-CLIP 
data, we collected ChIP-Seq data, although ChIP data are available for single genes or 
genome-wide using various other techniques or set-ups (Keogh, Podolny, and 
Buratowski 2003, Kim et al. 2004, Liu et al. 2005, Pokholok et al. 2005, Weiner et al. 
2015, Kim et al. 2010, Mayer et al. 2010, Ng et al. 2003, Kizer et al. 2005, Krogan, 
Kim, et al. 2003). Metagene analysis of our ChIP-Seq data revealed that EF 
occupancy increased within 100-600 bp downstream of the TSS, and was generally 
high in gene bodies (Figure 15, red lines). In contrast, PAR-CLIP results showed that 
EFs interacted with RNA already from around 20 nt downstream of the capped 5'-end 
of mRNAs (Figure 15, blue lines). This difference was most pronounced for Set2, 
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which occupies transcripts at the 5'-end but showed peak levels of genome association 
only in the downstream region, with peak levels 450-300 bp upstream of the pA site. 
These results are consistent with the idea that RNA contributes to EF recruitment to 
transcribed genes, and that the contribution of RNA-based recruitment differs for 
different EFs. 
 
Figure 15 Comparison of PAR-CLIP and ChIP-Seq occupancy profiles. Averaged ChIP-
Seq (red) and PAR-CLIP (blue) occupancy profiles of EFs and ChIP-Seq of the histone marks 
H3K4me3, H3K79me3 and H3K36me3 (yellow) centered around TSSs [-150 bp to +600 bp] 
and pA sites [-600 bp to +150 bp] individually normalized to range between 0 and 1.  
 
Comparison of our histone methyltransferase PAR-CLIP data sets with ChIP-
Seq data of the corresponding methylation marks (Figure 15, left, orange lines) 
provides further support of the model that RNA binding can contribute to EF 
recruitment to transcribed regions. In the direction of transcription, the PAR-CLIP 
signals for methyltransferases increased first, followed by an onset of ChIP-Seq 
signals for the respective histone methylation marks, which in turn preceded the 
increase in ChIP-Seq signals for the enzymes (Figure 15, left). This sequence of 
signal onsets is consistent with the model that these EFs are recruited by nascent RNA 
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and then modify histones as Pol II moves downstream. Taken together, these results 
suggest that interactions of EFs with nascent RNA contribute to EF recruitment to 
actively transcribed genes in vivo. 
 
Figure 16 Optimization of two major steps for ChIP followed by high-throughput 
sequencing (ChIP-Seq). Example of electropherogram acquired on a Tapestation showing 
DNA fragment size distribution after chromatin sharing (A) and fragment size distribution of 
a DNA library after size selection (B). 
 
 
 
 
Figure 17 Comparison of replicate measurements for ChIP-Seq. Comparison of ChIP-Seq 
IP replicate measurements for elongation factors Bur1, Ctk1 and Rtf1 and histone methylation 
mark H3K36me3. The scatterplots compare average log2 read counts of all transcripts shown 
in Figure 7 using Spearman correlation. 
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4 Discussion 
Here we present a large set of system-wide occupancy data for yeast transcription 
elongation factors on RNA (PAR-CLIP) and DNA (ChIP-Seq), and complementary 
biochemical data. The remarkable finding from our work is that many elongation 
factors (EFs) interact with nascent RNA in vivo. Additional in vitro results support 
these findings and indicate that RNA can contribute to EF recruitment and the 
stability of the transcription elongation complex. These results extend our 
understanding of how the transcription elongation complex is assembled and 
maintained on active genes. The emerging view from our data is that nascent RNA 
contributes to EF recruitment and elongation complex stability to different extents for 
different EFs. We note that our results do not reveal whether and which EFs are 
initially recruited by RNA, and which EFs establish RNA interactions only after they 
have been recruited by alternative interactions, although EF binding in the very 5′-
region of transcripts argues for an RNA-based recruitment model. 
Our PAR-CLIP data revealed that EFs studied here bind nascent transcripts 
without the need of a specific sequence motif –as shown for traditionally studied 
RBPs, such as Nrd1 (Schulz et al. 2013). Additionally, the RNA binding affinities of 
EFs are relatively low when compared to RNA binding proteins involved in RNA 
export or RNA degradation pathways (Baejen et al. 2014). By contrast, elongation 
factors bind DNA with high affinity, as shown by ChIP-Seq. The relative affinities of 
proteins for RNA versus DNA may reflect the main function of the protein. For 
instance, the transfer of an EF from RNA to DNA will be energetically favorable only 
if the factor has a higher affinity for DNA than for RNA. All the above leads us to 
believe that nascent RNA can act as a general binding platform for transcription 
elongation factors that are then transferred to the transcribing chromatin. 
Our results also elucidate the long-standing question how the yeast CTD Ser2 
kinases Ctk1 and Bur1, which are essential for transcription elongation, are recruited 
to transcribing Pol II. The Pol II Ser2 kinases give rise to strong PAR-CLIP signals 
and their chromatin association is strongly dependent on RNA. In addition, we show 
that purified CTDK-I complex strongly binds to RNA in vitro. This all indicates that 
nascent RNA plays an important role in recruiting Ser2 kinases to transcribing Pol II. 
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Binding of the Ser2 kinases near the RNA 5′-end is consistent with stabilization of 
these kinases on the elongation complex by the cap-binding complex (Hossain et al. 
2013, Lidschreiber, Leike, and Cramer 2013). A model of kinase recruitment by 
capped RNA predicts that these enzymes are lost from the transcribing enzyme upon 
RNA cleavage at the pA site, and this is indeed observed by ChIP-Seq. In conclusion, 
RNA-based recruitment of Ser2 kinases explains why Ser2 phosphorylation of the 
CTD is restricted to transcribing polymerases, whereas free or initiating polymerases 
are not phosphorylated at Ser2 residues. 
How can some EFs bind both RNA and Pol II? EFs are generally modular and 
contain multiple domains that can be involved in RNA or protein interactions. 
However, the same domain can mediate both RNA and protein interactions, as 
documented for the RNA export factor Yra1, which contains an RNA recognition 
motif (RRM) domain that binds both RNA and the phosphorylated CTD (MacKellar 
and Greenleaf 2011). Set1 contains two adjacent RRM domains (Tresaugues et al. 
2006), and Set2 contains a SRI domain that binds the phosphorylated CTD (Dengl et 
al. 2009, Sun et al. 2010, Yoh et al. 2007, MacKellar and Greenleaf 2011), but may 
also bind RNA. The three Paf1C subunits that bind RNA in vivo, namely Cdc73, Ctr9 
and Rtf1, also interact with the phosphorylated CTD and the phosphorylated C-
terminal region (CTR) of Spt5 in vitro (Qiu et al. 2012). Rtf1 contains a positively 
charged Plus-3 domain (Finn et al. 2014) that binds the phosphorylated CTR (Wier et 
al. 2013) and single-stranded nucleic acids (de Jong et al. 2008). We predict that 
many EFs contain domains that can interact with RNA or with the phosphorylated 
CTD or CTR, which resemble RNA in its flexible nature and negative charge. 
Whereas for some EFs binding to RNA or the CTD may be mutually exclusive, others 
can bind both Pol II and RNA at the same time, for example Spt5. Due to a lack of 
solubility of individually expressed EF subunits, and the difficulty of preparing EF 
complexes in recombinant and pure form in large quantities, we had to limit our in 
vitro RNA-binding analysis to CTDK-I. 
Finally, we predict that RNA-based recruitment of EFs provides a missing link 
in our understanding of how the transcription cycle is coordinated. When the initiation 
complex assembles at the promoter, TFIIH phosphorylates Ser5 residues in the CTD 
and this enables recruitment of the capping enzyme (Cho et al. 1997, Fabrega et al. 
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2003, Rodriguez et al. 2000, Schroeder et al. 2000, Schwer and Shuman 2011). The 
nascent RNA then receives a 5′-cap (Martinez-Rucobo et al. 2015), and capped RNA 
could then help to recruit EFs. The requirement for a cap on RNA befits the 
observation that Ser5 phosphorylation is needed for high gene occupancy with some 
EFs (Qiu et al. 2012, Qiu, Hu, and Hinnebusch 2009, Qiu et al. 2006, Ng et al. 2003). 
RNA-based recruitment of the major Ser2 kinase, Ctk1 would then lead to CTD 
phosphorylation on Ser2 residues and stable binding of other EFs. Eventually, 
transcription of a pA site triggers RNA cleavage, and this would facilitate loss of 
many RNA-bound EFs and render the polymerase prone to transcription termination. 
Thus, the transcribing Pol II complex may be viewed as a self-organizing system that 
is encoded in the DNA, but only realized on the level of RNA, which plays crucial 
roles in complex assembly and disassembly. 
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5 Future perspectives 
Standard models suggest that regulation of gene expression first occurs during 
transcription and is mainly mediated by DNA binding proteins (e.g., transcription 
factors) (Cosma, Tanaka, and Nasmyth 1999, Felsenfeld and Groudine 2003, Mitchell 
and Tjian 1989).  Subsequently, RNA binding proteins (RBPs) bind the nascent 
transcripts to dictate post-transcriptional mechanisms, such as splicing, stability, 
localization and translation (Tuck and Tollervey 2013, Zhao et al. 2010). However, 
accumulating evidence suggests that nascent pre-mRNAs possess both protein-coding 
and transcription regulatory functions (reviewed in (Skalska et al. 2017)). Recent 
RNA-protein interaction studies revealed that many DNA binding proteins also 
associate with RNA (Di Ruscio et al. 2013, Hendrickson et al. 2016, Sigova et al. 
2015). Furthermore, as presented here, the recruitment of transcription elongation 
factors (EFs) to the nascent RNA seems to be a broadly acting cellular mechanism for 
regulating gene transcription. Some of the future challenges and open questions 
arising from our results are discussed below:  
Discovery of new RNA binding proteins in yeast and human cells 
Here we report in vivo interactions of the nascent pre-mRNA with transcription 
elongation factors in the yeast S. cerevisiae. Interestingly, many of the EFs included 
in our study lack classically defined RNA binding domains. Thus, our findings 
indicate the existence of unrevealed RNA-protein interactions that are yet to be 
discovered. More PAR-CLIP experiments and other RNA-protein interaction methods 
remain to be applied to proteins whose function and/or recruitment are not fully 
understood. In addition, these findings will help to further elucidate the role of the 
nascent RNA during its own transcription.  
Moreover, establishing our PAR-CLIP protocol for the human system would 
be the next logical step in our laboratory. For instance, PAR-CLIP or similar 
experiments are required to confirm direct interactions of regulatory factors, like 
p-TEFb and splicing factors, with RNAs in living cells and to identify where on the 
RNAs these interactions take place. Additionally, the findings reported in this thesis, 
particularly the binding of CTD kinases and histone methyltransferases to RNA, can 
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be now explored in the human system, providing results for which no extrapolation 
will be necessary. 
Nascent RNA and regulation of divergent transcription 
Divergent transcription refers to the production of coding mRNAs from the sense 
direction and non-coding RNAs upstream and antisense to the annotated gene 
(Marquardt et al. 2014). This phenomenon is seen at many promoters in both yeast 
and metazoans (Duttke et al. 2015, Weiner et al. 2015). In S. cerevisiae several 
cryptic unstable transcripts (CUTs) emerge from such promoters and are rapidly 
degraded by the exosome in a pathway involving Nrd1 (Schulz et al. 2013). However, 
regulation and function of CUTs are still poorly understood.  
Recent studies compared chromatin states between coding and non-coding 
regions during divergent transcription. They show that histone marks characteristic 
for 5′ ends of coding regions (e.g. H3K4me3) appear in both directions. In contrast, 
gene body marks (e.g. H3K36me3) correlate mostly with sense transcription (Weiner 
et al. 2015). Complementarily, our ChIP-Seq data revealed that elongation factor 
occupancies differ for sense and antisense transcription (unpublished). Here, we 
showed that also RNA-EF interactions differ for sense and antisense transcripts, 
especially for late EFs like Set2 and Spt6 (Figure 10 and Figure 11). Together, these 
data likely reflects rapid termination of antisense CUTs by the Nrd1–Nab3–Sen1 
(NNS) termination pathway (Porrua and Libri 2015). Early termination of antisense 
transcripts would prevent the transition of Pol II from initiation to elongation, thus 
stopping elongation factors to be recruited and histone marks to be deposited. To 
confirm this hypothesis, however, more experimental evidence is necessary. For 
instance PAR-CLIP and ChIP-Seq data of EFs in an Nrd1 depletion background will 
show if DNA and RNA interactions with these factors can then occur in the absence 
of Nrd1. These results will indicate whether Nrd1 RNA-binding or early-termination 
by Nrd1 prevent DNA/RNA binding of some EFs and thus the transition to productive 
elongation. 
Role of RNA in maintaining protein-chromatin interactions 
With our chromatin-binding assay after RNA degradation we provide strong evidence 
for a direct role of RNA in maintaining EF-chromatin interactions. We showed that 
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levels of EFs bound to chromatin were significantly decreased in the absence of RNA 
(Figure 12). It will be very interesting to extend these findings and test human 
homologs of the factors analyzed here in a similar assay to investigate how 
transcription factors in higher eukaryotes are recruited to transcribed genes.  
In vitro validation of in vivo RNA-protein interactions 
We purified recombinant CTDK-I kinase complex to demonstrate its binding to RNA 
in vitro, and thus validate our in vivo findings (Figure 13). Similarly, binding of 
additional factors, like the BUR kinase complex, the Spt6 histone chaperone and the 
Set2 histone methyltransferase, to RNA remain to be tested in vitro. Once having 
these complexes in a purified form, we will be able to perform different mutations to 
uncover the RNA binding domains of the studied proteins, given that many of them 
lack classically defined RNA binding domains. 
Nascent RNA as a recruitment platform for transcription factors 
We compared elongation factor occupancies on DNA (ChIP-Seq) and on RNA (PAR-
CLIP) (Figure 15) and showed that interactions of EFs with nascent RNA are 
established before EFs are recruited to chromatin. These results provide additional 
evidence for an RNA-based EF recruitment. Nonetheless, it was previously shown 
that protein-protein and chromatin-protein interactions are important for EF 
recruitment. For instance, Paf1C is required for H2B ubiquitination (H2Bub), which 
in turns enables recruitment of the Set1-containing COMPASS complex (Krogan, 
Dover, et al. 2003, Ng et al. 2003). 
To extend the finding that nascent RNA is also involved in the recruitment of 
Set1, ChIP experiments directly comparing Set1 occupancy on genes in strains 
lacking Paf1C will be important. Also, ChIP experiments of Set1 lacking its RNA 
recognition motif (RRM) can be performed. In a third experiment, both deletion of 
Paf1C and the RRM domain would be compared with the wild-type gene occupancy 
of Set1. If both Paf1C and RNA are important for Set1 recruitment, then impairing 
these mechanisms will abolish gene occupancy. Whereas Set1 ChIP in a Paf1C 
knockout background or in a strain lacking the RRM domain of Set1, should result 
only in a partial decrease of gene occupancy. 
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6 Additional unpublished data 
6.1 Investigation of novel factors in chromatin transcription 
Transcription regulation is intimately linked to changes in chromatin structure and 
modification (Smolle and Workman 2013). Factors that associate with the Pol II 
transcription machinery can remodel (Chd1) or modify (Set1, Set2) chromatin 
(Carrozza, Li, et al. 2005, Ng et al. 2003, Smolle et al. 2012). Specific chromatin 
structures and modifications can be associated with either active or inactive 
transcription. Histone H3K4 trimethylation and histone H3K9 methylation are typical 
examples of this (reviewed in (Smolle and Workman 2013)). These histone marks are 
recognized by specific factors that “read” this modification in order to perform their 
function (histone readers). Despite a large body of work, there still exist putative 
histone marks and readers that have not been sufficiently characterized to reveal their 
functions. Furthermore, specific enzymes that remove the histone mark remain to be 
identified, such as the demethylase of the active histone mark H3K79me3 (Nguyen 
and Zhang 2011). 
This project focuses on the discovery of new readers of the active histone 
marks H3K4me3, H3K36me3 and H3K79me3 that are written by the 
methyltransferases Set1, Set2 and Dot1, respectively. Readers of histone marks 
contain specific domains that recognize the target mark (Table 14; reviewed in 
(Smolle and Workman 2013)).   
Table 14 Transcription activating histone methylations (blue). Known methyltransferases 
and demethylases are shown in red and purple, respectively. Recognition modules (reader 
domains) that bind specific modifications are indicated in green (see Table 19, Table 20, 
Table 21 and Table 22 for references). 
Methyltransferase Histone Methylation Reader Domain Demethylase 
Set1 H3K4 (me1, me2, me3) PHD, Chromo, MBT, Zf-CW Jhd2 (PHD) 
Dot1 H3K79 (me1, me2, me3) Tudor Unknown 
Set2 H3K36 (me1, me2, me3) PHD, Chromo, PWWP Jhd1 (PHD) 
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We started our investigations by using the open-source software HHpred 
(Söding, Biegert, and Lupas 2005) to screen the S. cerevisiae genome for proteins 
containing reader domains known to bind these active histone marks (Table 14). This 
analysis provided us with a list of known and potential new readers of the specific 
histone marks that we were interested in. With this information, we first performed 
ChIP-qPCR experiments for the new potential readers to select for chromatin binders 
(Table 15 and Table 16). We then collected a large set of functional genome-wide 
data of the most promising candidates. First, we obtained genomic occupancy profiles 
(ChIP-Seq) and second, we monitored changes in newly synthesized transcription 
upon factor deletion (knockout; KO) or depletion (anchor-away; AA) (Haruki, 
Nishikawa, and Laemmli 2008) by 4tU-Seq. 4tU-Seq is a method that applies a short 
metabolic RNA labeling pulse to sequencing of the newly synthesized RNA and 
enables extraction of both RNA synthesis and degradation rates genome-wide (Schulz 
et al. 2013).  
 
Table 15 Factors containing reader domains with positive ChIP-qPCR signal. 
Complex Factor Domain 
Available data 
ChIP-qPCR ChIP-Seq 4tU-Seq 
- Asr1 PHD1; PHD2 ✓ ✓ ✓ AA 
- Bye1 PHD   ✓ ✓ KO 
NuA3 Nto1 PHD ✓ ✓   
Set3C Set3 PHD ✓ 	 	
- Set4 PHD ✓ ✓ ✓ AA 
COMPASS Spp1 PHD ✓ 	 	
NuA3 Yng1 PHD ✓ ✓ 	
NuA4 Yng2 PHD ✓ 	 	
- Rad9 Tudor ✓ ✓ 	
SAGA/SILK Sgf29 Tudor ✓ 	 	
Isw1b Ioc4 PWWP ✓ ✓ 	
NuA3b Pdp3 PWWP ✓ ✓ 	
 Chd1 Chromo ✓   	
NuA4 Esa1 Chromo ✓ 	 	
AA: anchor-away 
KO: knockout  
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Table 16 Factors containing reader domains without positive ChIP-qPCR signal. 
Complex Factor Domain 
Available data 
ChIP-qPCR 
Rpd3L Pho23 PHD ✓ 
Rpd3L Cti6 PHD ✓ 
- Jhd1 PHD ✓ 
- Jhd2 PHD ✓ 
Snt2C Ecm5 PHD ✓ 
Snt2C Snt2 PHD ✓ 
Rpd3S Rco1 PHD ✓ 
Rpd3S/NuA4 Eaf3 Tudor ✓ 
 
As a reference and positive control, we also collected such data sets for the 
histone methyltransferases Set1, Set2 and Dot1 (Table 17). Additionally, genome-
wide distributions were also obtained for the chromatin marks H3K4me3, H3K36me3 
and H3K79me3 (Table 18). We partially extended our data collection for some of the 
factors using PAR-CLIP, which can map RNA-associated factors over the 
transcriptome (Table 17; (Hafner et al. 2010)). See Table 15, Table 16, Table 17 and 
Table 18 for an overview of the data produced for this project during this thesis; see 
Table 19, Table 20, Table 21 and Table 22 for an overview of the available literature 
regarding writers, histone marks and histone readers discussed in this section. 
 
Table 17 Histone methyltransferases (writers) of active histone marks. 
Complex Factor Domain 
Available data 
ChIP-qPCR ChIP-Seq 4tU-Seq PAR-CLIP 
- Dot1  ✓ ✓   ✓ 
COMPASS Set1 SET ✓ ✓ ✓ AA&KO ✓ 
- Set2 SET ✓ ✓ ✓ AA&KO ✓ 
AA: anchor-away 
KO: knockout 
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Table 18 Histone marks related to active transcription. 
Histone mark 
Available data 
ChIP-qPCR ChIP-Seq 
H3K4me3 ✓ ✓ 
H3K36me3 ✓ ✓ 
H3K79me3 ✓ ✓ 
 
Our genome-wide data is currently under bioinformatics analysis. With the 
combination of these data sets, we aim to address the questions of where the novel 
chromatin factors are associated with the yeast genome, which genes require them for 
normal transcription, and how their occupancy and functional specificity is correlated 
with previously known, well-studied components of the transcription machinery. We 
thereby aim to further characterize the relationship between chromatin and 
transcription in yeast and thus extend the so called “histone code” (Jenuwein and Allis 
2001). Bioinformatics analysis will indicate which further wet lab work will be 
necessary to elucidate our questions. In vitro binding assays of the reader’s domain 
using histone peptide arrays, as well as ChIP-Seq experiments of new potential 
readers in a writer knockout background are experiments to be considered.   
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Table 19 Available information for factors containing reader domains with positive ChIP-
qPCR signal. 
Factor Protein function References 
Asr1 Ubiquitin ligase; binds Pol II CTD on Ser5-P (Daulny et al. 2008) 
Bye1 Binds H3K4me3 and Pol II (Kinkelin et al. 2013) 
Nto1 Subunit of the NuA3 histone acetyltransferase complex that acetylates H3 
(Shi et al. 
2007) 
Set3 Part of the Set3C histone deacetylase complex 
(Krogan, 
Kim, et al. 
2003) 
Set4 Function unknown; contains both a SET and a PHD domain (Pijnappel et al. 2001) 
Spp1 Subunit of the COMPASS (Set1C) complex that methylates H3K4 (Miller et al. 2001) 
Yng1 Subunit of the NuA3 histone acetyltransferase complex that acetylates H3 
(Martin et 
al. 2006) 
Yng2 Subunit of the NuA4 histone acetyltransferase complex that acetylates H4 and H2B 
(Chittuluru 
et al. 2011) 
Rad9 DNA damage-dependent checkpoint protein (Wang et al. 2012) 
Sgf29 Component of the transcription regulatory histone acetylation (HAT) complexes SAGA, SLIK, and ADA 
(Bian et al. 
2011) 
Ioc4 Binds H3K36me3; recruits the remodeling complex Isw1b to ORFs (Smolle et al. 2012) 
Pdp3 Binds H3K36me3; part of the new histone acetyltransferase complex NuA3b 
(Gilbert et 
al. 2014) 
Chd1 Chromatin-remodeling factor (Smolle et al. 2012) 
Esa1 Catalytic subunit of the NuA4 histone acetyltransferase complex  (Ginsburg et al. 2014) 
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Table 20 Available information for factors containing reader domains without ChIP-qPCR 
signal. 
Factor Protein function References 
Pho23 Subunit of the Rpd3L histone deacetylase complex (Terzi et al. 2011) 
Cti6 Component of the Rpd3L histone deacetylase complex 
(Carrozza, 
Florens, et al. 
2005) 
Jhd1 Histone demethylase that specifically demethylates H3K36 (Tsukada et al. 2006) 
Jhd2 Histone demethylase specific for H3K4 (Liang et al. 2007) 
Ecm5 Possible histone demethylase; recruits Rpd3p to a small number of promoters 
(Baker et al. 
2013) 
Snt2 Involved in ubiquitylation; recruits Rpd3p to a small number of promoters 
(Baker et al. 
2013, Singh 
et al. 2012) 
Rco1 Catalytic component of the Rpd3S histone deacetylase complex 
(Carrozza, 
Li, et al. 
2005) 
Eaf3 Component of the Rpd3S histone deacetylase complex and also part of NuA4 acetyltransferase 
(Carrozza, 
Li, et al. 
2005, Eisen 
et al. 2001) 
 
Table 21 Function of histone methyltransferases (writers). 
Factor Protein function References 
Set1 Mono-, di- and trimethylation of H3K4; involved in initiation (Ng et al. 2003) 
Set2 Mono-, di- and trimethylation of H3K36; involved in elongation 
(Krogan, 
Kim, et al. 
2003) 
Dot1 Mono-, di- and trimethylation of H3K79; involved in elongation (Nguyen and Zhang 2011) 
 
Table 22 Function of histone marks. 
Histone 
mark Function of histone mark References 
H3K4me3 Positive regulation of gene expression; present at promoters and 5′ region of genes 
(Mulder et al. 
2007) 
H3K36me3 Positive regulation of gene expression; present at gene-body (Kizer et al. 2005) 
H3K79me3 Positive regulation of gene expression; present at gene-body (Nguyen and Zhang 2011) 
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6.2 Genome-wide occupancy profiles of Pol II CTD phosphorylation 
marks 
Specific modifications on the C-terminal domain (CTD) of Pol II are linked to certain 
stages of gene transcription and RNA processing in various organisms (Heidemann et 
al. 2013). This refers to the hypothesis of the “CTD code”, where combinations of 
modifications are written and read by specific factors, thus coordinating the entire 
transcription cycle (Buratowski 2003). Correlation of gene occupancy profiles of 
transcription factors, as well as of possible new factors involved in transcription, with 
the different states of the Pol II CTD, should be a good starting point to address the 
genome-wide location or even the function of a given factor.  
 Available genome-wide data of the distribution of CTD phosphorylation 
marks in S. cerevisiae was obtained by ChIP followed by tiling microarray analysis 
(Mayer et al. 2010, Tietjen et al. 2010). Here, we performed higher resolution ChIP-
Seq experiments for three phosphorylation states of the Pol II CTD that will support 
our investigations in the discovery and characterization of new transcription factors 
by correlation analysis (Figure 18). Additionally, this high-resolution data is of great 
interest for the group for current and future research regarding gene transcription. 
 
Figure 18 Genome-wide average occupancy profiles of the CTD phosphorylation marks 
Tyr1-P, Ser2-P and Ser5-P revealed by ChIP-Seq experiments using specific monoclonal 
antibodies ((Chapman et al. 2007); Table 10). While Ser5-P peaks at the transcription start 
site (TSS) of genes, Tyr1-P and Ser2-P signals increase toward the 3′ end and 
polyadenylation site. 
 
 
Additional unpublished data 
 88 
  
References 
 89 
References 
Adelman, K., and J. T. Lis. 2012. "Promoter-proximal pausing of RNA polymerase II: 
emerging roles in metazoans."  Nat Rev Genet 13 (10):720-31. doi: 10.1038/nrg3293. 
Alexander, R. D., S. A. Innocente, J. D. Barrass, and J. D. Beggs. 2010. "Splicing-dependent 
RNA polymerase pausing in yeast."  Mol Cell 40 (4):582-93. doi: 
10.1016/j.molcel.2010.11.005. 
Andersson, R., C. Gebhard, I. Miguel-Escalada, I. Hoof, J. Bornholdt, M. Boyd, Y. Chen, X. 
Zhao, C. Schmidl, T. Suzuki, E. Ntini, E. Arner, E. Valen, K. Li, L. Schwarzfischer, 
D. Glatz, J. Raithel, B. Lilje, N. Rapin, F. O. Bagger, M. Jorgensen, P. R. Andersen, 
N. Bertin, O. Rackham, A. M. Burroughs, J. K. Baillie, Y. Ishizu, Y. Shimizu, E. 
Furuhata, S. Maeda, Y. Negishi, C. J. Mungall, T. F. Meehan, T. Lassmann, M. Itoh, 
H. Kawaji, N. Kondo, J. Kawai, A. Lennartsson, C. O. Daub, P. Heutink, D. A. 
Hume, T. H. Jensen, H. Suzuki, Y. Hayashizaki, F. Muller, Fantom Consortium, A. 
R. Forrest, P. Carninci, M. Rehli, and A. Sandelin. 2014. "An atlas of active 
enhancers across human cell types and tissues."  Nature 507 (7493):455-61. doi: 
10.1038/nature12787. 
Ard, R., and R. C. Allshire. 2016. "Transcription-coupled changes to chromatin underpin 
gene silencing by transcriptional interference."  Nucleic Acids Res 44 (22):10619-
10630. doi: 10.1093/nar/gkw801. 
Armache, K. J., H. Kettenberger, and P. Cramer. 2003. "Architecture of initiation-competent 
12-subunit RNA polymerase II."  Proc Natl Acad Sci U S A 100 (12):6964-8. doi: 
10.1073/pnas.1030608100. 
Armache, K. J., S. Mitterweger, A. Meinhart, and P. Cramer. 2005. "Structures of complete 
RNA polymerase II and its subcomplex, Rpb4/7."  J Biol Chem 280 (8):7131-4. doi: 
10.1074/jbc.M413038200. 
Asin-Cayuela, J., and C. M. Gustafsson. 2007. "Mitochondrial transcription and its regulation 
in mammalian cells."  Trends Biochem Sci 32 (3):111-7. doi: 
10.1016/j.tibs.2007.01.003. 
Baejen, C., J. Andreani, P. Torkler, S. Battaglia, B. Schwalb, M. Lidschreiber, K. C. Maier, 
A. Boltendahl, P. Rus, S. Esslinger, J. Söding, and P. Cramer. 2017. "Genome-wide 
Analysis of RNA Polymerase II Termination at Protein-Coding Genes."  Mol Cell. 
doi: 10.1016/j.molcel.2017.02.009. 
Baejen, C., P. Torkler, S. Gressel, K. Essig, J. Söding, and P. Cramer. 2014. "Transcriptome 
maps of mRNP biogenesis factors define pre-mRNA recognition."  Mol Cell 55 
(5):745-57. doi: 10.1016/j.molcel.2014.08.005. 
Baker, L. A., B. M. Ueberheide, S. Dewell, B. T. Chait, D. Zheng, and C. D. Allis. 2013. 
"The yeast Snt2 protein coordinates the transcriptional response to hydrogen 
peroxide-mediated oxidative stress."  Mol Cell Biol 33 (19):3735-48. doi: 
10.1128/MCB.00025-13. 
Banerji, J., S. Rusconi, and W. Schaffner. 1981. "Expression of a beta-globin gene is 
enhanced by remote SV40 DNA sequences."  Cell 27 (2 Pt 1):299-308. 
References 
 90 
Bannister, A. J., R. Schneider, F. A. Myers, A. W. Thorne, C. Crane-Robinson, and T. 
Kouzarides. 2005. "Spatial distribution of di- and tri-methyl lysine 36 of histone H3 
at active genes."  J Biol Chem 280 (18):17732-6. doi: 10.1074/jbc.M500796200. 
Barrandon, C., B. Spiluttini, and O. Bensaude. 2008. "Non-coding RNAs regulating the 
transcriptional machinery."  Biol Cell 100 (2):83-95. doi: 10.1042/BC20070090. 
Bartkowiak, B., P. Liu, H. P. Phatnani, N. J. Fuda, J. J. Cooper, D. H. Price, K. Adelman, J. 
T. Lis, and A. L. Greenleaf. 2010. "CDK12 is a transcription elongation-associated 
CTD kinase, the metazoan ortholog of yeast Ctk1."  Genes Dev 24 (20):2303-16. doi: 
10.1101/gad.1968210. 
Beltran, M., C. M. Yates, L. Skalska, M. Dawson, F. P. Reis, K. Viiri, C. L. Fisher, C. R. 
Sibley, B. M. Foster, T. Bartke, J. Ule, and R. G. Jenner. 2016. "The interaction of 
PRC2 with RNA or chromatin is mutually antagonistic."  Genome Res 26 (7):896-
907. doi: 10.1101/gr.197632.115. 
Bentley, D. L. 2005. "Rules of engagement: co-transcriptional recruitment of pre-mRNA 
processing factors."  Curr Opin Cell Biol 17 (3):251-6. doi: 
10.1016/j.ceb.2005.04.006. 
Berger, I., D. J. Fitzgerald, and T. J. Richmond. 2004. "Baculovirus expression system for 
heterologous multiprotein complexes."  Nat Biotechnol 22 (12):1583-7. doi: 
10.1038/nbt1036. 
Bian, C., C. Xu, J. Ruan, K. K. Lee, T. L. Burke, W. Tempel, D. Barsyte, J. Li, M. Wu, B. O. 
Zhou, B. E. Fleharty, A. Paulson, A. Allali-Hassani, J. Q. Zhou, G. Mer, P. A. Grant, 
J. L. Workman, J. Zang, and J. Min. 2011. "Sgf29 binds histone H3K4me2/3 and is 
required for SAGA complex recruitment and histone H3 acetylation."  EMBO J 30 
(14):2829-42. doi: 10.1038/emboj.2011.193. 
Bortvin, A., and F. Winston. 1996. "Evidence that Spt6p controls chromatin structure by a 
direct interaction with histones."  Science 272 (5267):1473-6. 
Buratowski, S. 2003. "The CTD code."  Nat Struct Biol 10 (9):679-80. doi: 10.1038/nsb0903-
679. 
Bushnell, D. A., and R. D. Kornberg. 2003. "Complete, 12-subunit RNA polymerase II at 4.1-
A resolution: implications for the initiation of transcription."  Proc Natl Acad Sci U S 
A 100 (12):6969-73. doi: 10.1073/pnas.1130601100. 
Bushnell, D. A., K. D. Westover, R. E. Davis, and R. D. Kornberg. 2004. "Structural basis of 
transcription: an RNA polymerase II-TFIIB cocrystal at 4.5 Angstroms."  Science 303 
(5660):983-8. doi: 10.1126/science.1090838. 
Carrillo Oesterreich, F., L. Herzel, K. Straube, K. Hujer, J. Howard, and K. M. Neugebauer. 
2016. "Splicing of Nascent RNA Coincides with Intron Exit from RNA Polymerase 
II."  Cell 165 (2):372-81. doi: 10.1016/j.cell.2016.02.045. 
Carrozza, M. J., L. Florens, S. K. Swanson, W. J. Shia, S. Anderson, J. Yates, M. P. 
Washburn, and J. L. Workman. 2005. "Stable incorporation of sequence specific 
repressors Ash1 and Ume6 into the Rpd3L complex."  Biochim Biophys Acta 1731 
(2):77-87; discussion 75-6. doi: 10.1016/j.bbaexp.2005.09.005. 
References 
 91 
Carrozza, M. J., B. Li, L. Florens, T. Suganuma, S. K. Swanson, K. K. Lee, W. J. Shia, S. 
Anderson, J. Yates, M. P. Washburn, and J. L. Workman. 2005. "Histone H3 
methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress 
spurious intragenic transcription."  Cell 123 (4):581-92. doi: 
10.1016/j.cell.2005.10.023. 
Chapman, R. D., M. Heidemann, T. K. Albert, R. Mailhammer, A. Flatley, M. Meisterernst, 
E. Kremmer, and D. Eick. 2007. "Transcribing RNA polymerase II is phosphorylated 
at CTD residue serine-7."  Science 318 (5857):1780-2. doi: 10.1126/science.1145977. 
Chapman, R. D., M. Heidemann, C. Hintermair, and D. Eick. 2008. "Molecular evolution of 
the RNA polymerase II CTD."  Trends Genet 24 (6):289-96. doi: 
10.1016/j.tig.2008.03.010. 
Cheng, B., and D. H. Price. 2007. "Properties of RNA polymerase II elongation complexes 
before and after the P-TEFb-mediated transition into productive elongation."  J Biol 
Chem 282 (30):21901-12. doi: 10.1074/jbc.M702936200. 
Chittuluru, J. R., Y. Chaban, J. Monnet-Saksouk, M. J. Carrozza, V. Sapountzi, W. Selleck, J. 
Huang, R. T. Utley, M. Cramet, S. Allard, G. Cai, J. L. Workman, M. G. Fried, S. 
Tan, J. Cote, and F. J. Asturias. 2011. "Structure and nucleosome interaction of the 
yeast NuA4 and Piccolo-NuA4 histone acetyltransferase complexes."  Nat Struct Mol 
Biol 18 (11):1196-203. doi: 10.1038/nsmb.2128. 
Cho, E. J., M. S. Kobor, M. Kim, J. Greenblatt, and S. Buratowski. 2001. "Opposing effects 
of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal 
domain."  Genes Dev 15 (24):3319-29. doi: 10.1101/gad.935901. 
Cho, E. J., T. Takagi, C. R. Moore, and S. Buratowski. 1997. "mRNA capping enzyme is 
recruited to the transcription complex by phosphorylation of the RNA polymerase II 
carboxy-terminal domain."  Genes Dev 11 (24):3319-26. 
Chong, Y. T., J. L. Koh, H. Friesen, S. K. Duffy, M. J. Cox, A. Moses, J. Moffat, C. Boone, 
and B. J. Andrews. 2015. "Yeast Proteome Dynamics from Single Cell Imaging and 
Automated Analysis."  Cell 161 (6):1413-24. doi: 10.1016/j.cell.2015.04.051. 
Connelly, S., and J. L. Manley. 1988. "A functional mRNA polyadenylation signal is required 
for transcription termination by RNA polymerase II."  Genes Dev 2 (4):440-52. 
Cosma, M. P., T. Tanaka, and K. Nasmyth. 1999. "Ordered recruitment of transcription and 
chromatin remodeling factors to a cell cycle- and developmentally regulated 
promoter."  Cell 97 (3):299-311. 
Cramer, P., D. A. Bushnell, and R. D. Kornberg. 2001. "Structural basis of transcription: 
RNA polymerase II at 2.8 angstrom resolution."  Science 292 (5523):1863-76. doi: 
10.1126/science.1059493. 
Crick, F. 1970. "Central dogma of molecular biology."  Nature 227 (5258):561-3. 
Crick, F. H. 1958. "On protein synthesis."  Symp Soc Exp Biol 12:138-63. 
Daulny, A., F. Geng, M. Muratani, J. M. Geisinger, S. E. Salghetti, and W. P. Tansey. 2008. 
"Modulation of RNA polymerase II subunit composition by ubiquitylation."  Proc 
Natl Acad Sci U S A 105 (50):19649-54. doi: 10.1073/pnas.0809372105. 
References 
 92 
Davidovich, C., L. Zheng, K. J. Goodrich, and T. R. Cech. 2013. "Promiscuous RNA binding 
by Polycomb repressive complex 2."  Nat Struct Mol Biol 20 (11):1250-7. doi: 
10.1038/nsmb.2679. 
Davison, B. L., J. M. Egly, E. R. Mulvihill, and P. Chambon. 1983. "Formation of stable 
preinitiation complexes between eukaryotic class B transcription factors and 
promoter sequences."  Nature 301 (5902):680-6. 
de Jong, R. N., V. Truffault, T. Diercks, E. Ab, M. A. Daniels, R. Kaptein, and G. E. Folkers. 
2008. "Structure and DNA binding of the human Rtf1 Plus3 domain."  Structure 16 
(1):149-59. doi: 10.1016/j.str.2007.10.018. 
Dengl, S., A. Mayer, M. Sun, and P. Cramer. 2009. "Structure and in vivo requirement of the 
yeast Spt6 SH2 domain."  J Mol Biol 389 (1):211-25. doi: 
10.1016/j.jmb.2009.04.016. 
Dermody, J. L., and S. Buratowski. 2010. "Leo1 subunit of the yeast paf1 complex binds 
RNA and contributes to complex recruitment."  J Biol Chem 285 (44):33671-9. doi: 
10.1074/jbc.M110.140764. 
Di Ruscio, A., A. K. Ebralidze, T. Benoukraf, G. Amabile, L. A. Goff, J. Terragni, M. E. 
Figueroa, L. L. De Figueiredo Pontes, M. Alberich-Jorda, P. Zhang, M. Wu, F. 
D'Alo, A. Melnick, G. Leone, K. K. Ebralidze, S. Pradhan, J. L. Rinn, and D. G. 
Tenen. 2013. "DNMT1-interacting RNAs block gene-specific DNA methylation."  
Nature 503 (7476):371-6. doi: 10.1038/nature12598. 
Dobin, A., C. A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, P. Batut, M. Chaisson, 
and T. R. Gingeras. 2013. "STAR: ultrafast universal RNA-seq aligner."  
Bioinformatics 29 (1):15-21. doi: 10.1093/bioinformatics/bts635. 
Duttke, S. H., S. A. Lacadie, M. M. Ibrahim, C. K. Glass, D. L. Corcoran, C. Benner, S. 
Heinz, J. T. Kadonaga, and U. Ohler. 2015. "Human promoters are intrinsically 
directional."  Mol Cell 57 (4):674-84. doi: 10.1016/j.molcel.2014.12.029. 
Ebright, R. H. 2000. "RNA polymerase: structural similarities between bacterial RNA 
polymerase and eukaryotic RNA polymerase II."  J Mol Biol 304 (5):687-98. doi: 
10.1006/jmbi.2000.4309. 
Eick, D., and M. Geyer. 2013. "The RNA polymerase II carboxy-terminal domain (CTD) 
code."  Chem Rev 113 (11):8456-90. doi: 10.1021/cr400071f. 
Eisen, A., R. T. Utley, A. Nourani, S. Allard, P. Schmidt, W. S. Lane, J. C. Lucchesi, and J. 
Cote. 2001. "The yeast NuA4 and Drosophila MSL complexes contain homologous 
subunits important for transcription regulation."  J Biol Chem 276 (5):3484-91. doi: 
10.1074/jbc.M008159200. 
Fabrega, C., V. Shen, S. Shuman, and C. D. Lima. 2003. "Structure of an mRNA capping 
enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase 
II."  Mol Cell 11 (6):1549-61. 
Felsenfeld, G., and M. Groudine. 2003. "Controlling the double helix."  Nature 421 
(6921):448-53. doi: 10.1038/nature01411. 
Finn, R. D., A. Bateman, J. Clements, P. Coggill, R. Y. Eberhardt, S. R. Eddy, A. Heger, K. 
Hetherington, L. Holm, J. Mistry, E. L. Sonnhammer, J. Tate, and M. Punta. 2014. 
References 
 93 
"Pfam: the protein families database."  Nucleic Acids Res 42 (Database issue):D222-
30. doi: 10.1093/nar/gkt1223. 
Fischl, H., F. S. Howe, A. Furger, and J. Mellor. 2017. "Paf1 Has Distinct Roles in 
Transcription Elongation and Differential Transcript Fate."  Mol Cell 65 (4):685-698 
e8. doi: 10.1016/j.molcel.2017.01.006. 
Fishburn, J., E. Galburt, and S. Hahn. 2016. "Transcription Start Site Scanning and the 
Requirement for ATP during Transcription Initiation by RNA Polymerase II."  J Biol 
Chem 291 (25):13040-7. doi: 10.1074/jbc.M116.724583. 
Gilbert, C., and J. Q. Svejstrup. 2006. "RNA immunoprecipitation for determining RNA-
protein associations in vivo."  Curr Protoc Mol Biol Chapter 27:Unit 27 4. doi: 
10.1002/0471142727.mb2704s75. 
Gilbert, T. M., S. L. McDaniel, S. D. Byrum, J. A. Cades, B. C. Dancy, H. Wade, A. J. 
Tackett, B. D. Strahl, and S. D. Taverna. 2014. "A PWWP domain-containing protein 
targets the NuA3 acetyltransferase complex via histone H3 lysine 36 trimethylation to 
coordinate transcriptional elongation at coding regions."  Mol Cell Proteomics 13 
(11):2883-95. doi: 10.1074/mcp.M114.038224. 
Ginsburg, D. S., T. E. Anlembom, J. Wang, S. R. Patel, B. Li, and A. G. Hinnebusch. 2014. 
"NuA4 links methylation of histone H3 lysines 4 and 36 to acetylation of histones H4 
and H3."  J Biol Chem 289 (47):32656-70. doi: 10.1074/jbc.M114.585588. 
Grohmann, D., J. Nagy, A. Chakraborty, D. Klose, D. Fielden, R. H. Ebright, J. Michaelis, 
and F. Werner. 2011. "The initiation factor TFE and the elongation factor Spt4/5 
compete for the RNAP clamp during transcription initiation and elongation."  Mol 
Cell 43 (2):263-74. doi: 10.1016/j.molcel.2011.05.030. 
Hafner, M., M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A. Rothballer, 
M. Ascano, A. C. Jungkamp, M. Munschauer, A. Ulrich, G. S. Wardle, S. Dewell, M. 
Zavolan, and T. Tuschl. 2010. "PAR-CliP--a method to identify transcriptome-wide 
the binding sites of RNA binding proteins."  J Vis Exp (41). doi: 10.3791/2034. 
Hahn, S. 2004. "Structure and mechanism of the RNA polymerase II transcription 
machinery."  Nat Struct Mol Biol 11 (5):394-403. doi: 10.1038/nsmb763. 
Halbach, A., H. Zhang, A. Wengi, Z. Jablonska, I. M. Gruber, R. E. Halbeisen, P. M. Dehe, P. 
Kemmeren, F. Holstege, V. Geli, A. P. Gerber, and B. Dichtl. 2009. "Cotranslational 
assembly of the yeast SET1C histone methyltransferase complex."  EMBO J 28 
(19):2959-70. doi: 10.1038/emboj.2009.240. 
Hampsey, M., B. N. Singh, A. Ansari, J. P. Laine, and S. Krishnamurthy. 2011. "Control of 
eukaryotic gene expression: gene loops and transcriptional memory."  Adv Enzyme 
Regul 51 (1):118-25. doi: 10.1016/j.advenzreg.2010.10.001. 
Hartzog, G. A., and J. Fu. 2013. "The Spt4-Spt5 complex: a multi-faceted regulator of 
transcription elongation."  Biochim Biophys Acta 1829 (1):105-15. doi: 
10.1016/j.bbagrm.2012.08.007. 
Haruki, H., J. Nishikawa, and U. K. Laemmli. 2008. "The anchor-away technique: rapid, 
conditional establishment of yeast mutant phenotypes."  Mol Cell 31 (6):925-32. doi: 
10.1016/j.molcel.2008.07.020. 
References 
 94 
Heidemann, M., C. Hintermair, K. Voss, and D. Eick. 2013. "Dynamic phosphorylation 
patterns of RNA polymerase II CTD during transcription."  Biochim Biophys Acta 
1829 (1):55-62. doi: 10.1016/j.bbagrm.2012.08.013. 
Hendrickson, D. G., D. R. Kelley, D. Tenen, B. Bernstein, and J. L. Rinn. 2016. "Widespread 
RNA binding by chromatin-associated proteins."  Genome Biol 17:28. doi: 
10.1186/s13059-016-0878-3. 
Henikoff, S. 2008. "Nucleosome destabilization in the epigenetic regulation of gene 
expression."  Nat Rev Genet 9 (1):15-26. doi: 10.1038/nrg2206. 
Hirata, A., B. J. Klein, and K. S. Murakami. 2008. "The X-ray crystal structure of RNA 
polymerase from Archaea."  Nature 451 (7180):851-4. doi: 10.1038/nature06530. 
Holstege, F. C., U. Fiedler, and H. T. Timmers. 1997. "Three transitions in the RNA 
polymerase II transcription complex during initiation."  EMBO J 16 (24):7468-80. 
doi: 10.1093/emboj/16.24.7468. 
Hossain, M. A., C. Chung, S. K. Pradhan, and T. L. Johnson. 2013. "The yeast cap binding 
complex modulates transcription factor recruitment and establishes proper histone 
H3K36 trimethylation during active transcription."  Mol Cell Biol 33 (4):785-99. doi: 
10.1128/mcb.00947-12. 
Hsin, J. P., and J. L. Manley. 2012. "The RNA polymerase II CTD coordinates transcription 
and RNA processing."  Genes Dev 26 (19):2119-37. doi: 10.1101/gad.200303.112. 
Jain, R., T. Devine, A. D. George, S. V. Chittur, T. E. Baroni, L. O. Penalva, and S. A. 
Tenenbaum. 2011. "RIP-Chip analysis: RNA-Binding Protein Immunoprecipitation-
Microarray (Chip) Profiling."  Methods Mol Biol 703:247-63. doi: 10.1007/978-1-
59745-248-9_17. 
Jenuwein, T., and C. D. Allis. 2001. "Translating the histone code."  Science 293 
(5532):1074-80. doi: 10.1126/science.1063127. 
Jeon, Y., and J. T. Lee. 2011. "YY1 tethers Xist RNA to the inactive X nucleation center."  
Cell 146 (1):119-33. doi: 10.1016/j.cell.2011.06.026. 
Jeronimo, C., A. R. Bataille, and F. Robert. 2013. "The writers, readers, and functions of the 
RNA polymerase II C-terminal domain code."  Chem Rev 113 (11):8491-522. doi: 
10.1021/cr4001397. 
Jonkers, I., and J. T. Lis. 2015. "Getting up to speed with transcription elongation by RNA 
polymerase II."  Nat Rev Mol Cell Biol 16 (3):167-77. doi: 10.1038/nrm3953. 
Kaneko, S., J. Son, R. Bonasio, S. S. Shen, and D. Reinberg. 2014. "Nascent RNA interaction 
keeps PRC2 activity poised and in check."  Genes Dev 28 (18):1983-8. doi: 
10.1101/gad.247940.114. 
Kaneko, S., J. Son, S. S. Shen, D. Reinberg, and R. Bonasio. 2013. "PRC2 binds active 
promoters and contacts nascent RNAs in embryonic stem cells."  Nat Struct Mol Biol 
20 (11):1258-64. doi: 10.1038/nsmb.2700. 
Keene, J. D., J. M. Komisarow, and M. B. Friedersdorf. 2006. "RIP-Chip: the isolation and 
identification of mRNAs, microRNAs and protein components of ribonucleoprotein 
complexes from cell extracts."  Nat Protoc 1 (1):302-7. doi: 10.1038/nprot.2006.47. 
References 
 95 
Keller, W., and L. Minvielle-Sebastia. 1997. "A comparison of mammalian and yeast pre-
mRNA 3'-end processing."  Curr Opin Cell Biol 9 (3):329-36. 
Keogh, M. C., V. Podolny, and S. Buratowski. 2003. "Bur1 kinase is required for efficient 
transcription elongation by RNA polymerase II."  Mol Cell Biol 23 (19):7005-18. 
Kim, H., B. Erickson, W. Luo, D. Seward, J. H. Graber, D. D. Pollock, P. C. Megee, and D. 
L. Bentley. 2010. "Gene-specific RNA polymerase II phosphorylation and the CTD 
code."  Nat Struct Mol Biol 17 (10):1279-86. doi: 10.1038/nsmb.1913. 
Kim, M., S. H. Ahn, N. J. Krogan, J. F. Greenblatt, and S. Buratowski. 2004. "Transitions in 
RNA polymerase II elongation complexes at the 3' ends of genes."  Embo j 23 
(2):354-64. doi: 10.1038/sj.emboj.7600053. 
Kinkelin, K., G. G. Wozniak, S. B. Rothbart, M. Lidschreiber, B. D. Strahl, and P. Cramer. 
2013. "Structures of RNA polymerase II complexes with Bye1, a chromatin-binding 
PHF3/DIDO homologue."  Proc Natl Acad Sci U S A 110 (38):15277-82. doi: 
10.1073/pnas.1311010110. 
Kizer, K. O., H. P. Phatnani, Y. Shibata, H. Hall, A. L. Greenleaf, and B. D. Strahl. 2005. "A 
novel domain in Set2 mediates RNA polymerase II interaction and couples histone 
H3 K36 methylation with transcript elongation."  Mol Cell Biol 25 (8):3305-16. doi: 
10.1128/mcb.25.8.3305-3316.2005. 
Klein, B. J., D. Bose, K. J. Baker, Z. M. Yusoff, X. Zhang, and K. S. Murakami. 2011. "RNA 
polymerase and transcription elongation factor Spt4/5 complex structure."  Proc Natl 
Acad Sci U S A 108 (2):546-50. doi: 10.1073/pnas.1013828108. 
Komarnitsky, P., E. J. Cho, and S. Buratowski. 2000. "Different phosphorylated forms of 
RNA polymerase II and associated mRNA processing factors during transcription."  
Genes Dev 14 (19):2452-60. 
Konig, J., K. Zarnack, G. Rot, T. Curk, M. Kayikci, B. Zupan, D. J. Turner, N. M. Luscombe, 
and J. Ule. 2010. "iCLIP reveals the function of hnRNP particles in splicing at 
individual nucleotide resolution."  Nat Struct Mol Biol 17 (7):909-15. doi: 
10.1038/nsmb.1838. 
Kornblihtt, A. R., M. de la Mata, J. P. Fededa, M. J. Munoz, and G. Nogues. 2004. "Multiple 
links between transcription and splicing."  Rna 10 (10):1489-98. doi: 
10.1261/rna.7100104. 
Krogan, N. J., J. Dover, A. Wood, J. Schneider, J. Heidt, M. A. Boateng, K. Dean, O. W. 
Ryan, A. Golshani, M. Johnston, J. F. Greenblatt, and A. Shilatifard. 2003. "The Paf1 
complex is required for histone H3 methylation by COMPASS and Dot1p: linking 
transcriptional elongation to histone methylation."  Mol Cell 11 (3):721-9. 
Krogan, N. J., M. Kim, A. Tong, A. Golshani, G. Cagney, V. Canadien, D. P. Richards, B. K. 
Beattie, A. Emili, C. Boone, A. Shilatifard, S. Buratowski, and J. Greenblatt. 2003. 
"Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to 
transcriptional elongation by RNA polymerase II."  Mol Cell Biol 23 (12):4207-18. 
Kulak, N. A., G. Pichler, I. Paron, N. Nagaraj, and M. Mann. 2014. "Minimal, encapsulated 
proteomic-sample processing applied to copy-number estimation in eukaryotic cells."  
Nat Methods 11 (3):319-24. doi: 10.1038/nmeth.2834. 
References 
 96 
Kusser, A. G., M. G. Bertero, S. Naji, T. Becker, M. Thomm, R. Beckmann, and P. Cramer. 
2008. "Structure of an archaeal RNA polymerase."  J Mol Biol 376 (2):303-7. doi: 
10.1016/j.jmb.2007.08.066. 
Kwak, H., N. J. Fuda, L. J. Core, and J. T. Lis. 2013. "Precise maps of RNA polymerase 
reveal how promoters direct initiation and pausing."  Science 339 (6122):950-3. doi: 
10.1126/science.1229386. 
Langmead, B., and S. L. Salzberg. 2012. "Fast gapped-read alignment with Bowtie 2."  Nat 
Methods 9 (4):357-9. doi: 10.1038/nmeth.1923. 
Lewis, J. D., and E. Izaurralde. 1997. "The role of the cap structure in RNA processing and 
nuclear export."  Eur J Biochem 247 (2):461-9. 
Li, B., L. Howe, S. Anderson, J. R. Yates, 3rd, and J. L. Workman. 2003. "The Set2 histone 
methyltransferase functions through the phosphorylated carboxyl-terminal domain of 
RNA polymerase II."  J Biol Chem 278 (11):8897-903. doi: 
10.1074/jbc.M212134200. 
Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, and 
R. Durbin. 2009. "The Sequence Alignment/Map format and SAMtools."  
Bioinformatics 25 (16):2078-9. doi: 10.1093/bioinformatics/btp352. 
Li, J., D. Moazed, and S. P. Gygi. 2002. "Association of the histone methyltransferase Set2 
with RNA polymerase II plays a role in transcription elongation."  J Biol Chem 277 
(51):49383-8. doi: 10.1074/jbc.M209294200. 
Li, W., D. Notani, and M. G. Rosenfeld. 2016. "Enhancers as non-coding RNA transcription 
units: recent insights and future perspectives."  Nat Rev Genet 17 (4):207-23. doi: 
10.1038/nrg.2016.4. 
Liang, G., R. J. Klose, K. E. Gardner, and Y. Zhang. 2007. "Yeast Jhd2p is a histone H3 Lys4 
trimethyl demethylase."  Nat Struct Mol Biol 14 (3):243-5. doi: 10.1038/nsmb1204. 
Licatalosi, D. D., A. Mele, J. J. Fak, J. Ule, M. Kayikci, S. W. Chi, T. A. Clark, A. C. 
Schweitzer, J. E. Blume, X. Wang, J. C. Darnell, and R. B. Darnell. 2008. "HITS-
CLIP yields genome-wide insights into brain alternative RNA processing."  Nature 
456 (7221):464-9. doi: 10.1038/nature07488. 
Lidschreiber, M., K. Leike, and P. Cramer. 2013. "Cap completion and C-terminal repeat 
domain kinase recruitment underlie the initiation-elongation transition of RNA 
polymerase II."  Mol Cell Biol 33 (19):3805-16. doi: 10.1128/mcb.00361-13. 
Listerman, I., A. K. Sapra, and K. M. Neugebauer. 2006. "Cotranscriptional coupling of 
splicing factor recruitment and precursor messenger RNA splicing in mammalian 
cells."  Nat Struct Mol Biol 13 (9):815-22. doi: 10.1038/nsmb1135. 
Liu, C. L., T. Kaplan, M. Kim, S. Buratowski, S. L. Schreiber, N. Friedman, and O. J. Rando. 
2005. "Single-nucleosome mapping of histone modifications in S. cerevisiae."  PLoS 
Biol 3 (10):e328. doi: 10.1371/journal.pbio.0030328. 
Liu, Y., L. Warfield, C. Zhang, J. Luo, J. Allen, W. H. Lang, J. Ranish, K. M. Shokat, and S. 
Hahn. 2009. "Phosphorylation of the transcription elongation factor Spt5 by yeast 
Bur1 kinase stimulates recruitment of the PAF complex."  Mol Cell Biol 29 
(17):4852-63. doi: 10.1128/mcb.00609-09. 
References 
 97 
Luehr, S., H. Hartmann, and J. Söding. 2012. "The XXmotif web server for eXhaustive, 
weight matriX-based motif discovery in nucleotide sequences."  Nucleic Acids Res 40 
(Web Server issue):W104-9. doi: 10.1093/nar/gks602. 
Luo, W., and D. Bentley. 2004. "A ribonucleolytic rat torpedoes RNA polymerase II."  Cell 
119 (7):911-4. doi: 10.1016/j.cell.2004.11.041. 
Luse, D. S. 2013. "Promoter clearance by RNA polymerase II."  Biochim Biophys Acta 1829 
(1):63-8. doi: 10.1016/j.bbagrm.2012.08.010. 
MacKellar, A. L., and A. L. Greenleaf. 2011. "Cotranscriptional association of mRNA export 
factor Yra1 with C-terminal domain of RNA polymerase II."  J Biol Chem 286 
(42):36385-95. doi: 10.1074/jbc.M111.268144. 
Manley, J. L., and Y. Takagaki. 1996. "The end of the message--another link between yeast 
and mammals."  Science 274 (5292):1481-2. 
Margaritis, T., and F. C. Holstege. 2008. "Poised RNA polymerase II gives pause for 
thought."  Cell 133 (4):581-4. doi: 10.1016/j.cell.2008.04.027. 
Marquardt, S., R. Escalante-Chong, N. Pho, J. Wang, L. S. Churchman, M. Springer, and S. 
Buratowski. 2014. "A chromatin-based mechanism for limiting divergent noncoding 
transcription."  Cell 157 (7):1712-23. doi: 10.1016/j.cell.2014.04.036. 
Marshall, N. F., J. Peng, Z. Xie, and D. H. Price. 1996. "Control of RNA polymerase II 
elongation potential by a novel carboxyl-terminal domain kinase."  J Biol Chem 271 
(43):27176-83. 
Marshall, N. F., and D. H. Price. 1995. "Purification of P-TEFb, a transcription factor 
required for the transition into productive elongation."  J Biol Chem 270 (21):12335-
8. 
Martin, D. G., K. Baetz, X. Shi, K. L. Walter, V. E. MacDonald, M. J. Wlodarski, O. Gozani, 
P. Hieter, and L. Howe. 2006. "The Yng1p plant homeodomain finger is a methyl-
histone binding module that recognizes lysine 4-methylated histone H3."  Mol Cell 
Biol 26 (21):7871-9. doi: 10.1128/MCB.00573-06. 
Martinez-Rucobo, F. W., R. Kohler, M. van de Waterbeemd, A. J. Heck, M. Hemann, F. 
Herzog, H. Stark, and P. Cramer. 2015. "Molecular Basis of Transcription-Coupled 
Pre-mRNA Capping."  Mol Cell 58 (6):1079-89. doi: 10.1016/j.molcel.2015.04.004. 
Martinez-Rucobo, F. W., S. Sainsbury, A. C. Cheung, and P. Cramer. 2011. "Architecture of 
the RNA polymerase-Spt4/5 complex and basis of universal transcription 
processivity."  Embo j 30 (7):1302-10. doi: 10.1038/emboj.2011.64. 
Mayekar, M. K., R. G. Gardner, and K. M. Arndt. 2013. "The recruitment of the 
Saccharomyces cerevisiae Paf1 complex to active genes requires a domain of Rtf1 
that directly interacts with the Spt4-Spt5 complex."  Mol Cell Biol 33 (16):3259-73. 
doi: 10.1128/mcb.00270-13. 
Mayer, A., M. Heidemann, M. Lidschreiber, A. Schreieck, M. Sun, C. Hintermair, E. 
Kremmer, D. Eick, and P. Cramer. 2012. "CTD tyrosine phosphorylation impairs 
termination factor recruitment to RNA polymerase II."  Science 336 (6089):1723-5. 
doi: 10.1126/science.1219651. 
References 
 98 
Mayer, A., M. Lidschreiber, M. Siebert, K. Leike, J. Söding, and P. Cramer. 2010. "Uniform 
transitions of the general RNA polymerase II transcription complex."  Nat Struct Mol 
Biol 17 (10):1272-8. doi: 10.1038/nsmb.1903. 
Mayer, A., A. Schreieck, M. Lidschreiber, K. Leike, D. E. Martin, and P. Cramer. 2012. "The 
spt5 C-terminal region recruits yeast 3' RNA cleavage factor I."  Mol Cell Biol 32 
(7):1321-31. doi: 10.1128/MCB.06310-11. 
McCracken, S., N. Fong, E. Rosonina, K. Yankulov, G. Brothers, D. Siderovski, A. Hessel, S. 
Foster, S. Shuman, and D. L. Bentley. 1997. "5'-Capping enzymes are targeted to pre-
mRNA by binding to the phosphorylated carboxy-terminal domain of RNA 
polymerase II."  Genes Dev 11 (24):3306-18. 
Meinhart, A., and P. Cramer. 2004. "Recognition of RNA polymerase II carboxy-terminal 
domain by 3'-RNA-processing factors."  Nature 430 (6996):223-6. doi: 
10.1038/nature02679. 
Mercer, T. R., S. Neph, M. E. Dinger, J. Crawford, M. A. Smith, A. M. Shearwood, E. 
Haugen, C. P. Bracken, O. Rackham, J. A. Stamatoyannopoulos, A. Filipovska, and J. 
S. Mattick. 2011. "The human mitochondrial transcriptome."  Cell 146 (4):645-58. 
doi: 10.1016/j.cell.2011.06.051. 
Meyer, P. A., S. Li, M. Zhang, K. Yamada, Y. Takagi, G. A. Hartzog, and J. Fu. 2015. 
"Structures and Functions of the Multiple KOW Domains of Transcription 
Elongation Factor Spt5."  Mol Cell Biol 35 (19):3354-69. doi: 10.1128/mcb.00520-
15. 
Mili, S., and J. A. Steitz. 2004. "Evidence for reassociation of RNA-binding proteins after cell 
lysis: implications for the interpretation of immunoprecipitation analyses."  RNA 10 
(11):1692-4. doi: 10.1261/rna.7151404. 
Miller, T., N. J. Krogan, J. Dover, H. Erdjument-Bromage, P. Tempst, M. Johnston, J. F. 
Greenblatt, and A. Shilatifard. 2001. "COMPASS: a complex of proteins associated 
with a trithorax-related SET domain protein."  Proc Natl Acad Sci U S A 98 
(23):12902-7. doi: 10.1073/pnas.231473398. 
Mischo, H. E., and N. J. Proudfoot. 2013. "Disengaging polymerase: terminating RNA 
polymerase II transcription in budding yeast."  Biochim Biophys Acta 1829 (1):174-
85. doi: 10.1016/j.bbagrm.2012.10.003. 
Missra, A., and D. S. Gilmour. 2010. "Interactions between DSIF (DRB sensitivity inducing 
factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II 
transcription elongation complex."  Proc Natl Acad Sci U S A 107 (25):11301-6. doi: 
10.1073/pnas.1000681107. 
Mitchell, P. J., and R. Tjian. 1989. "Transcriptional regulation in mammalian cells by 
sequence-specific DNA binding proteins."  Science 245 (4916):371-8. 
Moss, T., F. Langlois, T. Gagnon-Kugler, and V. Stefanovsky. 2007. "A housekeeper with 
power of attorney: the rRNA genes in ribosome biogenesis."  Cell Mol Life Sci 64 
(1):29-49. doi: 10.1007/s00018-006-6278-1. 
Muhlbacher, W., A. Mayer, M. Sun, M. Remmert, A. C. Cheung, J. Niesser, J. Söding, and P. 
Cramer. 2015. "Structure of Ctk3, a subunit of the RNA polymerase II CTD kinase 
References 
 99 
complex, reveals a noncanonical CTD-interacting domain fold."  Proteins 83 
(10):1849-58. doi: 10.1002/prot.24869. 
Mulder, K. W., A. B. Brenkman, A. Inagaki, N. J. van den Broek, and H. T. Timmers. 2007. 
"Regulation of histone H3K4 tri-methylation and PAF complex recruitment by the 
Ccr4-Not complex."  Nucleic Acids Res 35 (7):2428-39. doi: 10.1093/nar/gkm175. 
Murray, S., R. Udupa, S. Yao, G. Hartzog, and G. Prelich. 2001. "Phosphorylation of the 
RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase."  
Mol Cell Biol 21 (13):4089-96. doi: 10.1128/MCB.21.13.4089-4096.2001. 
Nakajima, N., M. Horikoshi, and R. G. Roeder. 1988. "Factors involved in specific 
transcription by mammalian RNA polymerase II: purification, genetic specificity, and 
TATA box-promoter interactions of TFIID."  Mol Cell Biol 8 (10):4028-40. 
Nechaev, S., and K. Adelman. 2011. "Pol II waiting in the starting gates: Regulating the 
transition from transcription initiation into productive elongation."  Biochim Biophys 
Acta 1809 (1):34-45. doi: 10.1016/j.bbagrm.2010.11.001. 
Ng, H. H., F. Robert, R. A. Young, and K. Struhl. 2003. "Targeted recruitment of Set1 
histone methylase by elongating Pol II provides a localized mark and memory of 
recent transcriptional activity."  Mol Cell 11 (3):709-19. 
Nguyen, A. T., and Y. Zhang. 2011. "The diverse functions of Dot1 and H3K79 methylation."  
Genes Dev 25 (13):1345-58. doi: 10.1101/gad.2057811. 
Ni, Z., A. Saunders, N. J. Fuda, J. Yao, J. R. Suarez, W. W. Webb, and J. T. Lis. 2008. "P-
TEFb is critical for the maturation of RNA polymerase II into productive elongation 
in vivo."  Mol Cell Biol 28 (3):1161-70. doi: 10.1128/MCB.01859-07. 
Orphanides, G., and D. Reinberg. 2000. "RNA polymerase II elongation through chromatin."  
Nature 407 (6803):471-5. doi: 10.1038/35035000. 
Orphanides, G., and D. Reinberg. 2002. "A unified theory of gene expression."  Cell 108 
(4):439-51. 
Pal, M., A. S. Ponticelli, and D. S. Luse. 2005. "The role of the transcription bubble and 
TFIIB in promoter clearance by RNA polymerase II."  Mol Cell 19 (1):101-10. doi: 
10.1016/j.molcel.2005.05.024. 
Parker, C. S., and J. Topol. 1984. "A Drosophila RNA polymerase II transcription factor 
binds to the regulatory site of an hsp 70 gene."  Cell 37 (1):273-83. 
Patturajan, M., N. K. Conrad, D. B. Bregman, and J. L. Corden. 1999. "Yeast carboxyl-
terminal domain kinase I positively and negatively regulates RNA polymerase II 
carboxyl-terminal domain phosphorylation."  J Biol Chem 274 (39):27823-8. 
Pelechano, V., W. Wei, and L. M. Steinmetz. 2013. "Extensive transcriptional heterogeneity 
revealed by isoform profiling."  Nature 497 (7447):127-31. doi: 
10.1038/nature12121. 
Pelham, H. R. 1982. "A regulatory upstream promoter element in the Drosophila hsp 70 heat-
shock gene."  Cell 30 (2):517-28. 
References 
 100 
Perales, R., and D. Bentley. 2009. ""Cotranscriptionality": the transcription elongation 
complex as a nexus for nuclear transactions."  Mol Cell 36 (2):178-91. doi: 
10.1016/j.molcel.2009.09.018. 
Peterlin, B. M., and D. H. Price. 2006. "Controlling the elongation phase of transcription with 
P-TEFb."  Mol Cell 23 (3):297-305. doi: 10.1016/j.molcel.2006.06.014. 
Phatnani, H. P., J. C. Jones, and A. L. Greenleaf. 2004. "Expanding the functional repertoire 
of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in 
the yeast proteome."  Biochemistry 43 (50):15702-19. doi: 10.1021/bi048364h. 
Pijnappel, W. W., D. Schaft, A. Roguev, A. Shevchenko, H. Tekotte, M. Wilm, G. Rigaut, B. 
Seraphin, R. Aasland, and A. F. Stewart. 2001. "The S. cerevisiae SET3 complex 
includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor 
of the sporulation gene program."  Genes Dev 15 (22):2991-3004. doi: 
10.1101/gad.207401. 
Pikaard, C. S., J. R. Haag, T. Ream, and A. T. Wierzbicki. 2008. "Roles of RNA polymerase 
IV in gene silencing."  Trends Plant Sci 13 (7):390-7. doi: 
10.1016/j.tplants.2008.04.008. 
Plaschka, C., M. Hantsche, C. Dienemann, C. Burzinski, J. Plitzko, and P. Cramer. 2016. 
"Transcription initiation complex structures elucidate DNA opening."  Nature 533 
(7603):353-8. doi: 10.1038/nature17990. 
Plaschka, C., L. Lariviere, L. Wenzeck, M. Seizl, M. Hemann, D. Tegunov, E. V. 
Petrotchenko, C. H. Borchers, W. Baumeister, F. Herzog, E. Villa, and P. Cramer. 
2015. "Architecture of the RNA polymerase II-Mediator core initiation complex."  
Nature 518 (7539):376-80. doi: 10.1038/nature14229. 
Pokholok, D. K., N. M. Hannett, and R. A. Young. 2002. "Exchange of RNA polymerase II 
initiation and elongation factors during gene expression in vivo."  Mol Cell 9 (4):799-
809. 
Pokholok, D. K., C. T. Harbison, S. Levine, M. Cole, N. M. Hannett, T. I. Lee, G. W. Bell, K. 
Walker, P. A. Rolfe, E. Herbolsheimer, J. Zeitlinger, F. Lewitter, D. K. Gifford, and 
R. A. Young. 2005. "Genome-wide map of nucleosome acetylation and methylation 
in yeast."  Cell 122 (4):517-27. doi: 10.1016/j.cell.2005.06.026. 
Porrua, O., and D. Libri. 2015. "Transcription termination and the control of the 
transcriptome: why, where and how to stop."  Nat Rev Mol Cell Biol 16 (3):190-202. 
doi: 10.1038/nrm3943. 
Proudfoot, N. J. 1989. "How RNA polymerase II terminates transcription in higher 
eukaryotes."  Trends Biochem Sci 14 (3):105-10. 
Proudfoot, N. J. 2011. "Ending the message: poly(A) signals then and now."  Genes Dev 25 
(17):1770-82. doi: 10.1101/gad.17268411. 
Qin, D., L. Huang, A. Wlodaver, J. Andrade, and J. P. Staley. 2016. "Sequencing of lariat 
termini in S. cerevisiae reveals 5' splice sites, branch points, and novel splicing 
events."  Rna 22 (2):237-53. doi: 10.1261/rna.052829.115. 
References 
 101 
Qiu, H., C. Hu, N. A. Gaur, and A. G. Hinnebusch. 2012. "Pol II CTD kinases Bur1 and 
Kin28 promote Spt5 CTR-independent recruitment of Paf1 complex."  EMBO J 31 
(16):3494-505. doi: 10.1038/emboj.2012.188. 
Qiu, H., C. Hu, and A. G. Hinnebusch. 2009. "Phosphorylation of the Pol II CTD by KIN28 
enhances BUR1/BUR2 recruitment and Ser2 CTD phosphorylation near promoters."  
Mol Cell 33 (6):752-62. doi: 10.1016/j.molcel.2009.02.018. 
Qiu, H., C. Hu, C. M. Wong, and A. G. Hinnebusch. 2006. "The Spt4p subunit of yeast DSIF 
stimulates association of the Paf1 complex with elongating RNA polymerase II."  
Mol Cell Biol 26 (8):3135-48. doi: 10.1128/MCB.26.8.3135-3148.2006. 
Quinlan, A. R., and I. M. Hall. 2010. "BEDTools: a flexible suite of utilities for comparing 
genomic features."  Bioinformatics 26 (6):841-2. doi: 10.1093/bioinformatics/btq033. 
Rahl, P. B., C. Y. Lin, A. C. Seila, R. A. Flynn, S. McCuine, C. B. Burge, P. A. Sharp, and R. 
A. Young. 2010. "c-Myc regulates transcriptional pause release."  Cell 141 (3):432-
45. doi: 10.1016/j.cell.2010.03.030. 
Ramanathan, Y., S. M. Rajpara, S. M. Reza, E. Lees, S. Shuman, M. B. Mathews, and T. 
Pe'ery. 2001. "Three RNA polymerase II carboxyl-terminal domain kinases display 
distinct substrate preferences."  J Biol Chem 276 (14):10913-20. doi: 
10.1074/jbc.M010975200. 
Ramirez, F., F. Dundar, S. Diehl, B. A. Gruning, and T. Manke. 2014. "deepTools: a flexible 
platform for exploring deep-sequencing data."  Nucleic Acids Res 42 (Web Server 
issue):W187-91. doi: 10.1093/nar/gku365. 
Richard, P., and J. L. Manley. 2009. "Transcription termination by nuclear RNA 
polymerases."  Genes Dev 23 (11):1247-69. doi: 10.1101/gad.1792809. 
Robzyk, K., J. Recht, and M. A. Osley. 2000. "Rad6-dependent ubiquitination of histone H2B 
in yeast."  Science 287 (5452):501-4. 
Rodriguez, C. R., E. J. Cho, M. C. Keogh, C. L. Moore, A. L. Greenleaf, and S. Buratowski. 
2000. "Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the 
recruitment of mRNA processing machinery to RNA polymerase II."  Mol Cell Biol 
20 (1):104-12. 
Sainsbury, S., C. Bernecky, and P. Cramer. 2015. "Structural basis of transcription initiation 
by RNA polymerase II."  Nat Rev Mol Cell Biol 16 (3):129-43. doi: 
10.1038/nrm3952. 
Saldi, T., M. A. Cortazar, R. M. Sheridan, and D. L. Bentley. 2016. "Coupling of RNA 
Polymerase II Transcription Elongation with Pre-mRNA Splicing."  J Mol Biol. doi: 
10.1016/j.jmb.2016.04.017. 
Schroder, S., E. Herker, F. Itzen, D. He, S. Thomas, D. A. Gilchrist, K. Kaehlcke, S. Cho, K. 
S. Pollard, J. A. Capra, M. Schnolzer, P. A. Cole, M. Geyer, B. G. Bruneau, K. 
Adelman, and M. Ott. 2013. "Acetylation of RNA polymerase II regulates growth-
factor-induced gene transcription in mammalian cells."  Mol Cell 52 (3):314-24. doi: 
10.1016/j.molcel.2013.10.009. 
References 
 102 
Schroeder, S. C., B. Schwer, S. Shuman, and D. Bentley. 2000. "Dynamic association of 
capping enzymes with transcribing RNA polymerase II."  Genes Dev 14 (19):2435-
40. 
Schulz, D., B. Schwalb, A. Kiesel, C. Baejen, P. Torkler, J. Gagneur, J. Söding, and P. 
Cramer. 2013. "Transcriptome surveillance by selective termination of noncoding 
RNA synthesis."  Cell 155 (5):1075-87. doi: 10.1016/j.cell.2013.10.024. 
Schwalb, B., M. Michel, B. Zacher, K. Fruhauf, C. Demel, A. Tresch, J. Gagneur, and P. 
Cramer. 2016. "TT-seq maps the human transient transcriptome."  Science 352 
(6290):1225-8. doi: 10.1126/science.aad9841. 
Schwer, B., X. Mao, and S. Shuman. 1998. "Accelerated mRNA decay in conditional mutants 
of yeast mRNA capping enzyme."  Nucleic Acids Res 26 (9):2050-7. 
Schwer, B., and S. Shuman. 1996. "Conditional inactivation of mRNA capping enzyme 
affects yeast pre-mRNA splicing in vivo."  RNA 2 (6):574-83. 
Schwer, B., and S. Shuman. 2011. "Deciphering the RNA polymerase II CTD code in fission 
yeast."  Mol Cell 43 (2):311-8. doi: 10.1016/j.molcel.2011.05.024. 
Schwinghammer, K., A. C. Cheung, Y. I. Morozov, K. Agaronyan, D. Temiakov, and P. 
Cramer. 2013. "Structure of human mitochondrial RNA polymerase elongation 
complex."  Nat Struct Mol Biol 20 (11):1298-303. doi: 10.1038/nsmb.2683. 
Shi, X., I. Kachirskaia, K. L. Walter, J. H. Kuo, A. Lake, F. Davrazou, S. M. Chan, D. G. 
Martin, I. M. Fingerman, S. D. Briggs, L. Howe, P. J. Utz, T. G. Kutateladze, A. A. 
Lugovskoy, M. T. Bedford, and O. Gozani. 2007. "Proteome-wide analysis in 
Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective 
binding modules of histone H3 methylated at either lysine 4 or lysine 36."  J Biol 
Chem 282 (4):2450-5. doi: 10.1074/jbc.C600286200. 
Shi, Y., and J. L. Manley. 2015. "The end of the message: multiple protein-RNA interactions 
define the mRNA polyadenylation site."  Genes Dev 29 (9):889-97. doi: 
10.1101/gad.261974.115. 
Shilatifard, A. 2004. "Transcriptional elongation control by RNA polymerase II: a new 
frontier."  Biochim Biophys Acta 1677 (1-3):79-86. doi: 
10.1016/j.bbaexp.2003.11.013. 
Shilatifard, A., R. C. Conaway, and J. W. Conaway. 2003. "The RNA polymerase II 
elongation complex."  Annu Rev Biochem 72:693-715. doi: 
10.1146/annurev.biochem.72.121801.161551. 
Sigova, A. A., B. J. Abraham, X. Ji, B. Molinie, N. M. Hannett, Y. E. Guo, M. Jangi, C. C. 
Giallourakis, P. A. Sharp, and R. A. Young. 2015. "Transcription factor trapping by 
RNA in gene regulatory elements."  Science 350 (6263):978-81. doi: 
10.1126/science.aad3346. 
Sims, R. J., 3rd, R. Belotserkovskaya, and D. Reinberg. 2004. "Elongation by RNA 
polymerase II: the short and long of it."  Genes Dev 18 (20):2437-68. doi: 
10.1101/gad.1235904. 
References 
 103 
Singh, R. K., M. Gonzalez, M. H. Kabbaj, and A. Gunjan. 2012. "Novel E3 ubiquitin ligases 
that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae."  
PLoS One 7 (5):e36295. doi: 10.1371/journal.pone.0036295. 
Skalska, L., M. Beltran-Nebot, J. Ule, and R. G. Jenner. 2017. "Regulatory feedback from 
nascent RNA to chromatin and transcription."  Nat Rev Mol Cell Biol. doi: 
10.1038/nrm.2017.12. 
Smolle, M., S. Venkatesh, M. M. Gogol, H. Li, Y. Zhang, L. Florens, M. P. Washburn, and J. 
L. Workman. 2012. "Chromatin remodelers Isw1 and Chd1 maintain chromatin 
structure during transcription by preventing histone exchange."  Nat Struct Mol Biol 
19 (9):884-92. doi: 10.1038/nsmb.2312. 
Smolle, M., and J. L. Workman. 2013. "Transcription-associated histone modifications and 
cryptic transcription."  Biochim Biophys Acta 1829 (1):84-97. doi: 
10.1016/j.bbagrm.2012.08.008. 
Söding, J., A. Biegert, and A. N. Lupas. 2005. "The HHpred interactive server for protein 
homology detection and structure prediction."  Nucleic Acids Res 33 (Web Server 
issue):W244-8. doi: 10.1093/nar/gki408. 
Sogaard, T. M., and J. Q. Svejstrup. 2007. "Hyperphosphorylation of the C-terminal repeat 
domain of RNA polymerase II facilitates dissociation of its complex with mediator."  
J Biol Chem 282 (19):14113-20. doi: 10.1074/jbc.M701345200. 
Sonenberg, N., and A. G. Hinnebusch. 2009. "Regulation of translation initiation in 
eukaryotes: mechanisms and biological targets."  Cell 136 (4):731-45. doi: 
10.1016/j.cell.2009.01.042. 
Steinmetz, E. J., and D. A. Brow. 1996. "Repression of gene expression by an exogenous 
sequence element acting in concert with a heterogeneous nuclear ribonucleoprotein-
like protein, Nrd1, and the putative helicase Sen1."  Mol Cell Biol 16 (12):6993-7003. 
Sterner, D. E., J. M. Lee, S. E. Hardin, and A. L. Greenleaf. 1995. "The yeast carboxyl-
terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase 
complex."  Mol Cell Biol 15 (10):5716-24. 
Sun, M., L. Lariviere, S. Dengl, A. Mayer, and P. Cramer. 2010. "A tandem SH2 domain in 
transcription elongation factor Spt6 binds the phosphorylated RNA polymerase II C-
terminal repeat domain (CTD)."  J Biol Chem 285 (53):41597-603. doi: 
10.1074/jbc.M110.144568. 
Sun, M., B. Schwalb, D. Schulz, N. Pirkl, S. Etzold, L. Lariviere, K. C. Maier, M. Seizl, A. 
Tresch, and P. Cramer. 2012. "Comparative dynamic transcriptome analysis (cDTA) 
reveals mutual feedback between mRNA synthesis and degradation."  Genome Res 22 
(7):1350-9. doi: 10.1101/gr.130161.111. 
Tennyson, C. N., H. J. Klamut, and R. G. Worton. 1995. "The human dystrophin gene 
requires 16 hours to be transcribed and is cotranscriptionally spliced."  Nat Genet 9 
(2):184-90. doi: 10.1038/ng0295-184. 
Terzi, N., L. S. Churchman, L. Vasiljeva, J. Weissman, and S. Buratowski. 2011. "H3K4 
trimethylation by Set1 promotes efficient termination by the Nrd1-Nab3-Sen1 
pathway."  Mol Cell Biol 31 (17):3569-83. doi: 10.1128/MCB.05590-11. 
References 
 104 
Thomas, M. C., and C. M. Chiang. 2006. "The general transcription machinery and general 
cofactors."  Crit Rev Biochem Mol Biol 41 (3):105-78. doi: 
10.1080/10409230600648736. 
Tietjen, J. R., D. W. Zhang, J. B. Rodriguez-Molina, B. E. White, M. S. Akhtar, M. 
Heidemann, X. Li, R. D. Chapman, K. Shokat, S. Keles, D. Eick, and A. Z. Ansari. 
2010. "Chemical-genomic dissection of the CTD code."  Nat Struct Mol Biol 17 
(9):1154-61. doi: 10.1038/nsmb.1900. 
Tresaugues, L., P. M. Dehe, R. Guerois, A. Rodriguez-Gil, I. Varlet, P. Salah, M. Pamblanco, 
P. Luciano, S. Quevillon-Cheruel, J. Sollier, N. Leulliot, J. Couprie, V. Tordera, S. 
Zinn-Justin, S. Chavez, H. van Tilbeurgh, and V. Geli. 2006. "Structural 
characterization of Set1 RNA recognition motifs and their role in histone H3 lysine 4 
methylation."  J Mol Biol 359 (5):1170-81. doi: 10.1016/j.jmb.2006.04.050. 
Tsukada, Y., J. Fang, H. Erdjument-Bromage, M. E. Warren, C. H. Borchers, P. Tempst, and 
Y. Zhang. 2006. "Histone demethylation by a family of JmjC domain-containing 
proteins."  Nature 439 (7078):811-6. doi: 10.1038/nature04433. 
Tuck, A. C., and D. Tollervey. 2013. "A transcriptome-wide atlas of RNP composition 
reveals diverse classes of mRNAs and lncRNAs."  Cell 154 (5):996-1009. doi: 
10.1016/j.cell.2013.07.047. 
Ule, J., K. B. Jensen, M. Ruggiu, A. Mele, A. Ule, and R. B. Darnell. 2003. "CLIP identifies 
Nova-regulated RNA networks in the brain."  Science 302 (5648):1212-5. doi: 
10.1126/science.1090095. 
Vasiljeva, L., M. Kim, H. Mutschler, S. Buratowski, and A. Meinhart. 2008. "The Nrd1-
Nab3-Sen1 termination complex interacts with the Ser5-phosphorylated RNA 
polymerase II C-terminal domain."  Nat Struct Mol Biol 15 (8):795-804. doi: 
10.1038/nsmb.1468. 
Venema, J., and D. Tollervey. 1999. "Ribosome synthesis in Saccharomyces cerevisiae."  
Annu Rev Genet 33:261-311. doi: 10.1146/annurev.genet.33.1.261. 
Villard, J. 2004. "Transcription regulation and human diseases."  Swiss Med Wkly 134 (39-
40):571-9. doi: 2004/39/smw-10191. 
Wang, D., D. A. Bushnell, K. D. Westover, C. D. Kaplan, and R. D. Kornberg. 2006. 
"Structural basis of transcription: role of the trigger loop in substrate specificity and 
catalysis."  Cell 127 (5):941-54. doi: 10.1016/j.cell.2006.11.023. 
Wang, G., X. Tong, S. Weng, and H. Zhou. 2012. "Multiple phosphorylation of Rad9 by 
CDK is required for DNA damage checkpoint activation."  Cell Cycle 11 (20):3792-
800. doi: 10.4161/cc.21987. 
Wang, K. C., Y. W. Yang, B. Liu, A. Sanyal, R. Corces-Zimmerman, Y. Chen, B. R. Lajoie, 
A. Protacio, R. A. Flynn, R. A. Gupta, J. Wysocka, M. Lei, J. Dekker, J. A. Helms, 
and H. Y. Chang. 2011. "A long noncoding RNA maintains active chromatin to 
coordinate homeotic gene expression."  Nature 472 (7341):120-4. doi: 
10.1038/nature09819. 
Wang, W., M. Carey, and J. D. Gralla. 1992. "Polymerase II promoter activation: closed 
complex formation and ATP-driven start site opening."  Science 255 (5043):450-3. 
References 
 105 
Wei, C. M., and B. Moss. 1975. "Methylated nucleotides block 5'-terminus of vaccinia virus 
messenger RNA."  Proc Natl Acad Sci U S A 72 (1):318-22. 
Wei, C., and B. Moss. 1977. "5'-Terminal capping of RNA by guanylyltransferase from HeLa 
cell nuclei."  Proc Natl Acad Sci U S A 74 (9):3758-61. 
Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. "A novel CDK9-
associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-
affinity, loop-specific binding to TAR RNA."  Cell 92 (4):451-62. 
Weiner, A., T. H. Hsieh, A. Appleboim, H. V. Chen, A. Rahat, I. Amit, O. J. Rando, and N. 
Friedman. 2015. "High-resolution chromatin dynamics during a yeast stress 
response."  Mol Cell 58 (2):371-86. doi: 10.1016/j.molcel.2015.02.002. 
Westover, K. D., D. A. Bushnell, and R. D. Kornberg. 2004. "Structural basis of transcription: 
nucleotide selection by rotation in the RNA polymerase II active center."  Cell 119 
(4):481-9. doi: 10.1016/j.cell.2004.10.016. 
White, R. J. 2011. "Transcription by RNA polymerase III: more complex than we thought."  
Nat Rev Genet 12 (7):459-63. doi: 10.1038/nrg3001. 
Wier, A. D., M. K. Mayekar, A. Heroux, K. M. Arndt, and A. P. VanDemark. 2013. 
"Structural basis for Spt5-mediated recruitment of the Paf1 complex to chromatin."  
Proc Natl Acad Sci U S A 110 (43):17290-5. doi: 10.1073/pnas.1314754110. 
Wood, A., N. J. Krogan, J. Dover, J. Schneider, J. Heidt, M. A. Boateng, K. Dean, A. 
Golshani, Y. Zhang, J. F. Greenblatt, M. Johnston, and A. Shilatifard. 2003. "Bre1, an 
E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a 
promoter."  Mol Cell 11 (1):267-74. 
Wyers, F., M. Rougemaille, G. Badis, J. C. Rousselle, M. E. Dufour, J. Boulay, B. Regnault, 
F. Devaux, A. Namane, B. Seraphin, D. Libri, and A. Jacquier. 2005. "Cryptic pol II 
transcripts are degraded by a nuclear quality control pathway involving a new 
poly(A) polymerase."  Cell 121 (5):725-37. doi: 10.1016/j.cell.2005.04.030. 
Xu, Z., W. Wei, J. Gagneur, F. Perocchi, S. Clauder-Munster, J. Camblong, E. Guffanti, F. 
Stutz, W. Huber, and L. M. Steinmetz. 2009. "Bidirectional promoters generate 
pervasive transcription in yeast."  Nature 457 (7232):1033-7. doi: 
10.1038/nature07728. 
Yang, Y. W., R. A. Flynn, Y. Chen, K. Qu, B. Wan, K. C. Wang, M. Lei, and H. Y. Chang. 
2014. "Essential role of lncRNA binding for WDR5 maintenance of active chromatin 
and embryonic stem cell pluripotency."  Elife 3:e02046. doi: 10.7554/eLife.02046. 
Yoh, S. M., H. Cho, L. Pickle, R. M. Evans, and K. A. Jones. 2007. "The Spt6 SH2 domain 
binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export."  Genes 
Dev 21 (2):160-74. doi: 10.1101/gad.1503107. 
Youdell, M. L., K. O. Kizer, E. Kisseleva-Romanova, S. M. Fuchs, E. Duro, B. D. Strahl, and 
J. Mellor. 2008. "Roles for Ctk1 and Spt6 in regulating the different methylation 
states of histone H3 lysine 36."  Mol Cell Biol 28 (16):4915-26. doi: 
10.1128/MCB.00001-08. 
Yudkovsky, N., J. A. Ranish, and S. Hahn. 2000. "A transcription reinitiation intermediate 
that is stabilized by activator."  Nature 408 (6809):225-9. doi: 10.1038/35041603. 
References 
 106 
Zhao, J., T. K. Ohsumi, J. T. Kung, Y. Ogawa, D. J. Grau, K. Sarma, J. J. Song, R. E. 
Kingston, M. Borowsky, and J. T. Lee. 2010. "Genome-wide identification of 
polycomb-associated RNAs by RIP-seq."  Mol Cell 40 (6):939-53. doi: 
10.1016/j.molcel.2010.12.011. 
Zhou, K., W. H. Kuo, J. Fillingham, and J. F. Greenblatt. 2009. "Control of transcriptional 
elongation and cotranscriptional histone modification by the yeast BUR kinase 
substrate Spt5."  Proc Natl Acad Sci U S A 106 (17):6956-61. doi: 
10.1073/pnas.0806302106. 
Zhou, Q., T. Li, and D. H. Price. 2012. "RNA polymerase II elongation control."  Annu Rev 
Biochem 81:119-43. doi: 10.1146/annurev-biochem-052610-095910. 
Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. 
Mathews, and D. H. Price. 1997. "Transcription elongation factor P-TEFb is required 
for HIV-1 tat transactivation in vitro."  Genes Dev 11 (20):2622-32. 
 
  
Abbreviations 
	
 107 
Abbreviations 
AA Anchor-away 
4sU 4-thiouridine 
4tU 4-thiouracil 
A Adenine, adenosine 
ADH1 Alcohol Dehydrogenase gene 
ALD5 Aldehyde Dehydrogenase gene 
ATP Adenosine triphosphate  
bp Base pairs 
BSA Bovine serum albumin  
BUR Bypass UAS Requirement 
C Cytosine, Cytidine 
Cdc73 Cell Division Cycle 
CDK Cyclin-dependent kinase  
CF Cleavage factor 
ChIP Chromatin immunoprecipitation 
CPF Cleavage and polyadenylation factor  
CSM Complete Supplement Mixture 
Ct Cycle threshold 
CTD Carboxy terminal domain (of Pol II)  
CTDK CTD Kinase 
CTR Carboxy terminal repeat (of Spt5) 
Ctr9 Cln Three (CLN3) Requiring 
CUTs Cryptic unstable transcripts  
DMSO Dimethyl sulfoxide  
dCTP Deoxycytidine triphosphate 
dGTP Deoxyguanosine triphosphate 
dNTP Deoxynucleoside triphosphate  
Dot1 Disruptor Of Telomeric silencing 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid  
EF Elongation factor 
eRNA Enhancer RNA 
fwd Forward primer 
G Guanine, guanosine 
GST Glutathion-S-Transferase  
GTF General transcription factor 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP Horseradish peroxidase  
IgG Immunoglobulin G 
ILV5 IsoLeucine-plus-Valine requiring gene 
K Lysine  
kb Kilo base pairs 
Kd,app Apparent disassociation constant 
kDa Kilodalton 
KO Knockout 
LB Luria-Bertani media  
Leo1 LEft Open reading frame 
LIC Ligation independent cloning 
lncRNA Long non-coding RNA  
m7G 7-methyl-guanosine 
MBP Maltose binding protein 
m/s Meter per second 
mRNA Messenger RNA  
MUP1  Methionine Uptake gene 
ncRNA Non-coding RNA 
NP-40 Nonyl phenoxypolyethoxylethanol  
nt Nucleotide 
Abbreviations 
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OD600 Optical density at 600 nm wavelength  
ORF Open reading frame 
pA Polyadenylation 
Paf1C Polymerase associated factor 1 complex 
PAR-CLIP Photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation 
PBS Phosphate buffered saline  
PCR Polymerase chain reaction 
PDC1 Pyruvate Decarboxylase gene 
PEG Polyethylene glycol 
PI Processing index 
PIC Preinitiation complex  
PMA1 Plasma Membrane ATPase gene 
PMSF  Phenylmethylsulfonyl fluoride 
PNK Polynucleotide kinase 
Pol Polymerase 
Prom. Promoter 
PVDF polyvinylidene difluoride 
qPCR Quantitative real-time PCR 
rev Reverse primer 
rpm Rotations per minute  
RRM RNA recognition motif  
rRNA Ribosomal RNA  
RT Room temperature or reverse transcription 
Rtf1 Restores TBP Function 
S. cerevisiae Saccharomyces cerevisiae 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SE Size exclusion 
-Seq Deep-sequencing  
Ser2-P, Ser5-P  Serine 2, Serine 5 phosphorylation  
SET Su(var)3-9, Enhancer-of-zeste and Trithorax 
snRNA Small nuclear RNA    
snoRNA Small nucleolar RNA 
Spt SuPpressor of Ty's 
T Thymine, thymidine 
TAE Tris-acetate-EDTA 
TAP Tandem affinity purification 
TBS Tris-buffered saline  
TCA Trichloroacetic acid  
TEV Tobacco etch virus 
tRNA Transfer RNA 
TSS Transcription start site  
Tris Tris-(hydroxymethyl)-aminomethan  
Tyr1-P Tyrosine 1 phosphorylation 
U Uracil, uridine 
UAS Upstream activating sequence 
yORF Your ORF 
YPD Yeast extract – peptone – dextrose (glucose) media  
v/v %   Volume/volume percent  
w/v % Weight/volume percent  
 
 
